Amedeo Smart

Free Medical Literature Service


 

Amedeo

COVID-19

  Free Subscription

Articles published in
J Med Virol
    November 2021
  1. TANI-SASSA C, Iwasaki Y, Ichimura N, Nagano K, et al
    Viral loads and profile of the patients infected with SARS-CoV-2 Delta, Alpha or R.1 variants in Tokyo.
    J Med Virol. 2021 Nov 26. doi: 10.1002/jmv.27479.
    >> Share

  2. MAAN HS, Chaurasia D, Kapoor G, Dave L, et al
    Intestinal viral infections of nSARS-CoV2 in the Indian community; Risk of virus spread in India.
    J Med Virol. 2021 Nov 26. doi: 10.1002/jmv.27480.
    >> Share

  3. FALLAHZADEH M, Pourhoseingholi MA, Boroujeni MG, Besharati S, et al
    Study of the Effects of Interferon beta-1a on Hospitalized Patients with COVID-19; SBMU Taskforce on the COVIFERON Study.
    J Med Virol. 2021 Nov 25. doi: 10.1002/jmv.27475.
    >> Share

  4. NIA MH, Rokni M, Mirinejad S, Kargar M, et al
    Association of polymorphisms in tumor necrosis factors with SARS-CoV-2 infection and mortality rate: a case-control study and in silico analyses.
    J Med Virol. 2021 Nov 25. doi: 10.1002/jmv.27477.
    >> Share

  5. YU J, Sun S, Tang Q, Wang C, et al
    Establish reference sequences for each clade of SARS-CoV-2 to provide a basis for virus variation and function research.
    J Med Virol. 2021 Nov 25. doi: 10.1002/jmv.27476.
    >> Share

  6. MARSICO C, Capretti MG, Aceti A, Vocale C, et al
    Severe neonatal COVID-19: challenges in management and therapeutic approach.
    J Med Virol. 2021 Nov 23. doi: 10.1002/jmv.27472.
    >> Share

  7. MALTEZOU HC, Krumbholz B, Mavrouli M, Tseroni M, et al
    A study of the evolution of the third COVID-19 pandemic wave in the Athens metropolitan area, Greece, through two cross-sectional seroepidemiological surveys: March, June 2021.
    J Med Virol. 2021 Nov 23. doi: 10.1002/jmv.27465.
    >> Share

  8. KUMAR A, Parashar R, Kumar S, Faiq MA, et al
    Emerging SARS-CoV-2 variants can potentially break set epidemiological barriers in COVID-19.
    J Med Virol. 2021 Nov 23. doi: 10.1002/jmv.27467.
    >> Share

  9. LABRIOLA L, Ruelle J, Scohy A, Seghers F, et al
    Dynamics of spreading of SARS-CoV-2 in a Belgian hemodialysis facility: the importance of the analysis of viral strains.
    J Med Virol. 2021 Nov 23. doi: 10.1002/jmv.27471.
    >> Share

  10. OZER M, Goksu SY, Conception R, Ulker E, et al
    Effectiveness and Safety of Ivermectin in COVID-19 Patients: A Prospective Study at A Safety-Net Hospital.
    J Med Virol. 2021 Nov 23. doi: 10.1002/jmv.27469.
    >> Share

  11. NAGHASHPOUR M, Ghiassian H, Mobarak S, Adelipour M, et al
    Profiling serum levels of glutathione reductase and interleukin-10 in positive and negative-PCR COVID-19 outpatients: a comparative study from southwestern Iran.
    J Med Virol. 2021 Nov 20. doi: 10.1002/jmv.27464.
    >> Share

  12. RASHEDI R, Samieefar N, Masoumi N, Mohseni S, et al
    COVID-19 vaccines Mix-and-Match: The Concept, the Efficacy and the Doubts.
    J Med Virol. 2021 Nov 19. doi: 10.1002/jmv.27463.
    >> Share

  13. GARCIA-SALGUERO C, Culebras E, Merino P, Baos E, et al
    Usefulness of SARS-CoV-2 Antigen Test Sample as input for SARS-CoV-2 RT-PCR analysis.
    J Med Virol. 2021 Nov 16. doi: 10.1002/jmv.27459.
    >> Share

  14. VALIAN NK, Pourakbari B, Ashari KA, Sadeghi RH, et al
    Evaluation of human coronavirus OC43 and SARS-COV-2 in children with respiratory tract infection during the COVID-19 pandemic.
    J Med Virol. 2021 Nov 16. doi: 10.1002/jmv.27460.
    >> Share

  15. SINGH UB, Rophina M, Chaudhry R, Senthivel V, et al
    Variants of Concern responsible for SARS-CoV-2 vaccine breakthrough infections from India.
    J Med Virol. 2021 Nov 16. doi: 10.1002/jmv.27461.
    >> Share

  16. CHANDAN S, Khan SR, Deliwala S, Mohan BP, et al
    Postvaccination SARS-CoV-2 infection among healthcare workers - A Systematic Review and meta-analysis.
    J Med Virol. 2021 Nov 15. doi: 10.1002/jmv.27457.
    >> Share

  17. SIVAN M, Parkin A, Makower S, Greenwood DC, et al
    Post-COVID Syndrome symptoms, functional disability and clinical severity phenotypes in hospitalised and non-hospitalised individuals: a cross-sectional evaluation from a community COVID rehabilitation service.
    J Med Virol. 2021 Nov 15. doi: 10.1002/jmv.27456.
    >> Share

  18. BENJAMANUKUL S, Traiyan S, Yorsaeng R, Vichaiwattana P, et al
    Safety and immunogenicity of inactivated COVID-19 vaccine in health care workers.
    J Med Virol. 2021 Nov 15. doi: 10.1002/jmv.27458.
    >> Share

  19. LIU K, Yang X, Feng C, Chen M, et al
    Clinical features and independent predictors for recurrence of positive SARS-CoV-2 RNA: A propensity score-matched analysis.
    J Med Virol. 2021 Nov 12. doi: 10.1002/jmv.27450.
    >> Share

  20. ANGELETTI S, Giovanetti M, Fogolari M, Cella E, et al
    SARS-CoV-2 AY.4.2 variant circulating in Italy: Genomic preliminary insight.
    J Med Virol. 2021 Nov 12. doi: 10.1002/jmv.27451.
    >> Share

  21. OZGOCER T, Dagli SN, Ceylan MR, Disli F, et al
    Analysis of long-term antibody response in COVID-19 patients by symptoms grade, gender, age, BMI, and medication.
    J Med Virol. 2021 Nov 12. doi: 10.1002/jmv.27452.
    >> Share

  22. SONG J, Li C, Rivailler P, Wang H, et al
    Molecular evolution and genomic characteristics of genotype H1 of measles virus.
    J Med Virol. 2021 Nov 11. doi: 10.1002/jmv.27448.
    >> Share

  23. FORERO-PENA DA, Carrion-Nessi FS, Mendoza-Millan DL, Omana-Avila OD, et al
    First wave of COVID-19 in Venezuela: Epidemiological, clinical, and paraclinical characteristics of first cases.
    J Med Virol. 2021 Nov 11. doi: 10.1002/jmv.27449.
    >> Share

  24. SAM IC, Chong YM, Abdullah A, Fu JYL, et al
    Changing predominant SARS-CoV-2 lineages drive successive COVID-19 waves in Malaysia, February 2020 to March 2021.
    J Med Virol. 2021 Nov 10. doi: 10.1002/jmv.27441.
    >> Share

  25. LEROUX X, Schock M, Augereau O, Lessire H, et al
    Factors associated with mechanical ventilation in SARS-CoV-2 patients treated with high flow nasal cannula oxygen and outcomes.
    J Med Virol. 2021 Nov 9. doi: 10.1002/jmv.27442.
    >> Share

  26. BRONSTEIN Y, Adler A, Katash H, Halutz O, et al
    Evolution of spike mutations following antibody treatment in two immunocompromised patients with persistent COVID-19 infection.
    J Med Virol. 2021 Nov 9. doi: 10.1002/jmv.27445.
    >> Share

  27. BARRERA-AVALOS C, Luraschi R, Vallejos-Vidal E, Figueroa M, et al
    ANALYSIS BY REAL-TIME PCR OF FIVE TRANSPORT AND CONSERVATION MEDIUM OF NASOPHARYNGEAL SWAB SAMPLES TO COVID-19 DIAGNOSIS IN SANTIAGO OF CHILE.
    J Med Virol. 2021 Nov 9. doi: 10.1002/jmv.27446.
    >> Share

  28. KERBAGE A, Haddad S, Nasr L, Riachy A, et al
    Impact of ABO and Rhesus Blood Groups on COVID-19 Susceptibility and Severity: A Case-control Study.
    J Med Virol. 2021 Nov 9. doi: 10.1002/jmv.27444.
    >> Share

  29. FORERO-PENA DA, Hernandez MM, Herrera IPM, Espinal IBC, et al
    Remitting Neuropsychiatric Symptoms in COVID-19 Patients: Viral Cause or Drug Effect?
    J Med Virol. 2021 Nov 9. doi: 10.1002/jmv.27443.
    >> Share

  30. FENG R, Wang B, Ma Z, Guo X, et al
    ALB level and COVID-19Dynamic change of serum albumin level can predict the prognosis of COVID-19 patients with hypoalbuminemia.
    J Med Virol. 2021 Nov 9. doi: 10.1002/jmv.27439.
    >> Share

  31. ALBAYAT SS, Arshad S, Arshad MA, Jabbar A, et al
    Precautionary measures for more transmissible C.1.2 COVID-19 variant: A caution for Qatar and the rest of the world.
    J Med Virol. 2021 Nov 9. doi: 10.1002/jmv.27438.
    >> Share

  32. SKOREK A, Jazwinska-Curyllo A, Romanowicz A, Kwasniewski K, et al
    Assessment of anti-SARS-CoV-2 antibodies level in convalescents plasma.
    J Med Virol. 2021 Nov 5. doi: 10.1002/jmv.27433.
    >> Share

  33. KIM HJ, Park MS, Il Shin J, Park J, et al
    Associations of heart failure with susceptibility and severe complications of COVID-19: A nationwide cohort study.
    J Med Virol. 2021 Nov 5. doi: 10.1002/jmv.27435.
    >> Share

  34. UMAIR M, Ikram A, Salman M, Haider SA, et al
    Genomic surveillance reveals the detection of SARS-CoV-2 Delta, Beta and Gamma VOCs during the third wave in Pakistan.
    J Med Virol. 2021 Nov 2. doi: 10.1002/jmv.27429.
    >> Share

    October 2021
  35. ADAMS O, Andree M, Rabl D, Ostermann PN, et al
    Humoral response to SARS-CoV-2 and seasonal coronaviruses in COVID-19 patients.
    J Med Virol. 2021 Oct 30. doi: 10.1002/jmv.27427.
    >> Share

  36. CHEN W, Yao M, Hu L, Zhang Y, et al
    Development and Validation of clinical prediction model to estimate the risk of critical patients with COVID-19.
    J Med Virol. 2021 Oct 30. doi: 10.1002/jmv.27428.
    >> Share

  37. FARAH Y, Syed Hasan A, Irfan U
    Norovirus Outbreak amid COVID-19 in the United Kingdom; Priorities for Achieving Control.
    J Med Virol. 2021 Oct 29. doi: 10.1002/jmv.27426.
    >> Share

  38. SAHIN D, Tanacan A, Erol SA, Yetiskin FDY, et al
    Management of Pregnant Women with COVID-19: A Tertiary Pandemic Center Experience on 1416 Cases.
    J Med Virol. 2021 Oct 29. doi: 10.1002/jmv.27423.
    >> Share

  39. CATTEL L, Giordano S, Traina S, Lupia T, et al
    Vaccine development and technology for SARS-CoV-2: current insights.
    J Med Virol. 2021 Oct 29. doi: 10.1002/jmv.27425.
    >> Share

  40. KIM MS, Jung SY, Ahn JG, Park SJ, et al
    Comparative safety of mRNA COVID-19 vaccines to influenza vaccines: a pharmacovigilance analysis of WHO international database.
    J Med Virol. 2021 Oct 28. doi: 10.1002/jmv.27424.
    >> Share

  41. YAMAMOTO Y, Shiroyama T, Hirata H, Kuge T, et al
    Prolonged corticosteroid therapy and cytomegalovirus infection in patients with severe COVID-19.
    J Med Virol. 2021 Oct 28. doi: 10.1002/jmv.27421.
    >> Share

  42. PAPADOPOULOU A, Fragkou PC, Maratou E, Dimopoulou D, et al
    "Angiotensin-Converting-Enzyme Insertion/Deletion (I/D) polymorphism, ACE activity and COVID-19: a rather controversial hypothesis. A case - control study".
    J Med Virol. 2021 Oct 28. doi: 10.1002/jmv.27417.
    >> Share

  43. UYSAL EB, Gumus S, Bektore B, Bozkurt H, et al
    EVALUATION OF ANTIBODY RESPONSE AFTER COVID-19 VACCINATION OF HEALTHCARE WORKERS.
    J Med Virol. 2021 Oct 27. doi: 10.1002/jmv.27420.
    >> Share

  44. LAINE P, Nihtila H, Mustanoja E, Lyyski A, et al
    SARS-CoV-2 variant with mutations in N gene affecting detection by widely used PCR primers.
    J Med Virol. 2021 Oct 26. doi: 10.1002/jmv.27418.
    >> Share

  45. RUBAYET UL ALAM ASM, Islam OK, Hasan MS, Islam MR, et al
    Dominant Clade-featured SARS-CoV-2 Co-occurring Mutations Reveals Plausible Epistasis: An in silico based Hypothetical Model.
    J Med Virol. 2021 Oct 22. doi: 10.1002/jmv.27416.
    >> Share

  46. MONTALVO VILLALBA MC, Sosa Glaria E, Rodriguez Lay LLA, Valdes Ramirez O, et al
    Performance evaluation of Elecsys SARS-CoV-2 Antigen immunoassay for diagnostic of COVID-19.
    J Med Virol. 2021 Oct 21. doi: 10.1002/jmv.27412.
    >> Share

  47. ARSLAN GULEN T, Bayraktar M, Yaksi N, Kayabas U, et al
    Is the course of COVID-19 associated with tuberculin skin test diameter? A retrospective study.
    J Med Virol. 2021 Oct 21. doi: 10.1002/jmv.27414.
    >> Share

  48. O'CONNOR RJ, Preston N, Parkin A, Makower S, et al
    The COVID-19 Yorkshire Rehabilitation Scale (C19-YRS): application and psychometric analysis in a post-COVID-19 syndrome cohort.
    J Med Virol. 2021 Oct 21. doi: 10.1002/jmv.27415.
    >> Share

  49. KOMURCU SZM, Artik Y, Cesur NP, Tanriverdi A, et al
    THE EVALUATION POTENTIAL GLOBAL IMPACT OF THE N501Y MUTATION IN SARS-COV-2 POSITIVE PATIENTS.
    J Med Virol. 2021 Oct 21. doi: 10.1002/jmv.27413.
    >> Share

  50. BARROS-LEITE BRAF, Lima MRO, Caminha M, Santos K, et al
    Short-term functional changes after hospital discharge by COVID-19 through teleconsultation at a reference service in Northeast Brazil: a cross-sectional study.
    J Med Virol. 2021 Oct 21. doi: 10.1002/jmv.27410.
    >> Share

  51. ASADI-POOYA AA, Akbari A, Emami A, Lotfi M, et al
    Long COVID syndrome-associated brain fog.
    J Med Virol. 2021 Oct 21. doi: 10.1002/jmv.27404.
    >> Share

  52. MANIK M, Singh RK
    Role of toll-like receptors in modulation of cytokine storm signaling in SARS-CoV-2-induced COVID-19.
    J Med Virol. 2021 Oct 21. doi: 10.1002/jmv.27405.
    >> Share

  53. GOBEILLE PARE S, Bestman-Smith J, Fafard J, Doualla-Bell F, et al
    Natural spring water gargle samples as an alternative to nasopharyngeal swabs for SARS-CoV-2 detection using a laboratory-developed test.
    J Med Virol. 2021 Oct 21. doi: 10.1002/jmv.27407.
    >> Share

  54. LI X
    Concerns on the multiple nomenclature systems for SARS-CoV-2.
    J Med Virol. 2021 Oct 21. doi: 10.1002/jmv.27406.
    >> Share

  55. KAYA H, Usuda D
    Duration from onset to discharge is longer in COVID-19 patients with low blood regulatory T-cell counts.
    J Med Virol. 2021 Oct 18. doi: 10.1002/jmv.27401.
    >> Share

  56. D'ETTORRE G, Gentilini Cacciola E, Santinelli L, De Girolamo G, et al
    Covid-19 sequelae in working age patients: A systematic review.
    J Med Virol. 2021 Oct 16. doi: 10.1002/jmv.27399.
    >> Share

  57. ISLAM K, Molla MA, Hasan P, Sharif M, et al
    Title: Persistence of Sleep Disturbance among Post-Covid Patients: Findings from a two-month follow-up study in a Bangladeshi cohort.
    J Med Virol. 2021 Oct 14. doi: 10.1002/jmv.27397.
    >> Share

  58. QUINCOZES-SANTOS A, Rosa RLD, Bobermin LD, Tureta EF, et al
    Association between molecular markers of COVID-19 and Alzheimer's disease.
    J Med Virol. 2021 Oct 14. doi: 10.1002/jmv.27391.
    >> Share

  59. KASHIMA S, Slavov SN, Giovanetti M, Rodrigues ES, et al
    INTRODUCTION OF SARS-COV-2 C.37 (WHO VOI LAMBDA) IN THE SAO PAULO STATE, SOUTHEAST BRAZIL.
    J Med Virol. 2021 Oct 14. doi: 10.1002/jmv.27389.
    >> Share

  60. LINO K, Alves LS, Raposo JV, Medeiros T, et al
    Presence and clinical impact of human Herpesvirus-6 infection in patients with moderate to critical Coronavirus disease-19.
    J Med Virol. 2021 Oct 14. doi: 10.1002/jmv.27392.
    >> Share

  61. ULHAQ ZS, Soraya GV, Indriana K, Devitasari R, et al
    The level of Ig anti-RBD SARS-CoV-2 after two doses of CoronaVac vaccine.
    J Med Virol. 2021 Oct 14. doi: 10.1002/jmv.27390.
    >> Share

  62. ALEXIEV I, Ivanov I, Philipova I, Korsun N, et al
    Postvaccination SARS-CoV-2 Alpha (B.1.1.7) Lineage Infection among Healthcare Workers on the Background of IgG Antibodies.
    J Med Virol. 2021 Oct 14. doi: 10.1002/jmv.27394.
    >> Share

  63. TONG L, Ji L, Li D, Xu H, et al
    The occurrence of COVID-19 is associated with air quality and relative humidity.
    J Med Virol. 2021 Oct 14. doi: 10.1002/jmv.27395.
    >> Share

  64. SILVA VO, Yamashiro R, Ahagon CM, Campos IB, et al
    Inhibition of Receptor-Binding Domain - ACE2 interaction after two doses of Sinovac's CoronaVac or AstraZeneca/Oxford's AZD1222 SARS-CoV-2 vaccines.
    J Med Virol. 2021 Oct 14. doi: 10.1002/jmv.27396.
    >> Share

  65. KUNO T, Sahashi Y, Kawahito S, Takahashi M, et al
    Prediction of in-hospital mortality with machine learning for COVID-19 patients treated with steroid and Remdesivir.
    J Med Virol. 2021 Oct 14. doi: 10.1002/jmv.27393.
    >> Share

  66. DEHNEN D, Dehnen K, Trilling M, Fiedler M, et al
    Discrepancy between frequent occurrence of COVID-19-like symptoms and low seroconversion rates among healthcare workers.
    J Med Virol. 2021 Oct 11. doi: 10.1002/jmv.27385.
    >> Share

  67. NANCHAL R, Patel D, Guddati AK, Sakhuja A, et al
    Outcomes of Covid 19 Patients - Are Hispanics at greater risk?
    J Med Virol. 2021 Oct 11. doi: 10.1002/jmv.27384.
    >> Share

  68. DASH GC, Subhadra S, Turuk J, Parai D, et al
    Breakthrough SARS-CoV-2 infections among BBV-152 (COVAXIN(R)) and AZD1222 (COVISHIELDT(M) ) recipients: Report from eastern state of India.
    J Med Virol. 2021 Oct 8. doi: 10.1002/jmv.27382.
    >> Share

  69. DUMONT S, Balduyck J, Reynders M, Vanwalleghem L, et al
    Acute SARS-CoV-2 Alpha variant infection leading to placental insufficiency and fetal distress.
    J Med Virol. 2021 Oct 7. doi: 10.1002/jmv.27379.
    >> Share

  70. TREGGIARI D, Piubelli C, Caldrer S, Mistretta M, et al
    SARS-CoV-2 rapid antigen test in comparison to RT-PCR targeting different genes: a real-life evaluation among unselected patients in a regional hospital of Italy.
    J Med Virol. 2021 Oct 7. doi: 10.1002/jmv.27378.
    >> Share

  71. BORETTI A, Banik B
    Modulation of Covid-19 cytokine storm by Tocilizumab.
    J Med Virol. 2021 Oct 7. doi: 10.1002/jmv.27380.
    >> Share

  72. TIAN D, Sun Y, Zhou J, Ye Q, et al
    The global epidemic of SARS-CoV-2 variants and their mutational immune escape.
    J Med Virol. 2021 Oct 5. doi: 10.1002/jmv.27376.
    >> Share

  73. KUNO T, So M, Takahashi M, Egorova NN, et al
    The association between famotidine and in-hospital mortality of patients with COVID-19.
    J Med Virol. 2021 Oct 5. doi: 10.1002/jmv.27375.
    >> Share

  74. WOLF JM, Kipper D, Borges GR, Streck AF, et al
    Temporal spread and evolution of SARS-CoV-2 in the second pandemic wave in Brazil.
    J Med Virol. 2021 Oct 1. doi: 10.1002/jmv.27371.
    >> Share

  75. MUTNAL MB, Johnson S, Mohamed N, Abddelgader R, et al
    Surveillance genome sequencing reveal multiple SARS-CoV-2 variants circulating in the central Texas, USA with a predominance of Delta variant and review of vaccine breakthrough cases.
    J Med Virol. 2021 Oct 1. doi: 10.1002/jmv.27373.
    >> Share

  76. LI H, Liu T, Wang L, Wang M, et al
    SARS-CoV-2 Delta Variant infects ACE2(low) primary human bronchial epithelial cells more efficiently than other variants.
    J Med Virol. 2021 Oct 1. doi: 10.1002/jmv.27372.
    >> Share

    September 2021
  77. MAK GCK, Au SSM, Yeung MCW, Lau DMW, et al
    Evaluation of rapid antigen detection test for individuals at risk of SARS-CoV-2 under quarantine.
    J Med Virol. 2021 Sep 30. doi: 10.1002/jmv.27369.
    >> Share

  78. MORELAND A, Gillezeau C, Alpert N, Taioli E, et al
    Assessing influenza vaccination success to inform COVID-19 vaccination campaign.
    J Med Virol. 2021 Sep 30. doi: 10.1002/jmv.27368.
    >> Share

  79. BERNARDINI N, Skroza N, Mambrin A, Proietti I, et al
    Herpes Zoster Ophthalmicus in two women after Pfizer-Biontech(BNT162b2) vaccine.
    J Med Virol. 2021 Sep 29. doi: 10.1002/jmv.27366.
    >> Share

  80. CHENEY-PETERS DR, Crystal Y Lee M P H, Mitsuhashi S, Zaret DS, et al
    Association of race/ethnicity and socioeconomic status with COVID-19 30-day mortality at a Philadelphia medical center using a retrospective cohort study.
    J Med Virol. 2021 Sep 29. doi: 10.1002/jmv.27365.
    >> Share

  81. BIRD PW, Riff R, Folwell A, Holmes CW, et al
    Increased incidence of COVID-19 in younger patients (May-July 2021) - an argument for extending vaccination?
    J Med Virol. 2021 Sep 29. doi: 10.1002/jmv.27363.
    >> Share

  82. BOSTAN E, Jarbou A
    Atypical Pityriasis Rosea Associated with mRNA Covid-19 Vaccine.
    J Med Virol. 2021 Sep 29. doi: 10.1002/jmv.27364.
    >> Share

  83. GULHAN PY, Eroz R, Ataoglu O, Ince N, et al
    Can Caspase-3 Gene Expression Levels Show the Degree of Injury in Cells in SARS-CoV-2 Infection?
    J Med Virol. 2021 Sep 29. doi: 10.1002/jmv.27362.
    >> Share

  84. GOLBETS E, Kaplan A, Shafat T, Yagel Y, et al
    Secondary Organizing Pneumonia After Recovery of Mild COVID-19 Infection.
    J Med Virol. 2021 Sep 28. doi: 10.1002/jmv.27360.
    >> Share

  85. WU J, Tang J, Zhang T, Chen YC, et al
    SARS-CoV-2 Delta VOC pneumonia with CT follow-ups: a case report.
    J Med Virol. 2021 Sep 28. doi: 10.1002/jmv.27361.
    >> Share

  86. SONI S, Pudake RN, Jain U, Chauhan N, et al
    A systematic review on SARS-CoV-2 Associated Fungal Co-Infections.
    J Med Virol. 2021 Sep 27. doi: 10.1002/jmv.27358.
    >> Share

  87. KUMAR G, Patel D, Hererra M, Jefferies D, et al
    Do High Dose Corticosteroids Improve Outcomes in Hospitalized COVID-19 Patients?
    J Med Virol. 2021 Sep 24. doi: 10.1002/jmv.27357.
    >> Share

  88. MESQUITA JR, Barradas P, Silva PGD, Ferreira AS, et al
    SARS-CoV-2 and blood donations in Portugal, June-July 2020.
    J Med Virol. 2021 Sep 21. doi: 10.1002/jmv.27353.
    >> Share

  89. SEBASTIAO CS, Gaston C, Paixao JP, Sacomboio ENM, et al
    Coinfection between SARS-CoV-2 and vector-borne diseases in Luanda, Angola.
    J Med Virol. 2021 Sep 21. doi: 10.1002/jmv.27354.
    >> Share

  90. ZHANG RK, Xiao Q, Zhu SL, Lin HY, et al
    Using Different Machine Learning Models to Classify Patients with Mild and Severe Cases of COVID-19 Based on Multivariate Blood Testing.
    J Med Virol. 2021 Sep 20. doi: 10.1002/jmv.27352.
    >> Share

  91. YAQOOB H, Greenberg D, Hwang F, Lee C, et al
    COMPARISON OF PULSE-DOSE AND HIGH-DOSE CORTICOSTEROIDS WITH NO CORTICOSTEROID TREATMENT FOR COVID-19 PNEUMONIA IN THE INTENSIVE CARE UNIT.
    J Med Virol. 2021 Sep 20. doi: 10.1002/jmv.27351.
    >> Share

  92. KESKIN AU, Bolukcu S, Ciragil P, Topkaya AE, et al
    SARS-CoV-2 specific antibody responses after third CoronaVac or BNT162b2 vaccine following two-dose CoronaVac vaccine regimen.
    J Med Virol. 2021 Sep 18. doi: 10.1002/jmv.27350.
    >> Share

  93. LI D, Liu Y, Lu Y, Gao S, et al
    Palmitoylation of SARS-CoV-2 S protein is critical for S-mediated syncytia formation and virus entry.
    J Med Virol. 2021 Sep 16. doi: 10.1002/jmv.27339.
    >> Share

  94. BANO I, Sharif M, Alam S
    Genetic drift in the genome of SARS COV-2 and its global health concern.
    J Med Virol. 2021 Sep 15. doi: 10.1002/jmv.27337.
    >> Share

  95. KITAGAWA Y, Imai K, Matsuoka M, Fukada A, et al
    Evaluation of the correlation between the Access SARS-CoV-2 IgM and IgG II antibody tests with the SARS-CoV-2 surrogate virus neutralization test.
    J Med Virol. 2021 Sep 15. doi: 10.1002/jmv.27338.
    >> Share

  96. LIU H, Li J, Lin Y, Bo X, et al
    Assessment of two-pool multiplex long-amplicon nanopore sequencing of SARS-CoV-2.
    J Med Virol. 2021 Sep 15. doi: 10.1002/jmv.27336.
    >> Share

  97. CHEN JM
    Should the world collaborate imminently to develop neglected live attenuated vaccines for COVID-19?
    J Med Virol. 2021 Sep 15. doi: 10.1002/jmv.27335.
    >> Share

  98. YUE L, Xie T, Yang T, Zhou J, et al
    A third booster dose may be necessary to mitigate neutralizing antibody fading after inoculation with two doses of an inactivated SARS-CoV-2 vaccine.
    J Med Virol. 2021 Sep 13. doi: 10.1002/jmv.27334.
    >> Share

  99. PHILLIPS MC, Sarff L, Banerjee J, Coffey C, et al
    Effect of Mortality from COVID-19 on Inpatient Outcomes.
    J Med Virol. 2021 Sep 13. doi: 10.1002/jmv.27332.
    >> Share

  100. MESSALI S, Campisi G, Giovanetti M, Ciccozzi M, et al
    The first Italian outbreak of SARS-CoV-2 B.1.1.7 lineage in Corzano, Lombardy.
    J Med Virol. 2021 Sep 13. doi: 10.1002/jmv.27333.
    >> Share

  101. WANG S, Xu X, Wei C, Li S, et al
    Molecular evolutionary characteristics of SARS-CoV-2 emerging in the United States.
    J Med Virol. 2021 Sep 10. doi: 10.1002/jmv.27331.
    >> Share

  102. KAZMI SK, Khan FMA, Natoli V, Hunain R, et al
    Viral hepatitis amidst COVID-19 in Africa: Implications and Recommendations.
    J Med Virol. 2021 Sep 10. doi: 10.1002/jmv.27330.
    >> Share

  103. UMAIR M, Ikram A, Badar N, Haider SA, et al
    Tracking down B.1.351 SARS-CoV-2 variant in Pakistan through genomic surveillance.
    J Med Virol. 2021 Sep 9. doi: 10.1002/jmv.27328.
    >> Share

  104. TSANG AKL, Mak GCK, Leung PKL, Cheng PKC, et al
    Emergence of SARS-CoV-2 lineage B.1.617.2 in the local community of Hong Kong.
    J Med Virol. 2021 Sep 9. doi: 10.1002/jmv.27326.
    >> Share

  105. DIVINO F, Ciccozzi M, Farcomeni A, Lasinio GJ, et al
    Unreliable predictions about COVID-19 infections and hospitalizations make people worry: the case of Italy.
    J Med Virol. 2021 Sep 8. doi: 10.1002/jmv.27325.
    >> Share

  106. CHAUDHRY R, Sreenath K, Batra P, Vinayaraj EV, et al
    Atypical bacterial co-infections among patients with COVID-19: a study from India.
    J Med Virol. 2021 Sep 7. doi: 10.1002/jmv.27324.
    >> Share

  107. PANDOLFI S, Chirumbolo S
    On reaching herd immunity during COVID-19 pandemic and further issues.
    J Med Virol. 2021 Sep 7. doi: 10.1002/jmv.27322.
    >> Share

  108. TANISLAV C, Kostev K
    Fewer non-Covid-19 respiratory tract infections and gastro-intestinal infections during the Covid-19 pandemic.
    J Med Virol. 2021 Sep 7. doi: 10.1002/jmv.27321.
    >> Share

  109. SARGIN ALTUNOK E, Satici C, Dinc V, Kamat S, et al
    Comparison of demographic and clinical characteristics of hospitalized COVID-19 patients with severe/critical illness in the first wave vs the second wave.
    J Med Virol. 2021 Sep 7. doi: 10.1002/jmv.27319.
    >> Share

  110. KAUR U, Bala S, Mbbs BO, Mbbs SJ, et al
    Occurrence of COVID-19 in priority groups receiving ChAdOx1 nCoV-19 coronavirus vaccine (recombinant): a preliminary analysis from north India.
    J Med Virol. 2021 Sep 7. doi: 10.1002/jmv.27320.
    >> Share

  111. YIGIT M, Ozkaya-Parlakay A, Cosgun Y, Ince YE, et al
    SHOULD A THIRD BOOSTER DOSE BE SCHEDULED AFTER TWO DOSES OF CORONAVAC? A SINGLE CENTER EXPERIENCE.
    J Med Virol. 2021 Sep 6. doi: 10.1002/jmv.27318.
    >> Share

  112. FINSTERER J, Almas T
    Guillain-Barre syndrome is immunogenic in SARS-CoV-2 infected.
    J Med Virol. 2021 Sep 1. doi: 10.1002/jmv.27314.
    >> Share

  113. SODEIFIAN F, Nikfarjam M, Kian N, Mohamed K, et al
    The Role of Type I Interferon in the Treatment of COVID-19.
    J Med Virol. 2021 Sep 1. doi: 10.1002/jmv.27317.
    >> Share

  114. PANDA S, Roy S, Garg RK, Hui G, et al
    COVID-19 Disease in Hospitalised Young Adults in India and China: Evaluation of Risk Factors Predicting Progression Across Two Major Ethnic Groups.
    J Med Virol. 2021 Sep 1. doi: 10.1002/jmv.27315.
    >> Share

  115. YALCIN TY, Topcu DI, Dogan O, Aydin S, et al
    Immunogenicity After Two Doses of Inactivated Virus Vaccine in Healthcare Workers with and without Previous COVID-19 Infection: Prospective Observational Study.
    J Med Virol. 2021 Sep 1. doi: 10.1002/jmv.27316.
    >> Share

    August 2021
  116. MALIK P, Patel K, Pinto C, Jaiswal R, et al
    Post-acute COVID-19 syndrome (PCS) and Health related Quality of life (HRQoL)- A systematic review and Meta-analysis.
    J Med Virol. 2021 Aug 31. doi: 10.1002/jmv.27309.
    >> Share

  117. MOUSAVI SA, Heydari K, Mehravaran H, Saeedi M, et al
    Melatonin effects on sleep quality and outcomes of COVID-19 patients: An open-label, Randomized, Controlled Trial.
    J Med Virol. 2021 Aug 30. doi: 10.1002/jmv.27312.
    >> Share

  118. AKINOSOGLOU K, Delastic AL, Dimakopoulou V, Marangos M, et al
    Elements of Th1 / Th2 response and disease severity in COVID-19 patients: A short report.
    J Med Virol. 2021 Aug 30. doi: 10.1002/jmv.27313.
    >> Share

  119. FERNANDEZ J, Bruneau N, Fasce R, Martin HS, et al
    Neutralization of Alpha, Gamma, and D614G SARS-CoV-2 variants by CoronaVac vaccine-induced antibodies.
    J Med Virol. 2021 Aug 30. doi: 10.1002/jmv.27310.
    >> Share

  120. XIE XP, Sheng LP, Han CQ, Jin Y, et al
    Features of capsule endoscopy in COVID-19 patients with a six-month follow up: a prospective observational study.
    J Med Virol. 2021 Aug 30. doi: 10.1002/jmv.27308.
    >> Share

  121. MISHRA B, Ranjan J, Purushotham P, Saha S, et al
    High proportion of low cycle threshold value as an early indicator of COVID-19 surge.
    J Med Virol. 2021 Aug 30. doi: 10.1002/jmv.27307.
    >> Share

  122. WASIM U, Tahir MJ, Siddiqi AR, Jabbar A, et al
    The impact of the COVID-19 pandemic on impending cancer deaths due to delays in diagnosis in the UK.
    J Med Virol. 2021 Aug 28. doi: 10.1002/jmv.27305.
    >> Share

  123. RATHORE SS, Hussain N, Manju AH, Wen Q, et al
    Prevalence and clinical outcomes of pleural effusion in COVID-19 patients: A systematic review and meta-analysis.
    J Med Virol. 2021 Aug 27. doi: 10.1002/jmv.27301.
    >> Share

  124. OLEA B, Albert E, Torres I, Gozalbo-Rovira R, et al
    SARS-CoV-2 N-antigenemia in critically ill adult COVID-19 patients: frequency and association with inflammatory and tissue-damage biomarkers.
    J Med Virol. 2021 Aug 27. doi: 10.1002/jmv.27300.
    >> Share

  125. PLASENCIA-DUENAS R, Failoc-Rojas VE, Rodriguez-Morales AJ
    Impact of the COVID-19 pandemic on the incidence of dengue fever in Peru.
    J Med Virol. 2021 Aug 26. doi: 10.1002/jmv.27298.
    >> Share

  126. SARKAR S, Kannan S, Khanna P, Singh AK, et al
    Role of platelet-to-lymphocyte count ratio (PLR), as a prognostic indicator in COVID-19: A systematic review and meta-analysis.
    J Med Virol. 2021 Aug 26. doi: 10.1002/jmv.27297.
    >> Share

  127. CATALAN IP, Marti CR, Sota DP, Alvarez AC, et al
    "Corticosteroids for COVID-19 symptoms and quality of life at one year from admission".
    J Med Virol. 2021 Aug 26. doi: 10.1002/jmv.27296.
    >> Share

  128. CABRELLE G, Zanon C, Crimi F, Quaia E, et al
    Can rapid antibody tests and chest computed tomography really substitute real-time polymerase chain reaction in COVID-19?
    J Med Virol. 2021 Aug 26. doi: 10.1002/jmv.27295.
    >> Share

  129. PORTILHO AI, Silva VO, Ahagon CM, Matsuda EM, et al
    Humoral response to spike S1 and S2 and nucleocapsid proteins on microarray after SARS-CoV-2 infection.
    J Med Virol. 2021 Aug 24. doi: 10.1002/jmv.27290.
    >> Share

  130. BAYRAKTAR N, Turan H, Bayraktar M, Ozturk A, et al
    Analysis of serum cytokine and protective vitamin D levels in severe cases of COVID-19.
    J Med Virol. 2021 Aug 24. doi: 10.1002/jmv.27294.
    >> Share

  131. STRUCK F, Schreiner P, Staschik E, Wochinz-Richter K, et al
    Incomplete IgG avidity maturation after seasonal coronavirus infections.
    J Med Virol. 2021 Aug 24. doi: 10.1002/jmv.27291.
    >> Share

  132. YAZDANPANAH N, Rezaei N
    Autoimmune Complications of COVID-19.
    J Med Virol. 2021 Aug 24. doi: 10.1002/jmv.27292.
    >> Share

  133. MURAT K, Ediz TE
    The Effectiveness of Inactivated SARS-CoV-2 Vaccine (CoronaVac) on Antibody Response in Participants Aged 65 Years and Older.
    J Med Virol. 2021 Aug 24. doi: 10.1002/jmv.27289.
    >> Share

  134. ZAWBAA HM, Osama H, El-Gendy A, Saeed H, et al
    Effect of mutation and vaccination on spread, severity, and mortality of COVID-19 disease.
    J Med Virol. 2021 Aug 24. doi: 10.1002/jmv.27293.
    >> Share

  135. OZDEMIR O
    Re-activation or Re-infection of COVID-19 disease?
    J Med Virol. 2021 Aug 20. doi: 10.1002/jmv.27286.
    >> Share

  136. BOSHIER FAT, Pang J, Penner J, Parker M, et al
    Evolution of viral variants in remdesivir treated and untreated SARS-CoV-2 infected paediatrics patients.
    J Med Virol. 2021 Aug 20. doi: 10.1002/jmv.27285.
    >> Share

  137. DOLSCHEID-POMMERICH R, Bartok E, Renn M, Kummerer BM, et al
    Correlation Between a Quantitative Anti-SARS-CoV-2 IgG ELISA and Neutralization Activity.
    J Med Virol. 2021 Aug 20. doi: 10.1002/jmv.27287.
    >> Share

  138. KAWASUJI H, Morinaga Y, Tani H, Yoshida Y, et al
    SARS-CoV-2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID-19.
    J Med Virol. 2021 Aug 19. doi: 10.1002/jmv.27282.
    >> Share

  139. GHORBANI SS, Taherpour N, Bayat S, Ghajari H, et al
    Epidemiologic characteristics of cases with re-infection, recurrence and hospital readmission due to COVID-19: a systematic review and meta-analysis.
    J Med Virol. 2021 Aug 19. doi: 10.1002/jmv.27281.
    >> Share

  140. SHAKERI H, Azimian A, Ghasemzadeh-Moghaddam H, Safdari M, et al
    Evaluation of the Relationship Between Serum levels of Zinc, Vitamin B12, Vitamin D and Clinical outcomes in Patients with COVID-19.
    J Med Virol. 2021 Aug 18. doi: 10.1002/jmv.27277.
    >> Share

  141. STOECKLE K, Witting B, Kapadia S, An A, et al
    Elevated Inflammatory Markers Are Associated With Poor Outcomes in COVID-19 Patients Treated With Remdesivir.
    J Med Virol. 2021 Aug 18. doi: 10.1002/jmv.27280.
    >> Share

  142. AI S, Awford A, Roncolato F
    Hemophagocytic lymphohistiocytosis following ChAdOx1 nCov-19 vaccination.
    J Med Virol. 2021 Aug 18. doi: 10.1002/jmv.27279.
    >> Share

  143. HASAN MM, Mohanan P, Emmanuella N, Costa ACDS, et al
    Challenges of HIV amidst COVID-19 in Africa: Can we conquer them?
    J Med Virol. 2021 Aug 17. doi: 10.1002/jmv.27276.
    >> Share

  144. TANG F, Zhang X, Zhang B, Zhu B, et al
    A nomogram prediction of outcome in patients with COVID-19 based on individual characteristics incorporating immune response-related indicators.
    J Med Virol. 2021 Aug 17. doi: 10.1002/jmv.27275.
    >> Share

  145. YAN X, Chen G, Jin Z, Zhang Z, et al
    Anti-SARS-CoV-2 IgG levels in relation to disease severity of COVID-19.
    J Med Virol. 2021 Aug 17. doi: 10.1002/jmv.27274.
    >> Share

  146. EBRAHIMI M, Farhadian N, Amiri AR, Hataminia F, et al
    Evaluating the efficacy of extracted squalene from seed oil in the form of microemulsion for the treatment of COVID-19: A clinical study.
    J Med Virol. 2021 Aug 17. doi: 10.1002/jmv.27273.
    >> Share

  147. YILMAZ G, Ebru O, Ibrahim B, Ulkem C, et al
    ASSESSMENT OF CLINICAL OUTCOMES IN RENAL TRANSPLANT RECIPIENTS WITH COVID-19.
    J Med Virol. 2021 Aug 13. doi: 10.1002/jmv.27271.
    >> Share

  148. FARI G, de Sire A, Giorgio V, Rizzo L, et al
    Impact of COVID-19 on the mental health in a cohort of Italian Rehabilitation health care workers.
    J Med Virol. 2021 Aug 13. doi: 10.1002/jmv.27272.
    >> Share

  149. STRUCK F, Schreiner P, Staschik E, Wochinz-Richter K, et al
    Vaccination versus infection with SARS-CoV-2: Establishment of a high avidity IgG response versus incomplete avidity maturation.
    J Med Virol. 2021 Aug 13. doi: 10.1002/jmv.27270.
    >> Share

  150. DENG J, Heybati K, Zhou F
    Letter to the editor in response to "Safety and Effectiveness of SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis".
    J Med Virol. 2021 Aug 13. doi: 10.1002/jmv.27269.
    >> Share

  151. ABBASS S, Salama M, Salman T, Sabry A, et al
    fficacy and safety of Sofosbuvir plus Daclatasvir or Ravidasvir in patients with COVID-19, A Randomized Controlled Trial.
    J Med Virol. 2021 Aug 11. doi: 10.1002/jmv.27264.
    >> Share

  152. ZHOU R, Liu L, Wang Y
    Viral Proteins Recognized by Different TLRs.
    J Med Virol. 2021 Aug 10. doi: 10.1002/jmv.27265.
    >> Share

  153. CICCOZZI M, Maruotti A, Ceccarelli G, Divino F, et al
    While we are discussing...the SARS-CoV-2 virus laughs.
    J Med Virol. 2021 Aug 10. doi: 10.1002/jmv.27266.
    >> Share

  154. MUNGMUNPUNTIPANTIP R, Wiwanitkit V
    Antibody response to SARS-CoV-2 vaccination, previous SARS-CoV-2 infection and change to single dose vaccination.
    J Med Virol. 2021 Aug 10. doi: 10.1002/jmv.27263.
    >> Share

  155. CHI G, Memar Montazerin S, Lee JJ, Kazmi SHA, et al
    Effect of Azithromycin and Hydroxychloroquine in Patients Hospitalized with COVID-19: Network Meta-Analysis of Randomized Controlled Trials.
    J Med Virol. 2021 Aug 9. doi: 10.1002/jmv.27259.
    >> Share

  156. PADILLA-ROJAS C, Jimenez-Vasquez V, Hurtado V, Mestanza O, et al
    Genomic analysis reveals a rapid spread and predominance of Lambda (C.37) SARS-COV-2 lineage in Peru despite circulation of variants of concern.
    J Med Virol. 2021 Aug 9. doi: 10.1002/jmv.27261.
    >> Share

  157. KUNO T, So M, Miyamoto Y, Iwagami M, et al
    The association of COVID-19 antibody with in-hospital outcomes in COVID-19 infected patients.
    J Med Virol. 2021 Aug 9. doi: 10.1002/jmv.27260.
    >> Share

  158. ESSAR MY, Kazmi SK, Hasan MM, Santos Costa ACD, et al
    The rampant use of cow-dung to treat COVID-19: Is India at the brink of a zoonotic disease outbreak?
    J Med Virol. 2021 Aug 5. doi: 10.1002/jmv.27258.
    >> Share

  159. QURESHI QH, Ashraf T, Rehman K, Khosa MK, et al
    Therapeutic interventions of remdesivir in diabetic and non-diabetic COVID-19 patients: A prospective observational study conducted on Pakistani population.
    J Med Virol. 2021 Aug 5. doi: 10.1002/jmv.27256.
    >> Share

  160. GUAN Y, Chen C, Guo A, Wei J, et al
    Prolonged Symptom Onset to Admission Time is Associated with Severe Coronavirus Disease: A Meta combined Propensity-adjusted Analysis.
    J Med Virol. 2021 Aug 4. doi: 10.1002/jmv.27253.
    >> Share

  161. ABDULAH DM
    ABDULAHPrevalence and correlates of COVID-19 vaccine hesitancy in general public in Iraqi Kurdistan: A cross-sectional study.
    J Med Virol. 2021 Aug 4. doi: 10.1002/jmv.27255.
    >> Share

    July 2021
  162. WERFEL S, Jakob CEM, Borgmann S, Schneider J, et al
    Development and Validation of a Simplified Risk Score for the Prediction of Critical COVID-19 Illness in Newly Diagnosed Patients.
    J Med Virol. 2021 Jul 31. doi: 10.1002/jmv.27252.
    >> Share

  163. UNSALER S, Okan A, Tekin S, Hafiz AM, et al
    Comparison of nasopharyngeal swab and nasopharyngeal aspiration in adults for SARS-CoV-2 identification using reverse transcription-polymerase chain reaction.
    J Med Virol. 2021 Jul 31. doi: 10.1002/jmv.27250.
    >> Share

  164. DESHPANDE K, Pt U, Kaduskar O, Vijay N, et al
    Performance assessment of seven SARS-CoV-2 IgG enzyme linked immunosorbent assays.
    J Med Virol. 2021 Jul 31. doi: 10.1002/jmv.27251.
    >> Share

  165. CASSUTO NG, Gravier A, Colin M, Theillay A, et al
    Evaluation of a SARS-CoV-2 antigen-detecting rapid diagnostic test as a self-test: diagnostic performance and usability.
    J Med Virol. 2021 Jul 31. doi: 10.1002/jmv.27249.
    >> Share

  166. MESSALI S, Bertelli A, Campisi G, Zani A, et al
    A cluster of the new SARS-CoV-2 B.1.621 lineage in Italy and sensitivity of the viral isolate to the BNT162b2 vaccine.
    J Med Virol. 2021 Jul 30. doi: 10.1002/jmv.27247.
    >> Share

  167. GHOLIPOUR E, Vizvari B, Babaqi T, Takacs S, et al
    Statistical analysis of the Hungarian COVID-19 victims.
    J Med Virol. 2021 Jul 29. doi: 10.1002/jmv.27242.
    >> Share

  168. BUTT MH, Safdar A, Amir A, Zaman M, et al
    Arboviral Diseases and COVID-19 Coincidence: Challenges for Pakistan's Derelict Healthcare System.
    J Med Virol. 2021 Jul 29. doi: 10.1002/jmv.27241.
    >> Share

  169. BENOIT P, Labbe AC, Lalancette L, Gagnon S, et al
    Comparison of SARS-CoV-2 detection with the cobas(R) 6800/8800 system on gargle samples using two sample processing methods with combined oropharyngeal/nasopharyngeal swab.
    J Med Virol. 2021 Jul 29. doi: 10.1002/jmv.27245.
    >> Share

  170. ZHANG F, Li W, Feng J, Ramos da Silva S, et al
    SARS-CoV-2 pseudovirus infectivity and expression of viral entry-related factors ACE2, TMPRSS2, Kim-1 and NRP-1 in human cells from respiratory, urinary, digestive, reproductive and immune systems.
    J Med Virol. 2021 Jul 29. doi: 10.1002/jmv.27244.
    >> Share

  171. KARA AA, Boncuoglu E, Kiymet E, Arikan KO, et al
    Evaluation of predictors of severe-moderate COVID-19 infections at children: a review of 292 children.
    J Med Virol. 2021 Jul 27. doi: 10.1002/jmv.27237.
    >> Share

  172. WAN Z, Zhao Y, Lu R, Dong Y, et al
    Rapid antigen detection alone may not be sufficient for early diagnosis and/or mass screening of COVID-19.
    J Med Virol. 2021 Jul 27. doi: 10.1002/jmv.27236.
    >> Share

  173. KERGET F, Kerget B, Kahraman CY, Araz O, et al
    Evaluation of the relationship between pentraxin 3 (PTX3) rs2305619 (281A/G) and rs1840680 (1449A/G) polymorphisms and the clinical course of COVID-19.
    J Med Virol. 2021 Jul 27. doi: 10.1002/jmv.27238.
    >> Share

  174. NAGANO K, Tani-Sassa C, Iwasaki Y, Takatsuki Y, et al
    SARS-CoV-2 R.1 lineage variants prevailed in Tokyo in March 2021.
    J Med Virol. 2021 Jul 27. doi: 10.1002/jmv.27240.
    >> Share

  175. BAJ A, Novazzi F, Ferrante FD, Genoni A, et al
    Introduction of SARS-COV-2 C.37 (WHO VOI lambda) from Peru to Italy.
    J Med Virol. 2021 Jul 27. doi: 10.1002/jmv.27235.
    >> Share

  176. WU B, Zhang H, Wang YC, Tang A, et al
    Sequencing on an imported case in China of COVID-19 Delta variant emerging from India in a cargo ship in Zhoushan, China.
    J Med Virol. 2021 Jul 27. doi: 10.1002/jmv.27239.
    >> Share

  177. SAADATIAN-ELAHI M, Amour S, Elias C, Henaff L, et al
    Tobacco smoking and severity of COVID-19: Experience from a hospital-based prospective cohort study in Lyon-France.
    J Med Virol. 2021 Jul 27. doi: 10.1002/jmv.27233.
    >> Share

  178. LI XQ, Liu H, Yin HY, Gao WY, et al
    Critical roles of cytokine storm and secondary bacterial infection in acute kidney injury development in COVID-19: A multi-center retrospective cohort study.
    J Med Virol. 2021 Jul 27. doi: 10.1002/jmv.27234.
    >> Share

  179. KANEKO S, Kurosaki M, Sugiyama T, Takahashi Y, et al
    The dynamics of quantitative SARS-CoV-2 anti-spike IgG response to BNT162b2 vaccination.
    J Med Virol. 2021 Jul 27. doi: 10.1002/jmv.27231.
    >> Share

  180. MORENO-ESCOBAR MC, Feizi P, Podury S, Tandon M, et al
    Acute Cerebellitis following SARS-CoV-2 infection: A Case Report and Review of Literature.
    J Med Virol. 2021 Jul 27. doi: 10.1002/jmv.27232.
    >> Share

  181. LIU T, Chen Z, Xu J
    Epidemiological characteristics and incubation period of SARS-CoV-2 during the 2020-2021 winter pandemic wave in north China: an observational study.
    J Med Virol. 2021 Jul 24. doi: 10.1002/jmv.27226.
    >> Share

  182. REICH N, Lowe CF, Puddicombe D, Matic N, et al
    Repeat virological and serological profiles in hospitalized patients initially tested by nasopharyngeal RT-PCR for SARS-CoV-2.
    J Med Virol. 2021 Jul 23. doi: 10.1002/jmv.27227.
    >> Share

  183. LIN Z, Qing H, Li R, Zheng L, et al
    Evolution Trace of SARS-CoV-2 from January 19 to March 12, 2020 in the United States.
    J Med Virol. 2021 Jul 22. doi: 10.1002/jmv.27225.
    >> Share

  184. SPRENGHOLZ P, Betsch C
    Previous SARS-CoV-2 infection is linked to lower vaccination intentions.
    J Med Virol. 2021 Jul 21. doi: 10.1002/jmv.27221.
    >> Share

  185. SUVVARI TK, Kutikuppala LS, Tsagkaris C, Corriero AC, et al
    Post COVID-19 Complications: Multi-Systemic Approach.
    J Med Virol. 2021 Jul 21. doi: 10.1002/jmv.27222.
    >> Share

  186. UWISHEMA O, Nnagha EM, Chalhoub E, Nchasi G, et al
    Dengue fever outbreak in Cook Island: A rising concern, Efforts, Challenges and Future recommendations.
    J Med Virol. 2021 Jul 21. doi: 10.1002/jmv.27223.
    >> Share

  187. NEISES JZ, Hossain MS, Sultana R, Wanniarachchi KN, et al
    Seroprevalence of SARS-CoV-2 Antibodies Among Rural Healthcare Workers.
    J Med Virol. 2021 Jul 21. doi: 10.1002/jmv.27224.
    >> Share

  188. HATTATOGLU DG, Yildiz BP
    Comparison Of Clinical And Biochemical Features Of Hospitalized COVID-19 And Influenza Pneumonia Patients.
    J Med Virol. 2021 Jul 21. doi: 10.1002/jmv.27218.
    >> Share

  189. CARBONELL-SAHUQUILLO S, Lazaro-Carreno MI, Camacho J, Barres-Fernandez A, et al
    Evaluation of a rapid antigen detection test (Panbio COVID-19 Ag Rapid Test Device) as a point-of-care diagnostic tool for COVID-19 in a Pediatric Emergency Department.
    J Med Virol. 2021 Jul 21. doi: 10.1002/jmv.27220.
    >> Share

  190. UWISHEMA O, Alshareif BAA, Yousif MYE, Omer MEA, et al
    Lassa fever amidst the COVID-19 Pandemic in Africa: A rising concern, Efforts, Challenges and Future recommendations.
    J Med Virol. 2021 Jul 21. doi: 10.1002/jmv.27219.
    >> Share

  191. WENBAN C, Heer RS, Baktash V, Kandiah P, et al
    Dexamethasone treatment may mitigate adverse effects of vitamin D deficiency in hospitalised Covid-19 patients.
    J Med Virol. 2021 Jul 17. doi: 10.1002/jmv.27215.
    >> Share

  192. NICHOLS L, Thompson M, Bentz GL
    Comparison of clinical characteristics of a patient with Epstein-Barr virus-associated seizure and patients with COVID-19-associated seizure.
    J Med Virol. 2021 Jul 16. doi: 10.1002/jmv.27197.
    >> Share

  193. AL KHAMES AGA QA, Alkhaffaf WH, Hatem TH, Nassir KF, et al
    SAFETY OF COVID-19 VACCINES.
    J Med Virol. 2021 Jul 16. doi: 10.1002/jmv.27214.
    >> Share

  194. LING Y, Zhong J, Luo J
    Safety and Effectiveness of SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis.
    J Med Virol. 2021 Jul 15. doi: 10.1002/jmv.27203.
    >> Share

  195. ARANHA C, Patel V, Bhor V, Gogoi D, et al
    Cycle threshold values in RT-PCR to determine dynamics of SARS-CoV-2 viral load: An approach to reduce isolation period for COVID-19 patients.
    J Med Virol. 2021 Jul 15. doi: 10.1002/jmv.27206.
    >> Share

  196. ABOBAKER A, Darrat M
    The association between biochemically confirmed thyroid gland disorder and morbidity and mortality in patients with COVID-19.
    J Med Virol. 2021 Jul 14. doi: 10.1002/jmv.27213.
    >> Share

  197. UWISHEMA O, Adanur I, Babatunde AO, Hasan MM, et al
    Viral Infections amidst COVID-19 in Africa: Implications and Recommendations.
    J Med Virol. 2021 Jul 14. doi: 10.1002/jmv.27211.
    >> Share

  198. PASCARELLA S, Ciccozzi M, Zella D, Bianchi M, et al
    SARS-CoV-2 B.1.617 Indian variants: are electrostatic potential changes responsible for a higher transmission rate?
    J Med Virol. 2021 Jul 14. doi: 10.1002/jmv.27210.
    >> Share

  199. GULEC EY, Cesur NP, Fazlioglu GY, Kazezoglu C, et al
    Effect of Different Storage Conditions on Covid-19 RT-PCR Results.
    J Med Virol. 2021 Jul 14. doi: 10.1002/jmv.27204.
    >> Share

  200. AKDEMIR Y, Haciseyitoglu D, Celebi G, Aydemir C, et al
    Probable viremia and positive placental swabs for SARS-CoV-2 in a preterm pregnant woman with mild COVID-19.
    J Med Virol. 2021 Jul 14. doi: 10.1002/jmv.27202.
    >> Share

  201. OZTURK A, Bozok T, Bozok TS
    Evaluation of Rapid Antibody Test and Chest Computed Tomography Results of COVID-19 Patients: A Retrospective Study.
    J Med Virol. 2021 Jul 14. doi: 10.1002/jmv.27209.
    >> Share

  202. RAHMAN FI, Islam MR, Bhuiyan MA
    Mucormycosis or black fungus infection is a new scare in South Asian countries during COVID-19 pandemic: Associated risk factors and preventive measures.
    J Med Virol. 2021 Jul 14. doi: 10.1002/jmv.27207.
    >> Share

  203. BORGOGNA C, De Andrea M, Griffante G, Lai A, et al
    SARS-CoV-2 re-infection in a cancer patient with a defective neutralizing humoral response.
    J Med Virol. 2021 Jul 14. doi: 10.1002/jmv.27200.
    >> Share

  204. ZHANG S, Ning Y, Rong Y, Nie Y, et al
    Rapid immunoassay and clinical evaluation of the SARS-CoV-2 antibody assay on the Real Express-6 analyzer.
    J Med Virol. 2021 Jul 13. doi: 10.1002/jmv.27201.
    >> Share

  205. KALANTARI S, Fard SR, Maleki D, Taher MT, et al
    Comparing the effectiveness of Atazanavir/Ritonavir/Dolutegravir/Hydroxychloroquine and Lopinavir/Ritonavir/Hydroxychloroquine treatment regimens in COVID-19 patients.
    J Med Virol. 2021 Jul 13. doi: 10.1002/jmv.27195.
    >> Share

  206. KAYAASLAN B, Eser F, Kalem AK, Kaya G, et al
    Post-covid Syndrome: A Single-Center Questionnaire Study On 1007 Participants Recovered from COVID-19.
    J Med Virol. 2021 Jul 13. doi: 10.1002/jmv.27198.
    >> Share

  207. ZELLA D, Giovanetti M, Benedetti F, Unali F, et al
    The variants question: what is the problem?
    J Med Virol. 2021 Jul 13. doi: 10.1002/jmv.27196.
    >> Share

  208. ELGENDY MO, Abdelrahim MEA
    Public awareness about coronavirus vaccine, vaccine acceptance, and hesitancy.
    J Med Virol. 2021 Jul 13. doi: 10.1002/jmv.27199.
    >> Share

  209. CONTICINI E, D'Alessandro M, Bergantini L, Bargagli E, et al
    Relapse of microscopic polyangiitis after vaccination against COVID-19: a case report.
    J Med Virol. 2021 Jul 12. doi: 10.1002/jmv.27192.
    >> Share

  210. FANG S, Liu S, Shen J, Lu AZ, et al
    Updated SARS-CoV-2 Single Nucleotide Variants and Mortality Association.
    J Med Virol. 2021 Jul 10. doi: 10.1002/jmv.27191.
    >> Share

  211. ABUSREWIL Z, Alhudiri IM, Kaal HH, Meshri SEE, et al
    Time scale performance of rapid antigen testing for SARS-COV-2: evaluation of ten rapid antigen assays.
    J Med Virol. 2021 Jul 9. doi: 10.1002/jmv.27186.
    >> Share

  212. SAHIN E, Bozdayi G, Yigit S, Muftah H, et al
    Genomic Characterization of SARS-CoV-2 Isolates from Patients in Turkey Reveals the Presence of Novel Mutations in Spike and nsp12 Proteins.
    J Med Virol. 2021 Jul 9. doi: 10.1002/jmv.27188.
    >> Share

  213. AFSHAR ZM, Babazadeh A, Hasanpour A, Barary M, et al
    Dermatological manifestations associated with COVID-19: A comprehensive review of the current knowledge.
    J Med Virol. 2021 Jul 9. doi: 10.1002/jmv.27187.
    >> Share

  214. AKSAKAL A, Kerget B, Kerget F, Askin S, et al
    Evaluation of the relationship between macrophage migration inhibitory factor level and clinical course in patients with COVID-19 pneumonia.
    J Med Virol. 2021 Jul 9. doi: 10.1002/jmv.27189.
    >> Share

  215. SLAVOV SN, Patane JSL, Bezerra RDS, Giovanetti M, et al
    GENOMIC MONITORING UNVEIL THE EARLY DETECTION OF THE SARS-COV-2 B.1.351 (BETA) VARIANT (20H/501Y.V2) IN BRAZIL.
    J Med Virol. 2021 Jul 9. doi: 10.1002/jmv.27190.
    >> Share

  216. ALAY H, Laloglu E
    The Role of Angiopoietin-2 and Surfactant Protein-D Levels in SARS-CoV-2-related lung injury: A prospective, observational, cohort study.
    J Med Virol. 2021 Jul 7. doi: 10.1002/jmv.27184.
    >> Share

  217. TANBOGA IH
    Statistical modelling, dichotomization and non-linearity.
    J Med Virol. 2021 Jul 7. doi: 10.1002/jmv.27183.
    >> Share

  218. SUVVARI TK, Rajesh E, D Silva RG, Corriero AC, et al
    SARS-CoV-2 Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT): Promoting Awareness to Improve Patient-Doctor Trust.
    J Med Virol. 2021 Jul 7. doi: 10.1002/jmv.27176.
    >> Share

  219. SINGH Y, Fuloria NK, Fuloria S, Subramaniyan V, et al
    N-terminal domain of SARS CoV-2 spike protein mutation associated reduction in effectivity of neutralizing antibody with vaccinated individuals.
    J Med Virol. 2021 Jul 7. doi: 10.1002/jmv.27181.
    >> Share

  220. BISTROVIC P, Lucijanic M
    Remdesivir might induce changes in electrocardiogram beyond bradycardia in patients with Coronavirus disease 2019 (COVID-19) - the pilot study.
    J Med Virol. 2021 Jul 7. doi: 10.1002/jmv.27177.
    >> Share

  221. YU JL, Hou S, Feng YT, Bu G, et al
    Emergence of a young case infected with avian influenza A (H5N6) in Anhui Province, East China during the COVID-19 pandemic.
    J Med Virol. 2021 Jul 7. doi: 10.1002/jmv.27179.
    >> Share

  222. KUITUNEN I, Artama M, Haapanen M, Renko M, et al
    Rhinovirus spread in children during the COVID-19 pandemic despite social restrictions-a nationwide register study in Finland.
    J Med Virol. 2021 Jul 6. doi: 10.1002/jmv.27180.
    >> Share

  223. SHAHID S, Raza M, Junejo S, Maqsood S, et al
    Clinical Features and Outcome of COVID-19 positive children from a tertiary healthcare Hospital in Karachi.
    J Med Virol. 2021 Jul 6. doi: 10.1002/jmv.27178.
    >> Share

  224. MOUSAVI-ROKNABADI RS, Haddad F, Fazlzadeh A, Kheirabadi D, et al
    Investigation of plasma exchange and hemoperfusion effects and complications for the treatment of patients with severe COVID-19 (SARS-CoV-2) disease: a systematic scoping review.
    J Med Virol. 2021 Jul 6. doi: 10.1002/jmv.27182.
    >> Share

  225. RASHKI A, Hoseinpour Dehkordi A, Nemati R, Tavousi P, et al
    What does COVID-19 Testing Results Really Say? The Real Statistics Concealed Behind the Accessible Data.
    J Med Virol. 2021 Jul 5. doi: 10.1002/jmv.27173.
    >> Share

  226. MARCO C, Sheyda K, Angelo C, Riccardo C, et al
    AstraZeneca (AZD1222) Covid 19 vaccine-associated adverse drug event: a case report.
    J Med Virol. 2021 Jul 2. doi: 10.1002/jmv.27175.
    >> Share

  227. ASGHAR MS, Yasmin F, Dapke K, Phadke R, et al
    Derangements of Biochemical Markers and Thyroid Function Analysis Among COVID-19 Positive Patients: A Developing Country Single-Center Experience.
    J Med Virol. 2021 Jul 2. doi: 10.1002/jmv.27174.
    >> Share

  228. RAMIREZ-HINOJOSA JP, Rodriguez-Sanchez Y, Romero-Gonzalez AK, Chavez-Gutierrez M, et al
    Association between cycle threshold (Ct) values and clinical and laboratory data in inpatients with COVID-19 and asymptomatic health workers.
    J Med Virol. 2021 Jul 1. doi: 10.1002/jmv.27170.
    >> Share

  229. LUKASZEWICZ AC, Venet F, Faure A, Vignot E, et al
    Immunostimulation with Interferon-gamma in protracted SARS-Cov-2 pneumonia.
    J Med Virol. 2021 Jul 1. doi: 10.1002/jmv.27172.
    >> Share

  230. CAMARGO JF, Lin RY, Komanduri KV
    Lack of correlation between the SARS-CoV-2 cycle threshold (Ct) value and clinical outcomes in patients with COVID-19.
    J Med Virol. 2021 Jul 1. doi: 10.1002/jmv.27171.
    >> Share

    June 2021
  231. HASAN MM, Costa ACDS, Xenophontos E, Mohanan P, et al
    Lassa Fever and COVID-19 in Africa: A double crisis on the fragile health system.
    J Med Virol. 2021 Jun 30. doi: 10.1002/jmv.27169.
    >> Share

  232. ABE H, Ushijima Y, Bikangui R, Zoa-Assoumou S, et al
    Unrecognized introduction of SARS-CoV-2 variants of concern to Central Africa: Import and local transmission of B.1.1.7 in Gabon in the very early stage of the variant spread to the African continent.
    J Med Virol. 2021 Jun 29. doi: 10.1002/jmv.27164.
    >> Share

  233. IVANOV A, Semenova E
    Long-term monitoring of the development and extinction of IgA and IgG responses to SARS-CoV-2 infection.
    J Med Virol. 2021 Jun 29. doi: 10.1002/jmv.27166.
    >> Share

  234. JUSCAMAYTA-LOPEZ E, Carhuaricra D, Tarazona D, Valdivia F, et al
    Phylogenomics reveals multiple introductions and early spread of SARS-CoV-2 into Peru.
    J Med Virol. 2021 Jun 29. doi: 10.1002/jmv.27167.
    >> Share

  235. UWISHEMA O, Adriano LF, Torbati T, Onyeaka H, et al
    Measles crisis in Africa amidst the COVID-19 pandemic: Delayed measles vaccine administration may cause a measles outbreak in Africa.
    J Med Virol. 2021 Jun 28. doi: 10.1002/jmv.27150.
    >> Share

  236. BIRD PW, Sandhu K, Fletcher O, Ames B, et al
    Retrospective SARS-CoV-2 IgG screening during the first wave (March-June 2020) of the COVID-19 pandemic in the UK.
    J Med Virol. 2021 Jun 26. doi: 10.1002/jmv.27162.
    >> Share

  237. ABDELRAHMAN MM, Abd-Elrahman NM, Bakheet TM
    Persistence of symptoms after improvement of acute COVID19 infection, a longitudinal study.
    J Med Virol. 2021 Jun 25. doi: 10.1002/jmv.27156.
    >> Share

  238. CELIK SK, Genc GC, Piskin N, Acikgoz B, et al
    Polymorphisms of ACE (I/D) and ACE2 Receptor Gene (Rs2106809, Rs2285666) are not Related to the Clinical Course of COVID-19; A Case Study.
    J Med Virol. 2021 Jun 25. doi: 10.1002/jmv.27160.
    >> Share

  239. PANDOLFI S, Simonetti V, Ricevuti G, Chirumbolo S, et al
    Paracetamol in the home treatment of early COVID-19 symptoms: A possible foe rather than a friend for elderly patients?
    J Med Virol. 2021 Jun 25. doi: 10.1002/jmv.27158.
    >> Share

  240. MATSUZAKI N, Orihara Y, Kodana M, Kitagawa Y, et al
    Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS((R)) SARS-CoV-2 Antigen Test.
    J Med Virol. 2021 Jun 25. doi: 10.1002/jmv.27153.
    >> Share

  241. KHAN F, Sharma P, Pandey S, Sharma D, et al
    COVID-19-associated Guillain Barre syndrome: Post-infectious alone or neuroinvasive too?
    J Med Virol. 2021 Jun 25. doi: 10.1002/jmv.27159.
    >> Share

  242. TANG CY, Wang Y, McElroy JA, Li T, et al
    Reinfection with two genetically distinct SARS-CoV-2 viruses within 19 days.
    J Med Virol. 2021 Jun 25. doi: 10.1002/jmv.27154.
    >> Share

  243. PERCHETTI GA, Zhu H, Mills MG, Shrestha L, et al
    Specific allelic discrimination of N501Y and other SARS-CoV-2 mutations by ddPCR detects B.1.1.7 lineage in Washington State.
    J Med Virol. 2021 Jun 25. doi: 10.1002/jmv.27155.
    >> Share

  244. ZENG F, Wu M, Wang J, Li J, et al
    Over one-year duration and age difference of SARS-CoV-2 antibody in convalescent COVID-19 patients.
    J Med Virol. 2021 Jun 25. doi: 10.1002/jmv.27152.
    >> Share

  245. DURMAZ B, Abdulmajed O, Durmaz R, Koroglu M, et al
    RESPIRATORY VIRUSES IN HEALTHY MIDDLE EAR AND MIDDLE EAR WITH OTITIS MEDIA WITH EFFUSION.
    J Med Virol. 2021 Jun 23. doi: 10.1002/jmv.27151.
    >> Share

  246. ELEFTHERIOU I, Dasoula F, Dimopoulou D, Lebessi E, et al
    Real-life evaluation of a COVID-19 rapid antigen detection test in hospitalized children.
    J Med Virol. 2021 Jun 22. doi: 10.1002/jmv.27149.
    >> Share

  247. ANGELETTI S, Travaglino F, Spoto S, Pascarella MC, et al
    COVID-19 Sniffer Dog experimental training: which protocol and which implications for reliable identification?
    J Med Virol. 2021 Jun 21. doi: 10.1002/jmv.27147.
    >> Share

  248. POURHOSEINGHOLI MA, Jafari R, Jafari NJ, Rahimi-Bashar F, et al
    Predicting One-year post-COVID-19 mortality based on chest computed tomography scan.
    J Med Virol. 2021 Jun 21. doi: 10.1002/jmv.27146.
    >> Share

  249. ULLAH I, Hassan W, Tahir MJ, Ahmed A, et al
    Antiretrovirals shortage in Kenya amid COVID-19.
    J Med Virol. 2021 Jun 18. doi: 10.1002/jmv.27134.
    >> Share

  250. HIROI S, Kubota-Koketsu R, Sasaki T, Morikawa S, et al
    Infectivity Assay for Detection of SARS-CoV-2 in Samples from Patients with COVID-19.
    J Med Virol. 2021 Jun 17. doi: 10.1002/jmv.27145.
    >> Share

  251. LEI J, Li M, Wang X
    Predicting the development trend of the second wave of COVID-19 in five European countries.
    J Med Virol. 2021 Jun 17. doi: 10.1002/jmv.27143.
    >> Share

  252. PICCHI G, Di Norcia M, Cofini V, Sinatti G, et al
    Laboratory Parameters related to Severe Disease and Death in SARS-CoV-2 Pneumonia: Retrospective Analysis.
    J Med Virol. 2021 Jun 17. doi: 10.1002/jmv.27141.
    >> Share

  253. LUNDSTROM A, Ziegler L, Havervall S, Rudberg AS, et al
    Soluble angiotensin-converting enzyme 2 is transiently elevated in COVID-19 and correlates with specific inflammatory and endothelial markers.
    J Med Virol. 2021 Jun 17. doi: 10.1002/jmv.27144.
    >> Share

  254. MOHAN A, Temitope RA, Cavdaroglu S, Hasan MM, et al
    Measles returns to the Democratic Republic of Congo: A new predicament amid the COVID-19 crisis.
    J Med Virol. 2021 Jun 17. doi: 10.1002/jmv.27137.
    >> Share

  255. BARUA S, Hoque M, Kelly PJ, Bai J, et al
    High-resolution melting curve FRET-PCR rapidly identifies SARS-CoV-2 mutations.
    J Med Virol. 2021 Jun 17. doi: 10.1002/jmv.27139.
    >> Share

  256. MORENO-PEREZ O, Ramos JM, Gimeno A, Rodriguez JC, et al
    Medium-term serostatus in Spanish case series recovered from SARS-CoV-2 infection.
    J Med Virol. 2021 Jun 17. doi: 10.1002/jmv.27135.
    >> Share

  257. ZHU C, He G, Yin Q, Zeng L, et al
    Molecular biology of the SARs-CoV-2 spike protein: A review of current knowledge.
    J Med Virol. 2021 Jun 14. doi: 10.1002/jmv.27132.
    >> Share

  258. NAKHLBAND A, Fakhari A, Azizi H
    Interferon-alpha position in combating with COVID-19: A systematic review.
    J Med Virol. 2021 Jun 8. doi: 10.1002/jmv.27072.
    >> Share

  259. POON KS, Tee NW
    Detecting SARS-CoV-2 RNA in fecal specimens: The practical challenges.
    J Med Virol. 2021 Jun 8. doi: 10.1002/jmv.27071.
    >> Share

  260. AL-JARALLAH M, Rajan R, Dashti R, Saber AA, et al
    In-hospital Mortality in SARS-CoV-2 stratified by serum 25-Hydroxy-Vitamin D levels: A Retrospective Study.
    J Med Virol. 2021 Jun 7. doi: 10.1002/jmv.27133.
    >> Share

  261. RODRIGUEZ-VIDALES EP, Garza-Carrillo D, Perez-Trujillo JJ, Robles-Rodriguez OA, et al
    PREVALENCE OF IgG ANTIBODIES INDUCED BY THE SARS-COV-2 VIRUS IN ASYMPTOMATIC ADULTS IN NUEVO LEON, MEXICO.
    J Med Virol. 2021 Jun 7. doi: 10.1002/jmv.27131.
    >> Share

  262. KARCIOGLU BATUR L, Hekim N
    Correlation between interleukin gene polymorphisms and current prevalence and mortality rates due to novel coronavirus disease 2019 (COVID-2019) in 23 countries.
    J Med Virol. 2021 Jun 3. doi: 10.1002/jmv.27127.
    >> Share

  263. UWISHEMA O, Adriano LF, Chalhoub E, Onyeaka H, et al
    Bird Flu Outbreak Amidst COVID-19 Pandemic in South Africa: Efforts and Challenges at Hand.
    J Med Virol. 2021 Jun 3. doi: 10.1002/jmv.27124.
    >> Share

  264. DEGERLI E, Derin S, Oruc K, Samanci NS, et al
    The Demographic Characteristic, Prognosis and the Relationship with Cancer Subtypes of Hospitalised Covid-19 Patients with Malignancy: A Single-Center Experience.
    J Med Virol. 2021 Jun 3. doi: 10.1002/jmv.27123.
    >> Share

  265. FINSTERER J
    Diagnose SARS-CoV-2 associated Guillain-Barre syndrome upon appropriate criteria and after exclusion of differentials.
    J Med Virol. 2021 Jun 3. doi: 10.1002/jmv.27129.
    >> Share

  266. SINACI S, Ocal DF, Seven B, Anuk AT, et al
    Vertical Transmission of SARS-CoV-2: a prospective cross-sectional study from a tertiary center.
    J Med Virol. 2021 Jun 3. doi: 10.1002/jmv.27128.
    >> Share

  267. BARCHUK A, Shirokov D, Sergeeva M, Tursun Zade R, et al
    Evaluation of the performance of SARS-CoV-2 antibody assays for the longitudinal population-based study of COVID-19 spread in St. Petersburg, Russia: Interpretation.
    J Med Virol. 2021 Jun 3. doi: 10.1002/jmv.27126.
    >> Share

  268. ABD-ELSALAM S, Noor RA, Badawi R, Khalaf M, et al
    Clinical study evaluating the efficacy of ivermectin in COVID-19 treatment: A randomized controlled study.
    J Med Virol. 2021 Jun 2. doi: 10.1002/jmv.27122.
    >> Share

  269. NIGAR S, Tanjil Shah SM, Setu MAA, Dip SD, et al
    Relative expression of pro-inflammatory molecules in COVID-19 patients manifested disease severities.
    J Med Virol. 2021 Jun 1. doi: 10.1002/jmv.27112.
    >> Share

  270. MOHAN A, Fakhor H, Nimavat N, Wara UU, et al
    Dengue and COVID-19: A risk of coepidemic in Ethiopia.
    J Med Virol. 2021 Jun 1. doi: 10.1002/jmv.27116.
    >> Share

  271. YANG Y, Yang P, Huang C, Wu Y, et al
    Inhibitory effect on SARS-CoV-2 infection of neferine by blocking Ca(2+) -dependent membrane fusion.
    J Med Virol. 2021 Jun 1. doi: 10.1002/jmv.27117.
    >> Share

  272. WANG Y, Feng R, Xu J, Hou H, et al
    An updated meta-analysis on the association between tuberculosis and COVID-19 severity and mortality.
    J Med Virol. 2021 Jun 1. doi: 10.1002/jmv.27119.
    >> Share

  273. EMMERICH P, von Possel R, Hemmer CJ, Fritzsche C, et al
    Longitudinal detection of SARS-CoV-2-specific antibody responses with different serological methods.
    J Med Virol. 2021 Jun 1. doi: 10.1002/jmv.27113.
    >> Share

    May 2021
  274. KARATAS M, Tatar E, Simsek C, Yildirim AM, et al
    COVID-19 pneumonia in kidney transplant recipients: A promising treatment algorithm in the absence of a disease-specific drug.
    J Med Virol. 2021 May 29. doi: 10.1002/jmv.27110.
    >> Share

  275. WOLTERS F, Grunberg M, Huber M, Kessler HH, et al
    European multicenter evaluation of Xpert(R) Xpress SARS-CoV-2/Flu/RSV test.
    J Med Virol. 2021 May 29. doi: 10.1002/jmv.27111.
    >> Share

  276. ABI ZEID DAOU C, Natout MA, El Hadi N
    Biphasic anaphylaxis after exposure to the first dose of Pfizer-BioNTech COVID-19 mRNA vaccine.
    J Med Virol. 2021 May 29. doi: 10.1002/jmv.27109.
    >> Share

  277. BLAIRON L, Cupaiolo R, Thomas I, Piteus S, et al
    Efficacy comparison of three rapid antigen tests for SARS-CoV-2 and how viral load impact their performance.
    J Med Virol. 2021 May 29. doi: 10.1002/jmv.27108.
    >> Share

  278. AKAMA-GARREN EH, Li JX
    Prior immunosuppressive therapy is associated with mortality in COVID-19 patients: a retrospective study of 835 patients.
    J Med Virol. 2021 May 27. doi: 10.1002/jmv.27105.
    >> Share

  279. SOYTAS RB, Cengiz M, Islamoglu MS, Uysal BB, et al
    Does the COVID-19 seroconversion in older adults resemble the young?
    J Med Virol. 2021 May 27. doi: 10.1002/jmv.27106.
    >> Share

  280. GUARIN G, Lo KB, Bhargav R, Salacup G, et al
    Factors Associated with Hospital Readmissions among Patients with COVID-19: A Single Center Experience.
    J Med Virol. 2021 May 27. doi: 10.1002/jmv.27104.
    >> Share

  281. DAO MH, Phan LT, Cao TM, Luong QC, et al
    Genome-wide analysis of SARS-CoV-2 in VietnamGenome-wide analysis of SARS-CoV-2 strains circulating in Vietnam: understanding the nature of the epidemic and role of the D614G mutation.
    J Med Virol. 2021 May 27. doi: 10.1002/jmv.27103.
    >> Share

  282. AGHBASH PS, Eslami N, Shirvaliloo M, Baghi HB, et al
    Viral Co-infections in COVID-19.
    J Med Virol. 2021 May 25. doi: 10.1002/jmv.27102.
    >> Share

  283. BARDAKCI MI, Ozturk EN, Ozkarafakili MA, Ozkurt H, et al
    EVALUATION of LONG TERM RADIOLOGICAL FINDINGS, PULMONARY FUNCTIONS AND HEALTH-RELATED QUALITY OF LIFE IN SURVIVORS OF SEVERE COVID-19.
    J Med Virol. 2021 May 25. doi: 10.1002/jmv.27101.
    >> Share

  284. BAYRAM A, Demirbakan H, Karadeniz PG, Erdogan M, et al
    Quantitation of antibodies against SARS-CoV-2 spike protein after two doses of CoronaVac in health care workers.
    J Med Virol. 2021 May 21. doi: 10.1002/jmv.27098.
    >> Share

  285. KERGET B, Kerget F, Aksakal A, Askin S, et al
    Evaluation of the relationship between KIM-1 and suPAR levels and clinical severity in COVID-19 patients: A different perspective on suPAR.
    J Med Virol. 2021 May 21. doi: 10.1002/jmv.27099.
    >> Share

  286. ERDOGAN A, Can FE, Gonullu H
    Evaluation of the prognostic role of NLR, LMR, PLR and LCR ratio in COVID-19 patients.
    J Med Virol. 2021 May 21. doi: 10.1002/jmv.27097.
    >> Share

  287. GAO X, Liu Y, Zou S, Liu P, et al
    Genome-wide screening of SARS-CoV-2 infection-related genes based on the blood leucocytes sequencing dataset of patients with COVID-19.
    J Med Virol. 2021 May 19. doi: 10.1002/jmv.27093.
    >> Share

  288. ABORODE AT, Olofinsao OA, Osmond E, Batubo AP, et al
    Equal Access of COVID-19 Vaccine distribution in Africa: Challenges and Way Forward.
    J Med Virol. 2021 May 19. doi: 10.1002/jmv.27095.
    >> Share

  289. LAPIC I, Segulja D, Rogic D
    Assessment of salivary antibody response to BNT162b2 mRNA COVID-19 vaccination.
    J Med Virol. 2021 May 19. doi: 10.1002/jmv.27096.
    >> Share

  290. REZA S, Corentin D, Te-Din H, Pierre B, et al
    Rapid COVID-19 antigenic tests: Usefulness of a modified method for diagnosis.
    J Med Virol. 2021 May 19. doi: 10.1002/jmv.27094.
    >> Share

  291. PEREZ-GARCIA F, Romanyk J, Gutierrez HM, Ballestero AL, et al
    Comparative evaluation of Panbio and SD Biosensor antigen rapid diagnostic tests for COVID-19 diagnosis.
    J Med Virol. 2021 May 17. doi: 10.1002/jmv.27089.
    >> Share

  292. HUBERT F, Chessa C, Beby-Defaux A, Bourgoin A, et al
    Emergence of the SARS-CoV-2 B.1.1.7 variant observed at the Poitiers University Hospital.
    J Med Virol. 2021 May 17. doi: 10.1002/jmv.27092.
    >> Share

  293. MAHMOUD SA, Ganesan S, Ibrahim E, Thakre B, et al
    Evaluation of six different rapid methods for nucleic acid detection of SARS-COV-2 virus.
    J Med Virol. 2021 May 17. doi: 10.1002/jmv.27090.
    >> Share

  294. MATIASHOVA L, Isayeva G, Shanker A, Tsagkaris C, et al
    COVID-19 vaccination in Ukraine: An update on the status of vaccination and the challenges at hand.
    J Med Virol. 2021 May 17. doi: 10.1002/jmv.27091.
    >> Share

  295. KHO J, Mandal AKJ, Geraldes R, Tuzlali H, et al
    COVID-19 encephalitis and Wernicke's encephalopathy.
    J Med Virol. 2021 May 15. doi: 10.1002/jmv.27088.
    >> Share

  296. WU D, Rao Q, Zhang W
    The natural course of COVID-19 patients without clinical intervention.
    J Med Virol. 2021 May 15. doi: 10.1002/jmv.27087.
    >> Share

  297. ABBAS M, Verma S, Verma S, Siddiqui S, et al
    Association of GSTM1 and GSTT1 gene polymorphisms with COVID-19 susceptibility and its outcome.
    J Med Virol. 2021 May 15. doi: 10.1002/jmv.27076.
    >> Share

  298. VADAKEDATH S, Kandi V, Mohapatra RK, Pinnelli VBK, et al
    Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease-19 (COVID-19): a scoping review.
    J Med Virol. 2021 May 15. doi: 10.1002/jmv.27081.
    >> Share

  299. FINSTERER J, Scorza FA
    Consider differentials before diagnosing SARS-CoV-2 associated Guillain-Barre syndrome.
    J Med Virol. 2021 May 15. doi: 10.1002/jmv.27084.
    >> Share

  300. PEREIRA F, Tosta S, Lima MM, Reboredo de Oliveira da Silva L, et al
    Genomic surveillance activities unveil the introduction of the SARS-CoV-2 B.1.525 variant of interest in Brazil: Case Report.
    J Med Virol. 2021 May 15. doi: 10.1002/jmv.27086.
    >> Share

  301. VIANA-GARCIA A, Pina-Belmonte A, Salavert-Pamblanco S, Atienza-Garcia A, et al
    Multisystemic inflammatory syndrome in a young adult after SARS-CoV2 infection: case report.
    J Med Virol. 2021 May 15. doi: 10.1002/jmv.27083.
    >> Share

  302. GETACHEW B, Tizabi Y
    Vitamin D and COVID-19: Role of ACE2, Age, Gender and Ethnicity.
    J Med Virol. 2021 May 14. doi: 10.1002/jmv.27075.
    >> Share

  303. PUNEET G, Surender K, Sudhan SS
    SARS-CoV-2 prevalence, maternal and perinatal outcomes among pregnant women admitted for delivery: Experience from Covid-19 dedicated maternity hospital in Jammu, Jammu and Kashmir (India).
    J Med Virol. 2021 May 11. doi: 10.1002/jmv.27074.
    >> Share

  304. HUANG C, Jiang Y, Yan J
    Comparative Analyses of ACE2 and TMPRSS2 gene: Implications for the Risk for Which Vertebrate Animals Are Susceptible to SARS-CoV-2.
    J Med Virol. 2021 May 11. doi: 10.1002/jmv.27073.
    >> Share

  305. HENRY BM, Szergyuk I, Oliveira MHS, Lippi G, et al
    Complement levels at admission as a reflection of Coronavirus Disease 19 (COVID-19) severity state.
    J Med Virol. 2021 May 11. doi: 10.1002/jmv.27077.
    >> Share

  306. POURAKBARI B, Mahmoudi S, Mahmoudieh Y, Eshaghi H, et al
    SARS-CoV-2 RNAaemia in children: An Iranian referral hospital-based study.
    J Med Virol. 2021 May 10. doi: 10.1002/jmv.27065.
    >> Share

  307. KESHAVARZ P, Yazdanpanah F, Azhdari S, Kavandi H, et al
    Coronavirus Disease 2019 (COVID-19): A Systematic Review of 133 Children Presented with Kawasaki-like Multisystem Inflammatory Syndrome.
    J Med Virol. 2021 May 10. doi: 10.1002/jmv.27067.
    >> Share

  308. NOVAZZI F, Baj A, Genoni A, Spezia PG, et al
    SARS-CoV-2 B.1.1.7 reinfection after previous COVID-19 in two immunocompetent Italian patients.
    J Med Virol. 2021 May 10. doi: 10.1002/jmv.27066.
    >> Share

  309. HOLZNER C, Pabst D, Anastasiou OE, Dittmer U, et al
    SARS-CoV-2 rapid antigen test: Fast-safe or dangerous? An analysis in the emergency department of an university hospital.
    J Med Virol. 2021 May 9. doi: 10.1002/jmv.27033.
    >> Share

  310. HERNANDEZ MM, Banu R, Shrestha P, Patel A, et al
    RT-PCR/MALDI-TOF mass spectrometry-based detection of SARS-CoV-2 in saliva specimens.
    J Med Virol. 2021 May 8. doi: 10.1002/jmv.27069.
    >> Share

  311. GURSOY B, Surmeli CD, Alkan M, Satici C, et al
    Cytokine Storm in Severe COVID-19 Pneumonia.
    J Med Virol. 2021 May 8. doi: 10.1002/jmv.27068.
    >> Share

  312. DI GIACOMO S, Mercatelli D, Rakhimov A, Giorgi FM, et al
    Preliminary report on SARS-CoV-2 Spike mutation T478K.
    J Med Virol. 2021 May 5. doi: 10.1002/jmv.27062.
    >> Share

  313. EROL SA, Polat N, Akdas S, Ayral PA, et al
    Maternal Selenium Status has Crucial Role on Clinical Outcomes Of Pregnant Women With COVID-19 Infection.
    J Med Virol. 2021 May 5. doi: 10.1002/jmv.27064.
    >> Share

  314. MAK GC, Lau AW, Chan AM, Lam ET, et al
    The surveillance of spike protein for patients with COVID-19 detected in Hong Kong in 2020.
    J Med Virol. 2021 May 5. doi: 10.1002/jmv.27063.
    >> Share

  315. MANGANOTTI P, Bellavita G, Tommasini V, D'Acunto L, et al
    Cerebrospinal fluid and serum interleukins 6 and 8 during the acute and recovery phase in COVID-19 neuropathies patients.
    J Med Virol. 2021 May 5. doi: 10.1002/jmv.27061.
    >> Share

  316. ZABOLI E, Majidi H, Alizadeh-Navaei R, Hedayatizadeh-Omran A, et al
    Lymphopenia and lung complications in patients with coronavirus disease-2019 (COVID-19): A retrospective study based on clinical data.
    J Med Virol. 2021 May 4. doi: 10.1002/jmv.27060.
    >> Share

  317. KUITUNEN I
    Influenza season 2020-2021 did not begin in Finland despite the looser social restrictions during the second wave of COVID-19: A nationwide register study.
    J Med Virol. 2021 May 4. doi: 10.1002/jmv.27048.
    >> Share

  318. DE GREEF J, Scohy A, Zech F, Frank A, et al
    Determinants of IgG antibodies kinetics after severe and critical COVID-19.
    J Med Virol. 2021 May 4. doi: 10.1002/jmv.27059.
    >> Share

  319. TANVEER M, Ahmed A, Siddiqui A, Gudi SK, et al
    The mystery of plummeting cases of measles during COVID-19 pandemic in Pakistan: Hidden impact of collateral damage.
    J Med Virol. 2021 May 3. doi: 10.1002/jmv.27045.
    >> Share

  320. CAMOU F, Tinevez C, Beguet-Yachine M, Bellecave P, et al
    Feasibility of convalescent plasma therapy in severe COVID-19 patients with persistent SARS-CoV-2 viremia.
    J Med Virol. 2021 May 3. doi: 10.1002/jmv.27032.
    >> Share

  321. SAWAL I, Ahmad S, Tariq W, Tahir MJ, et al
    Unequal distribution of COVID-19 vaccine: A looming crisis.
    J Med Virol. 2021 May 3. doi: 10.1002/jmv.27031.
    >> Share

  322. LOPES EN, Fonseca V, Frias D, Tosta S, et al
    Betacoronaviruses genome analysis reveals evolution toward specific codons usage: implications for SARS-CoV-2 mitigation strategies.
    J Med Virol. 2021 May 2. doi: 10.1002/jmv.27056.
    >> Share

  323. PURUT YE, Giray B, Gurbuz E
    Effect of The Coronavirus Pandemic on Tumor Markers.
    J Med Virol. 2021 May 1. doi: 10.1002/jmv.27057.
    >> Share

  324. ZERVOU FN, Louie P, Stachel A, Zacharioudakis IM, et al
    SARS-CoV-2 antibodies: IgA correlates with severity of disease in early COVID-19 infection.
    J Med Virol. 2021 May 1. doi: 10.1002/jmv.27058.
    >> Share

    April 2021
  325. NIANOGO RA, Emeruwa, Gounder P, Manuel V, et al
    Optimal Uses of Pooled Testing for COVID-19 incorporating imperfect test performance and pool dilution effect: An Application to Congregate Settings in Los Angeles County.
    J Med Virol. 2021 Apr 30. doi: 10.1002/jmv.27054.
    >> Share

  326. LEI G, Meng F, Wang C, Yan J, et al
    The breadth of concomitant virological features in a family cluster outbreak of COVID-19 pneumonia.
    J Med Virol. 2021 Apr 30. doi: 10.1002/jmv.27055.
    >> Share

  327. TORRES I, Qualai J, Albert E, Bueno F, et al
    Real-life evaluation of a rapid extraction-free SARS-CoV-2 RT-PCR assay (COVID-19 PCR Fast-L) for the diagnosis of COVID-19.
    J Med Virol. 2021 Apr 29. doi: 10.1002/jmv.27039.
    >> Share

  328. HERNANDEZ C, Florez C, Castaneda S, Ballesteros N, et al
    Evaluation of the diagnostic performance of nine commercial RT-PCR kits for the detection of SARS-CoV-2 in Colombia.
    J Med Virol. 2021 Apr 29. doi: 10.1002/jmv.27051.
    >> Share

  329. KANG D, Ellgen C, Kulstad E
    Possible Effects of Air Temperature on COVID-19 Disease Severity and Transmission Rates.
    J Med Virol. 2021 Apr 29. doi: 10.1002/jmv.27042.
    >> Share

  330. RUSK DS, Strachan CC, Hunter BR
    Lack of Immune Response After mRNA Vaccination to SARS-CoV-2 in a Solid Organ Transplant Patient.
    J Med Virol. 2021 Apr 29. doi: 10.1002/jmv.27044.
    >> Share

  331. HAN L, Zhuang MW, Deng J, Zheng Y, et al
    SARS-CoV-2 ORF9b Antagonizes Type I and III Interferons by Targeting Multiple Components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING Signaling Pathways.
    J Med Virol. 2021 Apr 29. doi: 10.1002/jmv.27050.
    >> Share

  332. AGHAJANI MH, Moradi O, Amini H, Tehrani HA, et al
    Decreased In-Hospital Mortality Associated with Aspirin Administration in Hospitalized Patients Due to Severe COVID-19.
    J Med Virol. 2021 Apr 29. doi: 10.1002/jmv.27053.
    >> Share

  333. LEACH S, Harandi AM, Bergstrom T, Andersson LM, et al
    Comparable endemic coronavirus nucleoprotein-specific antibodies in mild and severe Covid-19 patients.
    J Med Virol. 2021 Apr 29. doi: 10.1002/jmv.27038.
    >> Share

  334. EID E, Abdullah L, Kurban M, Abbas O, et al
    Herpes Zoster emergence following mRNA COVID-19 Vaccine.
    J Med Virol. 2021 Apr 29. doi: 10.1002/jmv.27036.
    >> Share

  335. FENOGLIO D, Dentone C, Parodi A, Di Biagio A, et al
    Characterization of T lymphocytes in severe COVID-19 patients.
    J Med Virol. 2021 Apr 29. doi: 10.1002/jmv.27037.
    >> Share

  336. OBANDO-PEREDA G
    Can molecular mimicry explain the cytokine storm of SARS-CoV-2?: an in silico approach.
    J Med Virol. 2021 Apr 29. doi: 10.1002/jmv.27040.
    >> Share

  337. GILLEZEAU C, Alpert N, Caltabiano M, Flores R, et al
    Informing the Global COVID-19 Response by Estimating Excess Deaths in Italy During the COVID-19 and 1918 Influenza Pandemics.
    J Med Virol. 2021 Apr 29. doi: 10.1002/jmv.27052.
    >> Share

  338. BEST JH, Kong AM, Kaplan-Lewis E, Brawley OW, et al
    Treatment Patterns in US Patients Hospitalized With COVID-19 and Pulmonary Involvement.
    J Med Virol. 2021 Apr 29. doi: 10.1002/jmv.27049.
    >> Share

  339. LEE J, Song JU
    Diagnostic accuracy of the Cepheid Xpert Xpress and the Abbott ID NOW assay for rapid detection of SARS-CoV-2: A systematic review and meta-analysis.
    J Med Virol. 2021 Apr 29. doi: 10.1002/jmv.26994.
    >> Share

  340. DUBEY A, Kotnala G, Mandal TK, Sonkar SC, et al
    Evidence of presence of SARS-CoV-2 virus in atmospheric air and surfaces of dedicated COVID hospital.
    J Med Virol. 2021 Apr 29. doi: 10.1002/jmv.27029.
    >> Share

  341. CAKIR B
    "Development and Validation of Clinical Prediction Models to Estimate the Probability of Death in Hospitalized Patients with COVID-19: Insights from a Nationwide Database".
    J Med Virol. 2021 Apr 23. doi: 10.1002/jmv.27030.
    >> Share

  342. CAVDAROGLU S, Hasan MM, Mohan A, Xenophontos E, et al
    The spread of Yellow fever amidst the COVID-19 pandemic in Africa and the ongoing efforts to mitigate it.
    J Med Virol. 2021 Apr 19. doi: 10.1002/jmv.27027.
    >> Share

  343. MENDES CORREA MC, Leal FE, Villas Boas LS, Witkin SS, et al
    Prolonged presence of replication-competent SARS-CoV-2 in mildly symptomatic individuals: A Report of 2 Cases.
    J Med Virol. 2021 Apr 14. doi: 10.1002/jmv.27021.
    >> Share

  344. WILSON JM, Platts Mills TAE, Keshavarz B
    Reply to: The antibody response to the glycan alpha-Gal correlates with COVID-19 symptoms.
    J Med Virol. 2021 Apr 14. doi: 10.1002/jmv.27022.
    >> Share

  345. AKCAY N, Menetoglu ME, Bektas G, Sevketoglu E, et al
    Axonal Guillain-Barre syndrome associated with SARS-CoV-2 infection in a child.
    J Med Virol. 2021 Apr 14. doi: 10.1002/jmv.27018.
    >> Share

  346. HEMIDA MG, Alhammadi M, Almathen F, Alnaeem A, et al
    Exploring the potential roles of some rodents in the transmission of the Middle East respiratory syndrome coronavirus.
    J Med Virol. 2021 Apr 14. doi: 10.1002/jmv.27023.
    >> Share

  347. LABBE AC, Benoit P, Pare SG, Coutlee F, et al
    Comparison of saliva with oral and nasopharyngeal swabs for SARS-CoV-2 detection on various commercial and laboratory developed assays.
    J Med Virol. 2021 Apr 14. doi: 10.1002/jmv.27026.
    >> Share

  348. SIDDIQUI A, Ahmed A, Tanveer M, Arshad A, et al
    The crux of Pakistan's prolonged rabies vaccine shortage: a rising mortal threat in the COVID-19 pandemic.
    J Med Virol. 2021 Apr 14. doi: 10.1002/jmv.27024.
    >> Share

  349. ISHACK S, Lipner SR
    Bioinformatics and Immunoinformatics to Support COVID-19 Vaccine Development.
    J Med Virol. 2021 Apr 14. doi: 10.1002/jmv.27017.
    >> Share

  350. MURALIDAR S, Gopal G, Ambi SV
    Targeting the viral-entry facilitators of SARS-CoV-2 as a therapeutic strategy in COVID-19.
    J Med Virol. 2021 Apr 14. doi: 10.1002/jmv.27019.
    >> Share

  351. ALI Z, Sarwar M, Ansar S, Awan UA, et al
    COVID-19 vaccination hesitancy in patients with autoimmune diseases: A mystery that needs an immediate solution!
    J Med Virol. 2021 Apr 14. doi: 10.1002/jmv.27014.
    >> Share

  352. SHENG H, Wu L, Wu T, Peng B, et al
    Network Dynamic Model of Epidemic Transmission Introducing a Heterogeneous Control Factor.
    J Med Virol. 2021 Apr 14. doi: 10.1002/jmv.27025.
    >> Share

  353. GARCIA-CALAVARO C, Paternina-Caicedo A, Smith AD, Harrison LH, et al
    Covid-19 mortality needs age adjusting for international comparisons.
    J Med Virol. 2021 Apr 10. doi: 10.1002/jmv.27007.
    >> Share

  354. COSTA ACDS, Hasan MM, Xenophontos E, Mohanan P, et al
    COVID-19 And Zika: An emerging dilemma for Brazil.
    J Med Virol. 2021 Apr 10. doi: 10.1002/jmv.27006.
    >> Share

  355. TAHIR M
    Coronavirus genomic nsp14-ExoN, structure, role, mechanism, and potential application as a drug target.
    J Med Virol. 2021 Apr 10. doi: 10.1002/jmv.27009.
    >> Share

  356. RAPP JL, Tremblay D, Alpert N, Lieberman-Cribbin W, et al
    Red Cell Distribution Width is Associated with Mortality in Non-Anemic Patients with COVID-19.
    J Med Virol. 2021 Apr 10. doi: 10.1002/jmv.27011.
    >> Share

  357. ALI KM, Ali AM, Tawfeeq HM, Figueredo G, et al
    Hypoalbuminemia in Patients Following Their Recovery from Severe Coronavirus Disease 2019.
    J Med Virol. 2021 Apr 8. doi: 10.1002/jmv.27002.
    >> Share

  358. NAEMI FMA, Al-Adwani S, Al-Khatabi H, Al-Nazawi A, et al
    Association between the HLA genotype and the severity of COVID-19 infection among South Asians.
    J Med Virol. 2021 Apr 8. doi: 10.1002/jmv.27003.
    >> Share

  359. WAN XF, Tang CY, Ritter D, Wang Y, et al
    SARS-CoV-2 show no infectivity at later stages in a prolonged COVID-19 patient despite positivity in RNA testing.
    J Med Virol. 2021 Apr 8. doi: 10.1002/jmv.27001.
    >> Share

  360. NASIR N, Rehman F, Omair SF
    Article title: Risk factors for bacterial infections in patients with moderate to severe COVID-19: A case control study.
    J Med Virol. 2021 Apr 6. doi: 10.1002/jmv.27000.
    >> Share

  361. KADALI RAK, Janagama R, Peruru S, Gajula V, et al
    Adverse effects of COVID-19 mRNA-1273 vaccine: A randomized, cross-sectional study on healthcare workers with detailed self-reported symptoms.
    J Med Virol. 2021 Apr 6. doi: 10.1002/jmv.26996.
    >> Share

  362. RANI PR, Imran M, Lakshmi JV, Jolly B, et al
    Symptomatic reinfection of SARS-CoV-2 with spike protein variant N440K associated with immune escape.
    J Med Virol. 2021 Apr 5. doi: 10.1002/jmv.26997.
    >> Share

  363. FUKUDA Y, Homma T, Inoue H, Onitsuka C, et al
    Downregulation of type III interferons in patients with severe COVID-19.
    J Med Virol. 2021 Apr 3. doi: 10.1002/jmv.26993.
    >> Share

  364. MOVAHED SMM, Akhavizadegan H, Dolatkhani F, Nejadghaderi SA, et al
    Different incidences of acute kidney injury (AKI) and outcomes in COVID-19 patients with and without non-azithromycin antibiotics: a retrospective study.
    J Med Virol. 2021 Apr 1. doi: 10.1002/jmv.26992.
    >> Share

  365. KUMAR A, Sahu A, Kaushik J, Arora A, et al
    Unilateral sub-macular hemorrhage- novel presentation of COVID-19 infection.
    J Med Virol. 2021 Apr 1. doi: 10.1002/jmv.26991.
    >> Share

    March 2021
  366. CINGOLANI V
    Hypothesis of Zinc Ascorbate as best zinc ionophore for raising anti-viral resistance against Covid-19.
    J Med Virol. 2021 Mar 31. doi: 10.1002/jmv.26989.
    >> Share

  367. PHADKE R, Mohan A, Cavdaroglu S, Dapke K, et al
    Dengue amidst COVID-19 in India: The mystery of plummeting cases.
    J Med Virol. 2021 Mar 31. doi: 10.1002/jmv.26987.
    >> Share

  368. CALLEGARO A, Borleri D, Farina C, Napolitano G, et al
    Antibody response to SARS-CoV-2 vaccination is extremely vivacious in subjects with previous SARS-CoV-2 infection.
    J Med Virol. 2021 Mar 31. doi: 10.1002/jmv.26982.
    >> Share

  369. SEITZ T, Schindler S, Winkelmeyer P, Zach B, et al
    Evaluation of rapid antigen tests based on saliva for the detection of SARS-CoV-2.
    J Med Virol. 2021 Mar 31. doi: 10.1002/jmv.26983.
    >> Share

  370. LAMPEJO DT
    Remdesivir for the treatment of COVID-19 in pregnancy.
    J Med Virol. 2021 Mar 31. doi: 10.1002/jmv.26986.
    >> Share

  371. MATSUDA EM, de Campos IB, de Oliveira IP, Colpas DR, et al
    Field evaluation of COVID-19 antigen tests versus RNA based detection: Potential lower sensitivity compensated by immediate results, technical simplicity and low cost.
    J Med Virol. 2021 Mar 31. doi: 10.1002/jmv.26985.
    >> Share

  372. BOUAYED J, Bohn T
    The link between microglia and the severity of COVID-19: the 'two-hit' hypothesis.
    J Med Virol. 2021 Mar 31. doi: 10.1002/jmv.26984.
    >> Share

  373. GUNDUZ A, Firat M, Turkoglu G
    Comparison of the Simultaneous Conjunctiva and Oropharynx-Nasopharynx Swab Results in Patients Applying to the SARS-CoV-2 Outpatient Clinic for the First Time.
    J Med Virol. 2021 Mar 30. doi: 10.1002/jmv.26981.
    >> Share

  374. SPAGNOLELLO O, Pierangeli A, Cedrone MC, Di Biagio V, et al
    Viral Community Acquired Pneumonia at the Emergency Department: Report From the Pre COVID-19 Age.
    J Med Virol. 2021 Mar 30. doi: 10.1002/jmv.26980.
    >> Share

  375. CHRISTOS P, Vasiliki V
    A reduction of the number of assays and turnaround time by optimizing Polymerase Chain Reaction (PCR) pooled testing for SARS-CoV-2.
    J Med Virol. 2021 Mar 30. doi: 10.1002/jmv.26972.
    >> Share

  376. BERAN A, Zink E, Mhanna M, Abugharbyeh A, et al
    Transmissibility and viral replication of SARS-COV-2 in immunocompromised patients.
    J Med Virol. 2021 Mar 30. doi: 10.1002/jmv.26970.
    >> Share

  377. UGINET M, Breville G, Assal F, Lovblad KO, et al
    COVID-19 encephalopathy: clinical and neurobiological features.
    J Med Virol. 2021 Mar 30. doi: 10.1002/jmv.26973.
    >> Share

  378. REHMAN HA, Ramzan F, Basharat Z, Shakeel M, et al
    Comprehensive Comparative Genomic and Microsatellite Analysis of SARS, MERS, BAT-SARS and COVID-19 Coronaviruses.
    J Med Virol. 2021 Mar 30. doi: 10.1002/jmv.26974.
    >> Share

  379. EISEN AKA, Gularte JS, Demoliner M, de Abreu Goes Pereira VM, et al
    Low circulation of Influenza A and coinfection with SARS-CoV-2 among other respiratory viruses during the COVID-19 pandemic in a region of southern Brazil.
    J Med Virol. 2021 Mar 30. doi: 10.1002/jmv.26975.
    >> Share

  380. HAFEEZ S, Din M, Zia F, Ali M, et al
    Emerging concerns regarding COVID-19; second wave and new variant.
    J Med Virol. 2021 Mar 30. doi: 10.1002/jmv.26979.
    >> Share

  381. TORTAJADA C, Anon S, Ortiz MM, Andreu-Ballester JC, et al
    Interferon beta-1b for patients with moderate to severe COVID-19 in the inflammatory phase of the disease.
    J Med Virol. 2021 Mar 30. doi: 10.1002/jmv.26976.
    >> Share

  382. RONAN G, Kumar L, Davey M, O'Leary C, et al
    Factors associated with SARS-CoV-2 infection in patients attending an acute hospital ambulatory assessment unit.
    J Med Virol. 2021 Mar 26. doi: 10.1002/jmv.26966.
    >> Share

  383. WOLF JM, Streck AF, Fonseca A, Ikuta N, et al
    Dissemination and evolution of SARS-CoV-2 in the early pandemic phase in South America.
    J Med Virol. 2021 Mar 25. doi: 10.1002/jmv.26967.
    >> Share

  384. VALDESPINO-VAZQUEZ MY, Helguera-Repetto CA, Leon-Juarez M, Villavicencio-Carrisoza O, et al
    Fetal and placental infection with SARS-CoV-2 in early pregnancy.
    J Med Virol. 2021 Mar 25. doi: 10.1002/jmv.26965.
    >> Share

  385. TANG JW, Bialasiewicz S, Dwyer DE, Dilcher M, et al
    Where have all the viruses gone? Disappearance of seasonal respiratory viruses during the COVID-19 pandemic.
    J Med Virol. 2021 Mar 24. doi: 10.1002/jmv.26964.
    >> Share

  386. NAKAMURA A, Ando S, Endo H, Sato R, et al
    Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers in a non-epidemic region, Japan: A hospital-based study on May, 2020.
    J Med Virol. 2021 Mar 24. doi: 10.1002/jmv.26962.
    >> Share

  387. MALHOTRA V, Basu S, Sharma N, Kumar S, et al
    Outcomes among 10,314 hospitalized COVID-19 patients at a tertiary care government hospital in Delhi, India.
    J Med Virol. 2021 Mar 23. doi: 10.1002/jmv.26956.
    >> Share

  388. MANSUY JM, Bourcier M, Tremeaux P, Dimeglio C, et al
    COVID-19 pandemic period, where are the seasonal viruses?
    J Med Virol. 2021 Mar 23. doi: 10.1002/jmv.26959.
    >> Share

  389. CHAKRABARTI S, Chakrabarti SS, Kaur U, Agrawal BK, et al
    Cross-immunity and trained immunity in explaining variable COVID-19 mortality- guidance for future pandemics.
    J Med Virol. 2021 Mar 23. doi: 10.1002/jmv.26958.
    >> Share

  390. RABIU AT, Mohan A, Cavdaroglu S, Xenophontos E, et al
    Dengue and COVID-19: A double burden to Brazil.
    J Med Virol. 2021 Mar 23. doi: 10.1002/jmv.26955.
    >> Share

  391. HANNA HUANG Y, Huang JT
    Use of Chlorhexidine to Eradicate Oropharyngeal SARS-CoV-2 in COVID-19 Patients.
    J Med Virol. 2021 Mar 23. doi: 10.1002/jmv.26954.
    >> Share

  392. MA C, Gong C
    ACE2 models of frequently contacted animals provide clues of their SARS-CoV-2 S protein affinity and viral susceptibility.
    J Med Virol. 2021 Mar 23. doi: 10.1002/jmv.26953.
    >> Share

  393. DHAR MS, Vivekanand A, Uppili B, Tyagi N, et al
    Reinfection or Reactivation: Genome based two distinct SNP profile of SARS-CoV2 re-positivity in an Indian case.
    J Med Virol. 2021 Mar 22. doi: 10.1002/jmv.26948.
    >> Share

  394. JAIN S, Rocha ICN, Maheshwari C, Santos Costa ACD, et al
    Chikungunya and COVID-19 in Brazil: the danger of overlapping crises.
    J Med Virol. 2021 Mar 22. doi: 10.1002/jmv.26952.
    >> Share

  395. TSUCHIDA T, Nitahara Y, Suzuki S, Komase Y, et al
    Back to Normal; Serological Testing for COVID-19 Diagnosis Unveils Missed Infections.
    J Med Virol. 2021 Mar 19. doi: 10.1002/jmv.26949.
    >> Share

  396. ZHAO Y, Yin L, Jenil P, Tang L, et al
    The inflammatory markers of Multisystem Inflammatory Syndrome in children (MIS-C) and adolescents associated with COVID-19: A Meta-analysis.
    J Med Virol. 2021 Mar 19. doi: 10.1002/jmv.26951.
    >> Share

  397. FITOUSSI F, Dupont R, Tonen-Wolyec S, Belec L, et al
    Practicability and analytical performances of the novel VitaPCR(TM) SARS-CoV-2 Assay during the second wave of COVID-19 epidemic in France.
    J Med Virol. 2021 Mar 19. doi: 10.1002/jmv.26950.
    >> Share

  398. ZHAO X, Zhou Q, Wang A, Zhu F, et al
    The Impact of Awareness Diffusion on the Spread of COVID-19 based on Two-layer SEIR/V-UA Epidemic Model.
    J Med Virol. 2021 Mar 19. doi: 10.1002/jmv.26945.
    >> Share

  399. CIOTTI M, Nicolai E, Marcuccilli F, Bernardini S, et al
    Use of a rapid point-of-care molecular test in the triage of suspected COVID-19 cases.
    J Med Virol. 2021 Mar 17. doi: 10.1002/jmv.26944.
    >> Share

  400. YAN-CHAO L, Yan Z, Bai-Hong T
    What can cerebrospinal fluid testing and brain autopsies tell us about viral neuroinvasion of SARS-CoV-2.
    J Med Virol. 2021 Mar 16. doi: 10.1002/jmv.26943.
    >> Share

  401. OTLU B, Yakupogullari Y, Tanriverdi ES, Bayindir Y, et al
    An Evaluation of Patients with A Previous Endemic Coronavirus Infection during the COVID-19 Pandemic.
    J Med Virol. 2021 Mar 16. doi: 10.1002/jmv.26942.
    >> Share

  402. LEE CK, Tham JWM, Png S, Chai CN, et al
    Clinical Performance of Roche cobas 6800, Luminex ARIES, MiRXES Fortitude Kit 2.1, altona RealStar, and Applied Biosystems TaqPath for SARS-CoV-2 Detection in Nasopharyngeal Swabs.
    J Med Virol. 2021 Mar 14. doi: 10.1002/jmv.26940.
    >> Share

  403. TERESA VALENZUELA M, Urquidi C, Rodriguez N, Castillo L, et al
    Development of neutralizing antibody responses against SARS-CoV-2 in COVID-19 patients.
    J Med Virol. 2021 Mar 13. doi: 10.1002/jmv.26939.
    >> Share

  404. GIACOMELLI A, De Falco T, Oreni L, Pedroli A, et al
    Impact Of Gender On Patients Hospitalized For SARS-COV-2 Infection: A Prospective Observational Study.
    J Med Virol. 2021 Mar 12. doi: 10.1002/jmv.26933.
    >> Share

  405. MINKOBAME U, Nzoghe AM, Siawaya ACM, Alame-Emane AK, et al
    Case series of SARS-COV-2 infection in pregnant African women: focus on biological features.
    J Med Virol. 2021 Mar 12. doi: 10.1002/jmv.26927.
    >> Share

  406. YE Q, Zhang T, Lu D
    Potential false-positive reasons for SARS-CoV-2 antibody testing and its solution.
    J Med Virol. 2021 Mar 12. doi: 10.1002/jmv.26937.
    >> Share

  407. ALI N, Fariha KA, Islam F, Mohanto NC, et al
    Assessment of the role of zinc in the prevention of COVID-19 infections and mortality: a retrospective study in the Asian and European population.
    J Med Virol. 2021 Mar 12. doi: 10.1002/jmv.26932.
    >> Share

  408. HUSSAIN M, Shabbir S, Amnaullah A, Raza F, et al
    Immunoinformatic Analysis of Structural and Epitope Variations in Spike and Orf8 Proteins of SARS-CoV-2/B.1.1.7.
    J Med Virol. 2021 Mar 11. doi: 10.1002/jmv.26931.
    >> Share

  409. ATEYA AM
    CKD Patients: A High-Risk Category for Severe COVID-19.
    J Med Virol. 2021 Mar 11. doi: 10.1002/jmv.26929.
    >> Share

  410. HEMIDA MG
    The next-generation coronavirus diagnostic techniques with particular emphasis on the SARS-CoV-2.
    J Med Virol. 2021 Mar 10. doi: 10.1002/jmv.26926.
    >> Share

  411. RONCATI L, Corsi L
    Nucleoside-modified messenger RNA (modRNA) COVID-19 vaccine platform.
    J Med Virol. 2021 Mar 6. doi: 10.1002/jmv.26924.
    >> Share

  412. CECCARELLI G, Alessandri F, Oliva A, Borrazzo C, et al
    The role of teicoplanin in the treatment of SARS-CoV-2 infection: a retrospective study in critically ill COVID-19 patients (Tei-COVID Study).
    J Med Virol. 2021 Mar 6. doi: 10.1002/jmv.26925.
    >> Share

  413. MILLIERE L, Engelmann I, Tinez C, Bouarouro Y, et al
    Stool samples versus nasopharyngeal specimens for the initial diagnosis of SARS-CoV-2 infection.
    J Med Virol. 2021 Mar 5. doi: 10.1002/jmv.26923.
    >> Share

  414. HASHIM HT, Ramadhan MA
    The impact of COVID-19 Pandemic on Asthmatic patients.
    J Med Virol. 2021 Mar 5. doi: 10.1002/jmv.26919.
    >> Share

  415. DAMME EV, De Meyer S, Bojkova D, Ciesek S, et al
    In vitro activity of itraconazole against SARS-CoV-2.
    J Med Virol. 2021 Mar 5. doi: 10.1002/jmv.26917.
    >> Share

  416. ZHAN Y, Shang J, Gu Y, Huang Q, et al
    Efficacy of corticosteroid in patients with COVID-19: a multi-center retrospective study and meta-analysis.
    J Med Virol. 2021 Mar 5. doi: 10.1002/jmv.26914.
    >> Share

  417. KIRKUP C, Pawlowski C, Puranik A, Conrad I, et al
    Healthcare disparities among anticoagulation therapies for severe COVID-19 patients in the multi-site VIRUS registry.
    J Med Virol. 2021 Mar 5. doi: 10.1002/jmv.26918.
    >> Share

  418. MALEK AE, Dagher H, Hachem R, Chaftari AM, et al
    Is a single dose of mRNA vaccine sufficient for COVID-19 Survivors?
    J Med Virol. 2021 Mar 5. doi: 10.1002/jmv.26915.
    >> Share

  419. GERBER V, Velay A, Boehn L, Solis M, et al
    Protracted SARS-CoV-2 Pneumonia with Rituximab Treatment: about two cases.
    J Med Virol. 2021 Mar 5. doi: 10.1002/jmv.26921.
    >> Share

  420. CELIKBILEK A
    Vitamin D axis status and the severity of COVID-19.
    J Med Virol. 2021 Mar 5. doi: 10.1002/jmv.26920.
    >> Share

  421. CHIRUMBOLO S
    Vaccination hesitancy and the "myth" on mRNA-based vaccines in Italy in the COVID-19 era: does urgency meet major safety criteria?
    J Med Virol. 2021 Mar 5. doi: 10.1002/jmv.26922.
    >> Share

  422. STRAND R, Thelaus L, Fernstrom N, Sunnerhagen T, et al
    Rapid diagnostic testing for SARS-CoV-2: Validation and comparison of three point-of-care antibody tests.
    J Med Virol. 2021 Mar 5. doi: 10.1002/jmv.26913.
    >> Share

  423. KHALILI F, Yarani R, Haghgoo SM, Emami Aleagha MS, et al
    Letter to Editor in response to the article "Vitamin D insufficiency as a potential culprit in critical COVID-19 patients".
    J Med Virol. 2021 Mar 3. doi: 10.1002/jmv.26912.
    >> Share

    February 2021
  424. SAIED SM, Saied EM, Kabbash IA, Abdo SAE, et al
    Vaccine Hesitancy: Beliefs and Barriers Associated with COVID-19 Vaccination among Egyptian Medical Students.
    J Med Virol. 2021 Feb 28. doi: 10.1002/jmv.26910.
    >> Share

  425. ZHOU J, Tse G, Lee S, Liu T, et al
    Interaction effects between angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and steroid or anti-viral therapies in COVID-19: a population-based study.
    J Med Virol. 2021 Feb 27. doi: 10.1002/jmv.26904.
    >> Share

  426. DAO MH, Nguyen HT, Nguyen TV, Nguyen AH, et al
    New SARS-CoV-2 Variant of Concern Imported from the United Kingdom to Vietnam, December 2020.
    J Med Virol. 2021 Feb 27. doi: 10.1002/jmv.26908.
    >> Share

  427. ABBASI AZ, Kiyani DA, Hamid SM, Saalim M, et al
    Spiking dependence of SARS-CoV-2 pathogenicity on TMPRSS2.
    J Med Virol. 2021 Feb 27. doi: 10.1002/jmv.26911.
    >> Share

  428. GEORGY JT, Jayakaran JAJ, Jacob AS, Gunasekaran K, et al
    Evans syndrome and immune thrombocytopenia in two patients with COVID-19.
    J Med Virol. 2021 Feb 25. doi: 10.1002/jmv.26906.
    >> Share

  429. ALTAMIMI AM, Obeid DA, Alaifan TA, Taha MT, et al
    Assessment of 12 Qualitative RT-PCR commercial kits for the detection of SARS-CoV-2.
    J Med Virol. 2021 Feb 25. doi: 10.1002/jmv.26900.
    >> Share

  430. PATEL O, Chinni V, El-Khoury J, Perera M, et al
    A pilot double-blind safety and feasibility randomised controlled trial of high-dose intravenous zinc in hospitalised COVID-19 patients.
    J Med Virol. 2021 Feb 25. doi: 10.1002/jmv.26895.
    >> Share

  431. GUNER OZENEN G, Sahbudak Bal Z, Umit Z, Bilen NM, et al
    Demographic, clinical and laboratory features of COVID-19 in children: The role of mean platelet volume in predicting the hospitalization and severity.
    J Med Virol. 2021 Feb 25. doi: 10.1002/jmv.26902.
    >> Share

  432. PALLOTTO C, Suardi LR, Gabbuti A, Esperti S, et al
    Potential remdesivir-related transient bradycardia in patients with coronavirus disease 2019 (COVID-19).
    J Med Virol. 2021 Feb 23. doi: 10.1002/jmv.26898.
    >> Share

  433. IMAI K, Kitagawa Y, Tabata S, Kubota K, et al
    Antibody response patterns in COVID-19 patients with different levels of disease severity-Japan.
    J Med Virol. 2021 Feb 23. doi: 10.1002/jmv.26899.
    >> Share

  434. MAHAJAN A, Solanki R, Sivadas N
    Estimation of Undetected Symptomatic and Asymptomatic cases of COVID-19 Infection and prediction of its spread in USA.
    J Med Virol. 2021 Feb 23. doi: 10.1002/jmv.26897.
    >> Share

  435. COURTELLEMONT L, Guinard J, Guillaume C, Giache S, et al
    High performance of a novel antigen detection test on nasopharyngeal specimens for diagnosing SARS-CoV-2 infection.
    J Med Virol. 2021 Feb 21. doi: 10.1002/jmv.26896.
    >> Share

  436. RAHIMZADEH M, Naderi N
    Towards understanding of regulatory T cells in COVID-19: a systematic review.
    J Med Virol. 2021 Feb 19. doi: 10.1002/jmv.26891.
    >> Share

  437. KARAISMAILOGLU E, Karaismailoglu S
    Two novel nomograms for predicting the risk of hospitalization or mortality due to COVID-19 by naive Bayesian classifier method.
    J Med Virol. 2021 Feb 18. doi: 10.1002/jmv.26890.
    >> Share

  438. HAGUET H, Douxfils J, Eucher C, Elsen M, et al
    Clinical performance of the Panbio assay for the detection of SARS-CoV-2 IgM and IgG in COVID-19 patients.
    J Med Virol. 2021 Feb 18. doi: 10.1002/jmv.26884.
    >> Share

  439. GAO D, Zhu X, Lu B
    Development and application of sensitive, specific and rapid CRISPR-Cas13-based diagnosis.
    J Med Virol. 2021 Feb 18. doi: 10.1002/jmv.26889.
    >> Share

  440. CRETA M, Sagnelli C, Celentano G, Napolitano L, et al
    SARS-CoV-2 infection affects the lower urinary tract and male genital system: a systematic review.
    J Med Virol. 2021 Feb 17. doi: 10.1002/jmv.26883.
    >> Share

  441. ANDRADE JA, Muzykovsky K, Truong J
    Risk Factors for Mortality in COVID-19 Patients in a Community Teaching Hospital.
    J Med Virol. 2021 Feb 17. doi: 10.1002/jmv.26885.
    >> Share

  442. BIRD PW, Badhwar V, Kennedy B, Ladani S, et al
    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroconversion in haematology-oncology patients.
    J Med Virol. 2021 Feb 17. doi: 10.1002/jmv.26886.
    >> Share

  443. TANG K, Wu L, Luo Y, Gong B, et al
    Quantitative assessment of SARS-CoV-2 RNAemia and outcome in patients with Coronavirus Disease 2019.
    J Med Virol. 2021 Feb 16. doi: 10.1002/jmv.26876.
    >> Share

  444. ELALFY H, Besheer T, El-Mesery A, El-Gilany AH, et al
    Effect of a combination of Nitazoxanide, Ribavirin and Ivermectin plus zinc supplement (MANS.NRIZ study) on the clearance of mild COVID-19.
    J Med Virol. 2021 Feb 16. doi: 10.1002/jmv.26880.
    >> Share

  445. FIORE BD, Paola L, Eugenio M, Gaetano B, et al
    Anti-Spike S1 Receptor-Binding Domain Antibodies against SARS-CoV-2 Persist Several Months after Infection Regardless of Disease Severity.
    J Med Virol. 2021 Feb 16. doi: 10.1002/jmv.26878.
    >> Share

  446. MARUOTTI A, Ciccozzi M, Divino F
    On the misuse of the reproduction number in the COVID-19 surveillance system in Italy.
    J Med Virol. 2021 Feb 16. doi: 10.1002/jmv.26881.
    >> Share

  447. GANDO A, Alexay S, Galan Nunez JP, Cano LN, et al
    Comment on Hadadi et al., Does recombinant human erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects? J. Med. Virol 2020; 92:915-918.
    J Med Virol. 2021 Feb 16. doi: 10.1002/jmv.26879.
    >> Share

  448. GOSWAMI RP, Ganguli B, Chatterjee M
    Endemic infections, vaccinations and variability of SARS-COV2 worldwide epidemiology: a cross-sectional study.
    J Med Virol. 2021 Feb 13. doi: 10.1002/jmv.26875.
    >> Share

  449. BRAMANTE CT, Buse J, Tamaritz L, Palacio A, et al
    Outpatient metformin use is associated with reduced severity of COVID-19 disease in adults with overweight or obesity.
    J Med Virol. 2021 Feb 12. doi: 10.1002/jmv.26873.
    >> Share

  450. HU S, Wang J, Zhang Y, Bai H, et al
    Three salvianolic acids inhibit 2019-nCoV spike pseudovirus viropexis by binding to both its RBD and receptor ACE2.
    J Med Virol. 2021 Feb 12. doi: 10.1002/jmv.26874.
    >> Share

  451. ISOLDI S, Mallardo S, Marcellino A, Bloise S, et al
    Comprehensive Clinic, Laboratory and Instrumental Evaluation of Children with COVID-19: A 6-Months Prospective Study.
    J Med Virol. 2021 Feb 11. doi: 10.1002/jmv.26871.
    >> Share

  452. ROJAS-BOLIVAR D, Intimayta-Escalante C, Cardenas-Jara A, Jandarov R, et al
    COVID-19 case fatality rate and tuberculosis in a metropolitan setting.
    J Med Virol. 2021 Feb 11. doi: 10.1002/jmv.26868.
    >> Share

  453. KULUOZTURK M, In E, Telo S, Karabulut E, et al
    Efficacy of Copeptin in Distinguishing COVID-19 Pneumonia from Community-Acquired Pneumonia.
    J Med Virol. 2021 Feb 11. doi: 10.1002/jmv.26870.
    >> Share

  454. BADRAH M, Riad A, Kassem I, Boccuzzi M, et al
    Craniofacial Pain in COVID-19 Patients with Diabetes Mellitus: Clinical and Laboratory Description of Twenty-One Cases.
    J Med Virol. 2021 Feb 11. doi: 10.1002/jmv.26866.
    >> Share

  455. DE SIRE A, Giray E, Taskiran OO
    Chelsea Physical Assessment Tool for evaluating functioning in post-Intensive Care Unit COVID-19 patients.
    J Med Virol. 2021 Feb 11. doi: 10.1002/jmv.26867.
    >> Share

  456. UMAIR M, Ikram A, Salman M, Alam MM, et al
    Importation of SARS-CoV-2 Variant B.1.1.7 in Pakistan.
    J Med Virol. 2021 Feb 11. doi: 10.1002/jmv.26869.
    >> Share

  457. BAUER G, Struck F, Schreiner P, Staschik E, et al
    The challenge of avidity determination in SARS-CoV-2 serology.
    J Med Virol. 2021 Feb 10. doi: 10.1002/jmv.26863.
    >> Share

  458. SEYMEN CM
    Being pregnant in the COVID-19 pandemic: Effects on the placenta in all aspects.
    J Med Virol. 2021 Feb 9. doi: 10.1002/jmv.26857.
    >> Share

  459. KAUSHIK J, Singh A, Kochhar D, Murari T, et al
    Receptors Modulation On The Ocular Surface: A Novel Insight Into The Ocular Infection And Disease Transmission Of SARS-CoV-2.
    J Med Virol. 2021 Feb 9. doi: 10.1002/jmv.26858.
    >> Share

  460. VEYRENCHE N, Bollore K, Pisoni A, Bedin AS, et al
    Diagnosis value of SARS-CoV-2 antigen/antibody combined testing using rapid diagnostic tests at hospital admission.
    J Med Virol. 2021 Feb 8. doi: 10.1002/jmv.26855.
    >> Share

  461. LOFFREDO L, Campana A, Olivini N, Cotugno N, et al
    Hypoalbuminemia and Clinical Adverse Events in Children with COVID-19.
    J Med Virol. 2021 Feb 8. doi: 10.1002/jmv.26856.
    >> Share

  462. MOELLER ME, Fock J, Pah P, Veras AC, et al
    Evaluation of commercially available immuno-magnetic agglutination in comparison to enzyme-linked immunosorbent assays for rapid point-of-care diagnostics of COVID-19.
    J Med Virol. 2021 Feb 6. doi: 10.1002/jmv.26854.
    >> Share

  463. AYKAC K, Cura Yayla BC, Ozsurekci Y, Evren K, et al
    The Association of Viral load and Disease Severity in Children with COVID-19.
    J Med Virol. 2021 Feb 6. doi: 10.1002/jmv.26853.
    >> Share

  464. BAHGAT MM, Nadeem R, Nasraa MH, Awad MA, et al
    Impact of both socioeconomic level and occupational nature on the antibody prevalence to SARS-CoV-2 in an Egyptian cohort: the first episode.
    J Med Virol. 2021 Feb 6. doi: 10.1002/jmv.26852.
    >> Share

  465. OLUMADE TJ, Uzairue LI
    Clinical characteristics of 4499 COVID-19 patients in Africa: A meta-analysis.
    J Med Virol. 2021 Feb 5. doi: 10.1002/jmv.26848.
    >> Share

  466. POURFRIDONI M, Pajokh M, Seyedi F
    Letter to Editor: Bladder and bowel incontinence in COVID-19.
    J Med Virol. 2021 Feb 5. doi: 10.1002/jmv.26849.
    >> Share

  467. XIE W, Chen Z, Wang Q, Song M, et al
    Infection and disease spectrum in individuals with household exposure to SARS-CoV-2: A family cluster cohort study.
    J Med Virol. 2021 Feb 4. doi: 10.1002/jmv.26847.
    >> Share

  468. TANBOGA IH, Canpolat U, Cetin EHO, Kundi H, et al
    Development and Validation of Clinical Prediction Models to Estimate the Probability of death in Hospitalized Patients with COVID-19: Insights from a Nationwide Database.
    J Med Virol. 2021 Feb 2. doi: 10.1002/jmv.26844.
    >> Share

  469. SEENI R, Firzli T, Riddle MS, Krasner C, et al
    Using COVID-19 Cycle Threshold and Other Lab Values as Predictors of Hospitalization Need.
    J Med Virol. 2021 Feb 2. doi: 10.1002/jmv.26835.
    >> Share

  470. KOH H, Moh AMC, Yeoh E, Lin Y, et al
    Diabetes predicts severity of COVID-19 infection in a retrospective cohort: A mediatory role of the inflammatory biomarker C-reactive protein.
    J Med Virol. 2021 Feb 2. doi: 10.1002/jmv.26837.
    >> Share

  471. SHAYESTEHPOUR M, Zamani B
    Systemic lupus erythematosus and varicella-like rash following COVID-19 in a previously healthy patient.
    J Med Virol. 2021 Feb 2. doi: 10.1002/jmv.26838.
    >> Share

  472. ELSHAZLI RM, Kline A, Elgaml A, Aboutaleb MH, et al
    Gastroenterology manifestations and COVID-19 outcomes: A meta-analysis of 25,252 cohorts among the first and second waves.
    J Med Virol. 2021 Feb 2. doi: 10.1002/jmv.26836.
    >> Share

  473. LINDEMANN M, Krawczyk A, Dolff S, Konik M, et al
    SARS-CoV-2-specific humoral and cellular immunity in two renal transplant and two haemodialysis patients treated with convalescent plasma.
    J Med Virol. 2021 Feb 2. doi: 10.1002/jmv.26840.
    >> Share

  474. ROSSOTTI R, Molteni SN, Faccini M, Puoti M, et al
    Reply to: Epidemiological evidence for association between higher influenza vaccine uptake in the elderly and lower COVID-19 deaths in Italy.
    J Med Virol. 2021 Feb 2. doi: 10.1002/jmv.26841.
    >> Share

  475. TAKAGI H
    Eyeglasses in Wonderland of COVID-19.
    J Med Virol. 2021 Feb 2. doi: 10.1002/jmv.26845.
    >> Share

  476. ECHAVARRIA M, Reyes NS, Rodriguez PE, Ypas M, et al
    Self-collected saliva for SARS-CoV-2 detection: a prospective study in the emergency room.
    J Med Virol. 2021 Feb 2. doi: 10.1002/jmv.26839.
    >> Share

  477. KOMABAYASHI K, Matoba Y, Tanaka S, Seto J, et al
    Longitudinal epidemiology of human coronavirus OC43 in Yamagata, Japan, 2010-2017: Two groups based on spike gene appear one after another.
    J Med Virol. 2021;93:945-951.
    >> Share

  478. VEIGA ABGD, Martins LG, Riediger I, Mazetto A, et al
    More than just a common cold: Endemic coronaviruses OC43, HKU1, NL63, and 229E associated with severe acute respiratory infection and fatality cases among healthy adults.
    J Med Virol. 2021;93:1002-1007.
    >> Share

  479. CIOTTI M, Maurici M, Pieri M, Andreoni M, et al
    Performance of a rapid antigen test in the diagnosis of SARS-CoV-2 infection.
    J Med Virol. 2021 Feb 1. doi: 10.1002/jmv.26830.
    >> Share

  480. VIZZUSO A, Piciucchi S, Tortola D, Grosso C, et al
    Single dose of subcutaneous tocilizumab in COVID-pneumonia: CT evidence of lymph nodal and parenchymal response.
    J Med Virol. 2021;93:599-600.
    >> Share

    January 2021
  481. PERESON MJ, Flichman DM, Martinez AP, Bare P, et al
    Evolutionary analysis of SARS-CoV-2 spike protein for its different clades.
    J Med Virol. 2021 Jan 29. doi: 10.1002/jmv.26834.
    >> Share

  482. PIANTONI S, Salada L, Colombo E, Mendeni M, et al
    Reports of 3 long-term lung disease following SARS-CoV-2 infection.
    J Med Virol. 2021 Jan 29. doi: 10.1002/jmv.26831.
    >> Share

  483. DEMIR M, Demir F, Aygun H
    Vitamin D deficiency is associated with COVID-19 positivity and the severity of the disease.
    J Med Virol. 2021 Jan 29. doi: 10.1002/jmv.26832.
    >> Share

  484. CUBEDDU LX, Cubeddu RJ
    Early Remdesivir Treatment in Covid-19: Why Wait Another Day?
    J Med Virol. 2021 Jan 28. doi: 10.1002/jmv.26792.
    >> Share

  485. FANG ZF, Sun BQ, Zhu AR, Lin LC, et al
    Multiplexed analysis of circulating IgA antibodies for SARS-CoV-2 and Common Respiratory Pathogens in COVID-19 Patients.
    J Med Virol. 2021 Jan 28. doi: 10.1002/jmv.26829.
    >> Share

  486. RAMIREZ JD, Munoz M, Patino LH, Ballesteros N, et al
    Will the emergent SARS-CoV2 B.1.1.7 lineage affect molecular diagnosis of COVID19?
    J Med Virol. 2021 Jan 28. doi: 10.1002/jmv.26823.
    >> Share

  487. GANGULY B
    A parsimonious approach for recognizing SARS-CoV-2 and host interactions.
    J Med Virol. 2021 Jan 28. doi: 10.1002/jmv.26824.
    >> Share

  488. NASREDDINE R, Florence E, Moutschen M, Yombi JC, et al
    Clinical characteristics and outcomes of COVID-19 in people living with HIV in Belgium: A multicenter, retrospective cohort.
    J Med Virol. 2021 Jan 28. doi: 10.1002/jmv.26828.
    >> Share

  489. KHANMOHAMMADI S, Rezaei N
    Role of Toll-like receptors in the pathogenesis of COVID-19.
    J Med Virol. 2021 Jan 28. doi: 10.1002/jmv.26826.
    >> Share

  490. AWAN UA, Khattak AA, Afzal MS, Iqbal N, et al
    Emergence of SARS-CoV-2 Variant: A Wake-Up Call for Pakistan's overburdened Healthcare System.
    J Med Virol. 2021 Jan 28. doi: 10.1002/jmv.26825.
    >> Share

  491. LIAO L, Yang GH
    Clinical Significance of Cellular Immunity Function and Inflammatory Factors Assays in Alveolar Lavage Fluid for Severe COVID-19 Pneumonia.
    J Med Virol. 2021 Jan 28. doi: 10.1002/jmv.26827.
    >> Share

  492. CHIRUMBOLO S, Franzini M, Simonetti V, Valdenassi L, et al
    Oxygen-ozone autohemotherapy against COVID-19 needs to fit highly experienced, customized, and standardized protocols to succeed.
    J Med Virol. 2021 Jan 27. doi: 10.1002/jmv.26806.
    >> Share

  493. ELBADAWY HM, Khattab A, Alalawi A, Aljohani F, et al
    The detection of SRAS-CoV-2 in outpatient clinics and public facilities during the COVID19 pandemic.
    J Med Virol. 2021 Jan 26. doi: 10.1002/jmv.26819.
    >> Share

  494. MUTNAL MB, Lanham JA, Walker K, Rao A, et al
    False positive Influenza rapid tests using newly EUA cleared multiplex assay in a low prevalence setting.
    J Med Virol. 2021 Jan 26. doi: 10.1002/jmv.26820.
    >> Share

  495. EDIZ TUTUNCU E, Ozgur D, Karamese M
    Saliva samples for detection of SARS-CoV-2 in mildly symptomatic and asymptomatic patients.
    J Med Virol. 2021 Jan 26. doi: 10.1002/jmv.26821.
    >> Share

  496. ISLAM MT, Ul Alam ASMR, Sakib N, Hasan MS, et al
    A rapid and cost-effective multiplex ARMS-PCR method for the simultaneous genotyping of the circulating SARS-CoV-2 phylogenetic clades.
    J Med Virol. 2021 Jan 25. doi: 10.1002/jmv.26818.
    >> Share

  497. LUCIANI L, Ninove L, Zandotti C, Nougairede A, et al
    COVID-19 pandemic and its consequences disrupt epidemiology of enterovirus meningitis, South-East France.
    J Med Virol. 2021 Jan 22. doi: 10.1002/jmv.26785.
    >> Share

  498. PUNZO O, Bellino S, Palmieri L, Lo Noce C, et al
    Clinical characteristics of individuals under 40 years of age who died with COVID-19 in Italy.
    J Med Virol. 2021 Jan 22. doi: 10.1002/jmv.26788.
    >> Share

  499. SAHU KK, George L, Jones N, Mangla A, et al
    COVID-19 in patients with sickle cell disease: A single center experience from Ohio, United States.
    J Med Virol. 2021 Jan 21. doi: 10.1002/jmv.26816.
    >> Share

  500. FINZI E, Harrington A
    Zinc treatment of outpatient COVID-19: A retrospective review of 28 consecutive patients.
    J Med Virol. 2021 Jan 21. doi: 10.1002/jmv.26812.
    >> Share

  501. ANIRUDHAN V, Lee H, Cheng H, Cooper L, et al
    Targeting SARS-CoV-2 Viral Proteases as a Therapeutic Strategy to Treat COVID-19.
    J Med Virol. 2021 Jan 21. doi: 10.1002/jmv.26814.
    >> Share

  502. CHENG Y, Ma J, Wang H, Wang X, et al
    Co-Infection of Influenza A Virus and SARS-CoV-2: A Retrospective Cohort Study.
    J Med Virol. 2021 Jan 21. doi: 10.1002/jmv.26817.
    >> Share

  503. HOU CK, Qin YF, Wang G, Liu QL, et al
    Impact of a Long-Term Air Pollution Exposure on the Case Fatality Rate of COVID-19 Patients - A Multi-City Study.
    J Med Virol. 2021 Jan 20. doi: 10.1002/jmv.26807.
    >> Share

  504. LIU H, Ye C, Wang Y, Zhu W, et al
    The effectiveness of active surveillance measures for COVID-19 cases in Pudong New Area Shanghai, China, 2020.
    J Med Virol. 2021 Jan 19. doi: 10.1002/jmv.26805.
    >> Share

  505. MEYERS KJ, Dillman B, Williams C, Jiang J, et al
    Follow-up of SARS-CoV-2 Positive Subgroup from the Asymptomatic novel CORonavirus iNfection (ACORN) Study.
    J Med Virol. 2021 Jan 19. doi: 10.1002/jmv.26810.
    >> Share

  506. KHEIRABADI D, Haddad F, Mousavi-Roknabadi RS, Rezaeisadrabadi M, et al
    A complementary critical appraisal on systematic reviews regarding the most efficient therapeutic strategies for current COVID-19 (SARS-CoV-2) pandemic.
    J Med Virol. 2021 Jan 19. doi: 10.1002/jmv.26811.
    >> Share

  507. FU W, Chen C, Chen XL, Wang K, et al
    A U-shaped association between baseline neutrophil count and COVID-19-related mortality: a retrospective cohort study.
    J Med Virol. 2021 Jan 19. doi: 10.1002/jmv.26794.
    >> Share

  508. PIERI M, Nuccetelli M, Nicolai E, Sarubbi S, et al
    Clinical validation of a second generation anti-SARS-CoV-2 IgG and IgM automated chemiluminescent immunoassay.
    J Med Virol. 2021 Jan 19. doi: 10.1002/jmv.26809.
    >> Share

  509. UGOLOTTI MC, Pedrazzini M, Silini EM, Missale G, et al
    Vascular liver injury mimicking an intrahepatic cholangiocarcinoma in a COVID-19 patient.
    J Med Virol. 2021 Jan 17. doi: 10.1002/jmv.26803.
    >> Share

  510. SAFARI I, InanlooRahatloo K, Elahi E
    World-wide tracking of major SARS-CoV-2 genome haplotypes in sequences of June 1 to November 15, 2020 and discovery of rapid expansion of a new haplotype.
    J Med Virol. 2021 Jan 17. doi: 10.1002/jmv.26802.
    >> Share

  511. WANG G, Cai L, Chen D, Teng T, et al
    Influence of COVID-19 in patients with concurrent tuberculosis co-infections.
    J Med Virol. 2021 Jan 17. doi: 10.1002/jmv.26801.
    >> Share

  512. LEE JJ, Montazerin SM, Jamil A, Jamil U, et al
    Association between Red Blood Cell Distribution Width and Mortality and Severity among Patients with COVID-19: A Systematic Review and Meta-Analysis.
    J Med Virol. 2021 Jan 15. doi: 10.1002/jmv.26797.
    >> Share

  513. XIA Q, Xu K, Ni Q, Li Y, et al
    Clinical efficacy of Methylprednisolone and the combined use of Lopinavir/Ritonavir with Arbidol in treatment of Coronavirus Disease 2019.
    J Med Virol. 2021 Jan 15. doi: 10.1002/jmv.26798.
    >> Share

  514. LARDARO T, Wang AZ, Bucca A, Croft A, et al
    Characteristics of COVID-19 Patients with Bacterial Co-infection Admitted to the Hospital from the Emergency Department in a Large Regional Healthcare System.
    J Med Virol. 2021 Jan 15. doi: 10.1002/jmv.26795.
    >> Share

  515. MANTERO V, Abate L, Salmaggi A, Cordano C, et al
    Multiple Sclerosis and COVID-19: how therapeutic scenarios could change during the pandemic?
    J Med Virol. 2021 Jan 15. doi: 10.1002/jmv.26796.
    >> Share

  516. OCMANT A, Roisin S, De Meuter R, Brauner J, et al
    Clinical performance of the Advia Centaur anti-SARS-CoV-2 chemiluminescent immunoassay related to antibody kinetics.
    J Med Virol. 2021 Jan 15. doi: 10.1002/jmv.26800.
    >> Share

  517. DENG K, Fan Q, Yang Y, Deng X, et al
    Prognostic roles of KL-6 in disease severity and lung injury in COVID-19 patients: a longitudinal retrospective analysis.
    J Med Virol. 2021 Jan 12. doi: 10.1002/jmv.26793.
    >> Share

  518. RESHAMWALA SMS, Likhite V, Degani MS, Deb SS, et al
    Mutations in SARS-CoV-2 nsp7 and nsp8 proteins and their predicted impact on replication/transcription complex structure.
    J Med Virol. 2021 Jan 12. doi: 10.1002/jmv.26791.
    >> Share

  519. HO YI, Wong AH, Tang KPS, Wong RCW, et al
    Comparison of three commercial SARS-CoV-2 assays for pooled testing of deep throat saliva for surveillance of patients attending general outpatient clinics.
    J Med Virol. 2021 Jan 11. doi: 10.1002/jmv.26764.
    >> Share

  520. ANICHINI G, Gandolfo C, Terrosi C, Fabrizi S, et al
    Antibody response to SARS-CoV-2 in infected patients with different clinical outcome.
    J Med Virol. 2021 Jan 11. doi: 10.1002/jmv.26789.
    >> Share

  521. FUMIAN TM, Malta FC, Dos Santos DRL, Pauvolid-Correa A, et al
    SARS-CoV-2 RNA Detection in Stool Samples from Acute Gastroenteritis Cases, Brazil.
    J Med Virol. 2021 Jan 9. doi: 10.1002/jmv.26786.
    >> Share

  522. NISHANTH D, Jhuma S, Nitesh G, Ramesh Chand M, et al
    COVID-19 with and without anosmia/dysgeusia: A case-control study.
    J Med Virol. 2021 Jan 8. doi: 10.1002/jmv.26784.
    >> Share

  523. BLAIRON L, Piteus S, Beukinga I, Tre-Hardy M, et al
    Development and implementation of a RT-qPCR extraction-free protocol for the detection of SARS-CoV-2 and impact on the turn-around-time.
    J Med Virol. 2021 Jan 7. doi: 10.1002/jmv.26782.
    >> Share

  524. LI M, Guo X, Wang X
    Retrospective prediction of the epidemic trend of COVID-19 in Wuhan at four phases.
    J Med Virol. 2021 Jan 7. doi: 10.1002/jmv.26781.
    >> Share

  525. SPANAKIS N, Kassela K, Dovrolis N, Bampali M, et al
    A main event and multiple introductions of SARS-Cov2 initiated the COVID-19 epidemic in Greece.
    J Med Virol. 2021 Jan 6. doi: 10.1002/jmv.26778.
    >> Share

  526. SAXENA S, Manchanda V, Sagar T, Nagi N, et al
    Clinical characteristic and epidemiological features of SARS CoV -2 disease patients from a COVID 19 designated Hospital in New Delhi.
    J Med Virol. 2021 Jan 6. doi: 10.1002/jmv.26777.
    >> Share

  527. RASTAWICKI W, Gierczynski R, Juszczyk G, Mitura K, et al
    Evaluation of PCL rapid point of care antigen test for detection of SARS-CoV-2 in nasopharyngeal swabs.
    J Med Virol. 2021 Jan 6. doi: 10.1002/jmv.26765.
    >> Share

  528. SINGH S, Widrich C, Nap M, Schokker E, et al
    Antihypertensive and its relation to mortality by SARS-CoV-2 infection.
    J Med Virol. 2021 Jan 6. doi: 10.1002/jmv.26775.
    >> Share

  529. CHOUDHURY A, Chandra Das N, Patra R, Mukherjee S, et al
    In silico analyses on the comparative sensing of SARS-CoV-2 mRNA by the intracellular TLRs of human.
    J Med Virol. 2021 Jan 6. doi: 10.1002/jmv.26776.
    >> Share

  530. GARG P, Arora U, Kumar A, Malhotra A, et al
    Risk Factors for Prolonged Fatigue after Recovery from COVID-19.
    J Med Virol. 2021 Jan 4. doi: 10.1002/jmv.26774.
    >> Share

  531. WANG JH, Chen RD, Yang HK, Zeng LC, et al
    Inflammation-associated factors for predicting in-hospital mortality in patients with COVID-19.
    J Med Virol. 2021 Jan 4. doi: 10.1002/jmv.26771.
    >> Share

  532. RAO M, Rashid FA, Sabri FSAH, Jamil NN, et al
    COVID-19 screening test by using random oropharyngeal saliva.
    J Med Virol. 2021 Jan 4. doi: 10.1002/jmv.26773.
    >> Share

  533. HE J, Huang JR, Zhang YL, Zhang J, et al
    SARS-CoV-2 nucleocapsid protein intranasal inoculation induces local and systemic T cell responses in mice.
    J Med Virol. 2021 Jan 2. doi: 10.1002/jmv.26769.
    >> Share

  534. KRUGER S, Leskien M, Schuller P, Prifert C, et al
    Performance and feasibility of universal PCR admission screening for SARS-CoV-2 in a German tertiary care hospital.
    J Med Virol. 2021 Jan 2. doi: 10.1002/jmv.26770.
    >> Share

  535. NEJADGHADERI SA, Safiri S
    The dilemma of herd immunity for COVID-19.
    J Med Virol. 2021 Jan 2. doi: 10.1002/jmv.26768.
    >> Share

    December 2020
  536. GILIS M, Chagrot N, Koeberle S, Tannou T, et al
    Older adults with SARS-CoV2 infection: Utility of the Clinical Frailty Scale to predict mortality.
    J Med Virol. 2020 Dec 30. doi: 10.1002/jmv.26766.
    >> Share

  537. MEYERS C, Robison R, Milici J, Alam S, et al
    Rebuttal to Overinterpretation of the antiviral results for human coronavirus 229E (HCoV-229E) relative to severe acute respiratory syndrome coronavirus -2 (SARS-CoV-2) by Rowpar Pharmaceuticals.
    J Med Virol. 2020 Dec 29. doi: 10.1002/jmv.26762.
    >> Share

  538. STROFFOLINI T, Lombardi A, Ciancio A, Niro GA, et al
    Low influenza vaccination coverage in subjects with liver cirrhosis. An alert waiting winter season 2020-2021 during COVID-19 pandemic.
    J Med Virol. 2020 Dec 28. doi: 10.1002/jmv.26763.
    >> Share

  539. BUSTOS P, Tambley C, Acevedo A, Andrade W, et al
    Quantitative Detection of SARS-CoV-2 RNA in nasopharyngeal samples from infected patients with mild disease.
    J Med Virol. 2020 Dec 26. doi: 10.1002/jmv.26761.
    >> Share

  540. SHEWALE JG, Ratcliff JL
    Overinterpretation of the antiviral results for human coronavirus strain 229E (HCoV-229E) relative to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
    J Med Virol. 2020 Dec 25. doi: 10.1002/jmv.26722.
    >> Share

  541. MAHAJAN NN, Gajbhiye R, Bahirat S, Lokhande PD, et al
    Co-infection of malaria and early clearance of SARS-CoV-2 in healthcare workers.
    J Med Virol. 2020 Dec 24. doi: 10.1002/jmv.26760.
    >> Share

  542. TAHTASAKAL CA, Oncul A, Sevgi DY, Celik E, et al
    Could we predict the prognosis of the COVID-19 disease?
    J Med Virol. 2020 Dec 23. doi: 10.1002/jmv.26751.
    >> Share

  543. HUDSON B S, Kolte V, Khan A, Sharma G, et al
    Dynamic tracking of variant frequencies depicts the evolution of mutation sites amongst SARS-CoV-2 genomes from India.
    J Med Virol. 2020 Dec 23. doi: 10.1002/jmv.26756.
    >> Share

  544. ZHOU B, Kojima S, Kawamoto A, Fukushima M, et al
    COVID-19 pathogenesis, prognostic factors and treatment strategy: urgent recommendations.
    J Med Virol. 2020 Dec 23. doi: 10.1002/jmv.26754.
    >> Share

  545. COEN M, Kaiser C, Naimi R, Uginet M, et al
    Beyond silent hypoxemia: Does COVID-19 can blunt pain perception? Comment on "The neuroinvasive potential of SARS CoV2 may play a role in the respiratory failure of COVID 19 patients".
    J Med Virol. 2020 Dec 23. doi: 10.1002/jmv.26753.
    >> Share

  546. KUMAR A, Kumar P, Singh A, D S, et al
    Bilateral premacular sub-hyaloid hemorrhage-unmasking COVID-19 induced pancytopenia.
    J Med Virol. 2020 Dec 23. doi: 10.1002/jmv.26752.
    >> Share

  547. MERUGU GP, Neishwat Z, Balla M, Patel M, et al
    Predictors of Mortality in 217 COVID-19 Patients in Northwest Ohio, United States: A Retrospective Study.
    J Med Virol. 2020 Dec 22. doi: 10.1002/jmv.26750.
    >> Share

  548. CORDES AK, Rehrauer WM, Accola MA, Wolk B, et al
    Fully automated detection and differentiation of pandemic and endemic coronaviruses (NL63, 229E, HKU1, OC43 and SARS-CoV-2) on the Hologic Panther Fusion.
    J Med Virol. 2020 Dec 22. doi: 10.1002/jmv.26749.
    >> Share

  549. MISHRA D, Suri GS, Kaur G, Tiwari M, et al
    A comparative insight into genomic landscape of SARS-CoV-2 and identification of mutations associated with origin of infection and diversity.
    J Med Virol. 2020 Dec 21. doi: 10.1002/jmv.26744.
    >> Share

  550. ZANDIFAR A, Badrfam R
    COVID-19 and Anti-N-Methyl-D-Aspartate Receptor (Anti NMDAR) Encephalitis; Are we Facing an Increase in the Prevalence of Autoimmune Encephalitis?
    J Med Virol. 2020 Dec 18. doi: 10.1002/jmv.26745.
    >> Share

  551. ZRELLI S, Amairia S, Zrelli M
    Respiratory Syndrome Coronavirus-2 response: Micorobiots as Lactobacilli could make the difference.
    J Med Virol. 2020 Dec 18. doi: 10.1002/jmv.26746.
    >> Share

  552. CIZMECIOGLU A, Cizmecioglu HA, Goktepe MH, Emsen A, et al
    Apoptosis-Induced T Cell Lymphopenia Is Related to COVID-19 Severity.
    J Med Virol. 2020 Dec 17. doi: 10.1002/jmv.26742.
    >> Share

  553. SARKAR S, Khanna P, Singh AK
    Impact of COVID-19 in patients with concurrent co-infections: a systematic review and meta-analyses.
    J Med Virol. 2020 Dec 17. doi: 10.1002/jmv.26740.
    >> Share

  554. ZHOU C, Bu G, Sun Y, Ren C, et al
    Evaluation of serum IgM and IgG antibodies in COVID-19 patients by enzyme linked immunosorbent assay.
    J Med Virol. 2020 Dec 17. doi: 10.1002/jmv.26741.
    >> Share

  555. MARTI JLG, Wells A, Brufsky AM
    Dysregulation of the mevalonate pathway during SARS-CoV-2 infection: an in-silico study.
    J Med Virol. 2020 Dec 17. doi: 10.1002/jmv.26743.
    >> Share

  556. LIU X, Li X, Sun T, Qin H, et al
    East-West differences in clinical manifestations of COVID-19 patients: A systematic literature review and meta-analysis.
    J Med Virol. 2020 Dec 15. doi: 10.1002/jmv.26737.
    >> Share

  557. HO KS, Narasimhan B, Sheehan J, Wu L, et al
    Controversy over Smoking in COVID-19 - A Real World Experience in New York City.
    J Med Virol. 2020 Dec 15. doi: 10.1002/jmv.26738.
    >> Share

  558. CHEN HL, Chao CM, Lai CC
    The safety of remdesivir for COVID-19 patients.
    J Med Virol. 2020 Dec 15. doi: 10.1002/jmv.26735.
    >> Share

  559. LEUZINGER K, Gosert R, Sogaard KK, Naegele K, et al
    Epidemiology and precision of SARS-CoV-2 detection following lockdown and relaxation measures.
    J Med Virol. 2020 Dec 14. doi: 10.1002/jmv.26731.
    >> Share

  560. KARAM BS, Morris RS, Bramante CT, Puskarich M, et al
    mTOR inhibition in COVID-19: A commentary and review of efficacy in RNA viruses.
    J Med Virol. 2020 Dec 12. doi: 10.1002/jmv.26728.
    >> Share

  561. EROL SA, Tanacan A, Anuk AT, Tokalioglu EO, et al
    Evaluation of Maternal Serum Afamin and Vitamin E Levels in Pregnant Women with COVID-19 and Its Association with Composite Adverse Perinatal Outcomes.
    J Med Virol. 2020 Dec 12. doi: 10.1002/jmv.26725.
    >> Share

  562. MORADIMAJD P, Samaee H, Sedigh-Maroufi S, Kourosh-Aami M, et al
    Administration of intravenous immunoglobulin in the treatment of COVID-19: a review of available evidence.
    J Med Virol. 2020 Dec 12. doi: 10.1002/jmv.26727.
    >> Share

  563. ABDOLLAHI A, Sarvestani HK, Rafat Z, Ghaderkhani S, et al
    The Association Between the Level of Serum 25(OH) Vitamin D, Obesity, and underlying Diseases with the risk of Developing COVID-19 Infection: A case-control study of hospitalized patients in Tehran, Iran.
    J Med Virol. 2020 Dec 12. doi: 10.1002/jmv.26726.
    >> Share

  564. LIAO FL, Peng DH, Chen W, Hu HN, et al
    Evaluation of serum hepatic enzyme activities in different COVID-19 phenotypes.
    J Med Virol. 2020 Dec 12. doi: 10.1002/jmv.26729.
    >> Share

  565. BODNAR B, Patel K, Ho W, Luo JJ, et al
    Cellular mechanisms underlying neurological/neuropsychiatric manifestations of COVID-19.
    J Med Virol. 2020 Dec 10. doi: 10.1002/jmv.26720.
    >> Share

  566. SOARES CD, Mosqueda-Taylor A, Hernandez-Guerrero JC, de Carvalho MGF, et al
    Immunohistochemical expression of angiotensin-converting enzyme 2 (ACE2) in minor salivary glands during SARS-CoV-2 infection.
    J Med Virol. 2020 Dec 10. doi: 10.1002/jmv.26723.
    >> Share

  567. DOGAN HO, Senol O, Bolat S, Yildiz SN, et al
    Understanding the Pathophysiological Changes Via Untargated Metabolomics in COVID-19 Patients.
    J Med Virol. 2020 Dec 10. doi: 10.1002/jmv.26716.
    >> Share

  568. DIMEGLIO C, Collot S, Abravanel F, Saune K, et al
    Diagnosis options in patients suffering from COVID-19- like symptoms.
    J Med Virol. 2020 Dec 10. doi: 10.1002/jmv.26724.
    >> Share

  569. LIPPI G, Mattiuzzi C
    SARS-CoV-2 positive tests efficiently predict pressure on healthcare system.
    J Med Virol. 2020 Dec 9. doi: 10.1002/jmv.26718.
    >> Share

  570. AWAN UA, Khattak AA, Afzal MS, Khan HI, et al
    COVID-19 and Tuberculosis Overlapping epidemics: A holistic review from Pakistan.
    J Med Virol. 2020 Dec 9. doi: 10.1002/jmv.26714.
    >> Share

  571. BHATTACHARYA D, Parai D, Rout UK, Dash P, et al
    Saliva for diagnosis of SARS-CoV-2: first report from India.
    J Med Virol. 2020 Dec 9. doi: 10.1002/jmv.26719.
    >> Share

  572. FERRARO F, Calafiore D, Dambruoso F, Guidarini S, et al
    COVID-19 related fatigue: which role for rehabilitation in post-COVID-19 patients? A case series.
    J Med Virol. 2020 Dec 9. doi: 10.1002/jmv.26717.
    >> Share

  573. DAI W, Wu J, Li T, Shen J, et al
    Clinical outcomes for COVID-19 patients with diabetes mellitus treated with convalescent plasma transfusion in Wuhan, China.
    J Med Virol. 2020 Dec 7. doi: 10.1002/jmv.26712.
    >> Share

  574. CHEN H, Chen R, Yang H, Wang J, et al
    Development and Validation of a Nomogram Using on Admission Routine Laboratory Parameters to Predict In-hospital Survival of Patients With COVID-19.
    J Med Virol. 2020 Dec 7. doi: 10.1002/jmv.26713.
    >> Share

  575. ZAYET S, Gendrin V, Royer PY, Toko L, et al
    Comparison of COVID-19 and influenza in adult patients: neurological symptoms input.
    J Med Virol. 2020 Dec 3. doi: 10.1002/jmv.26710.
    >> Share

  576. CHAUHAN N, Soni S, Gupta A, Aslam M, et al
    Interpretative immune targets and contemporary position for vaccine development against SARS-CoV-2: A systematic review.
    J Med Virol. 2020 Dec 3. doi: 10.1002/jmv.26709.
    >> Share

  577. WANG P
    Significance of IgA antibody testing for early detection of SARS-CoV-2.
    J Med Virol. 2020 Dec 2. doi: 10.1002/jmv.26703.
    >> Share

  578. RIAD A, Kassem I, Badrah M, Klugar M, et al
    COVID-19 Transient Snoring (CVTS): Clinical and Laboratory Description.
    J Med Virol. 2020 Dec 2. doi: 10.1002/jmv.26705.
    >> Share

  579. TORAIH EA, Sedhom JA, Dokunmu TM, Hussein MH, et al
    Hidden in plain sight: The effects of BCG vaccination in COVID-19 pandemic.
    J Med Virol. 2020 Dec 2. doi: 10.1002/jmv.26707.
    >> Share

  580. KLINGEN RL, Katschinski B, Anastasiou OE, Stefan Ross R, et al
    Over 90% of clinical swabs used for SARS-CoV-2 diagnostics contain sufficient nucleic acid concentrations.
    J Med Virol. 2020 Dec 2. doi: 10.1002/jmv.26706.
    >> Share

    November 2020
  581. HENRIQUEZ-MARQUEZ KI, Lainez-Murillo DC, Sierra M, Munoz-Lara F, et al
    High impact of SARS-CoV-2/COVID-19 in the Honduran Health Personnel.
    J Med Virol. 2020 Nov 28. doi: 10.1002/jmv.26702.
    >> Share

  582. ALIZADEHSANI R, Sani ZA, Behjati M, Roshanzamir Z, et al
    Risk Factors Prediction, Clinical Outcomes and Mortality of COVID-19 Patients.
    J Med Virol. 2020 Nov 28. doi: 10.1002/jmv.26699.
    >> Share

  583. LUCIANI M, Bentivegna E, Spuntarelli V, Lamberti PA, et al
    Recurrent Covid-19 Pneumonia in the course of chemotherapy: consequence of a weakened immune system?
    J Med Virol. 2020 Nov 28. doi: 10.1002/jmv.26701.
    >> Share

  584. HARIYANTO TI, Kurniawan A
    Tocilizumab administration is associated with reduction in biomarkers of coronavirus disease 2019 (COVID-19) infection.
    J Med Virol. 2020 Nov 26. doi: 10.1002/jmv.26698.
    >> Share

  585. VALDIVIA A, Torres I, Latorre V, Frances-Gomez C, et al
    Suitability of Two Rapid Lateral Flow Immunochromatographic Assays for Predicting SARS-CoV-2 Neutralizing Activity of Sera.
    J Med Virol. 2020 Nov 25. doi: 10.1002/jmv.26697.
    >> Share

  586. KANG K, Huang L, Ouyang C, Du J, et al
    Development, Performance Evaluation and Clinical Application of A Rapid SARS-CoV-2 IgM and IgG Test Kit Based on Automated Fluorescence Immunoassay.
    J Med Virol. 2020 Nov 24. doi: 10.1002/jmv.26696.
    >> Share

  587. ZHANG G, Wu Y, Xu R, Du X, et al
    Effects of Renin-Angiotensin-Aldosterone System (RAAS) Inhibitors on Disease Severity and Mortality in Patients with COVID-19: A Meta-analysis.
    J Med Virol. 2020 Nov 24. doi: 10.1002/jmv.26695.
    >> Share

  588. AWAN UA, Zahoor S, Rehman K, Khattak AA, et al
    COVID-19 and Influenza H1N1: A dangerous combination for Pakistan in the upcoming winter season.
    J Med Virol. 2020 Nov 24. doi: 10.1002/jmv.26687.
    >> Share

  589. DESMET S, Ekinci E, Wouters I, Decru B, et al
    No SARS-CoV-2 carriage observed in children attending daycare centers during the first weeks of the epidemic in Belgium.
    J Med Virol. 2020 Nov 24. doi: 10.1002/jmv.26689.
    >> Share

  590. GARG A, Ghoshal U, Patel SS, Singh DV, et al
    Evaluation of seven commercial RT-PCR kits for COVID-19 testing in pooled clinical specimens.
    J Med Virol. 2020 Nov 24. doi: 10.1002/jmv.26691.
    >> Share

  591. BOSCHI C, Hoang VT, Giraud-Gatineau A, Ninove L, et al
    Co-infections with SARS-CoV-2 and other respiratory viruses in Southeastern France: a matter of sampling time.
    J Med Virol. 2020 Nov 24. doi: 10.1002/jmv.26692.
    >> Share

  592. OZSUREKCI Y, Aykac K, Er AG, Halacli B, et al
    Predictive Value of Cytokine/Chemokine Responses for the Disease Severity and Management in Children and Adult Cases with COVID-19.
    J Med Virol. 2020 Nov 23. doi: 10.1002/jmv.26683.
    >> Share

  593. ALSHARRAH D, Alhaddad F, Alyaseen M, Aljamaan S, et al
    Clinical Characteristics of Pediatric SARS-CoV-2 Infection and Coronavirus Disease 2019 (COVID-19) in Kuwait.
    J Med Virol. 2020 Nov 20. doi: 10.1002/jmv.26684.
    >> Share

  594. GIULIANI J, Bonetti A
    COVID-19 and Cancer: A Clear Change Not Only in Daily Clinical Practice But Also in Clinical Research Management.
    J Med Virol. 2020 Nov 20. doi: 10.1002/jmv.26680.
    >> Share

  595. AKINOSOGLOU K, Gogos A, Papageorgiou C, Angelopoulos E, et al
    Ketamine in COVID-19 patients: Thinking out of the box.
    J Med Virol. 2020 Nov 20. doi: 10.1002/jmv.26681.
    >> Share

  596. TAKAGI H
    A red mirage - Did the association of the 2016 presidential election results with the COVID-19 epidemic magically disappear in 2020?
    J Med Virol. 2020 Nov 20. doi: 10.1002/jmv.26682.
    >> Share

  597. VERALDI S, Spigariolo CB
    Pityriasis rosea and COVID-19.
    J Med Virol. 2020 Nov 18. doi: 10.1002/jmv.26679.
    >> Share

  598. MERCATELLI D, Triboli L, Fornasari E, Ray F, et al
    coronapp: A Web Application to Annotate and Monitor SARS-CoV-2 Mutations.
    J Med Virol. 2020 Nov 18. doi: 10.1002/jmv.26678.
    >> Share

  599. FAVRESSE J, Cadrobbi J, Eucher C, Elsen M, et al
    Clinical performances of three fully automated anti-SARS-CoV-2 immunoassays targeting the nucleocapsid or spike proteins.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26669.
    >> Share

  600. HILL JA, Menon MP, Dhanireddy S, Wurfel MM, et al
    Tocilizumab in hospitalized patients with COVID-19: Clinical outcomes, inflammatory marker kinetics, and safety.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26674.
    >> Share

  601. YANG J, Tian C, Chen Y, Zhu C, et al
    Obesity aggravates COVID-19: an updated systematic review and meta-analysis.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26677.
    >> Share

  602. SPOTO S, Agro FE, Sambuco F, Travaglino F, et al
    High value of Mid-regional proAdrenomedullin in COVID-19: a marker of widespread endothelial damage, disease severity and mortality.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26676.
    >> Share

  603. SWAMINATHAN N, Moussa P, Mody N, Bryan Lo K, et al
    COVID-19 in HIV infected patients: A Case series and Literature Review.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26671.
    >> Share

  604. AWAN UA, Zahoor S, Ayub A, Ahmed H, et al
    COVID-19 and Arboviral Diseases: Another Challenge for Pakistan's Delipidated Healthcare System.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26668.
    >> Share

  605. ATEYA AM, Sabri NA
    Angiotensin-converting enzyme inhibitors (ACEIs) and Angiotensin-receptor blockers (ARBs) benefits outweigh the risks in COVID-19 hypertensive patients.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26672.
    >> Share

  606. SEYMEN CM
    The other side of COVID-19 pandemic: Effects on male fertility.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26667.
    >> Share

  607. SYAL K
    Newly identified limitations of diagnostic tools for COVID-19 and consequences.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26673.
    >> Share

  608. WANG J, Zhu L, Xue L, Liu L, et al
    Risk factors of liver injury in patients with coronavirus disease 2019 in Jiangsu, China: a retrospective, multi-center study.
    J Med Virol. 2020 Nov 11. doi: 10.1002/jmv.26663.
    >> Share

  609. SHARMA B
    Does use of propofol aggravate the inflammatory markers and cause propofol infusion syndrome (PRIS) in intubated cases of severe COVID-19 infections?
    J Med Virol. 2020 Nov 9. doi: 10.1002/jmv.26657.
    >> Share

  610. LARROSA JMC
    Sars-Cov-2 in Argentina: Lockdown, Mobility, and Contagion.
    J Med Virol. 2020 Nov 9. doi: 10.1002/jmv.26659.
    >> Share

  611. HO YI, Wong AH, Leung EC, Wong RC, et al
    Rapid adaptation and continuous performance evaluation of SARS-CoV-2 envelope gene (E-gene) real-time RT-PCR assays to support the hospital surge in test demand.
    J Med Virol. 2020 Nov 9. doi: 10.1002/jmv.26660.
    >> Share

  612. TAKAGI H
    Survey of COVID-19 dynamics across US states.
    J Med Virol. 2020 Nov 9. doi: 10.1002/jmv.26658.
    >> Share

  613. MONREAL E, de la Maza SS, Gullon P, Natera-Villalba E, et al
    Non-severe immunosuppression might be associated with a lower risk of moderate-severe acute respiratory distress syndrome in COVID-19: a pilot study.
    J Med Virol. 2020 Nov 9. doi: 10.1002/jmv.26656.
    >> Share

  614. SAID EA, Al-Reesi I, Al-Shizawi N, Jaju S, et al
    Defining IL-6 Levels in Healthy Individuals: A Meta-Analysis.
    J Med Virol. 2020 Nov 6. doi: 10.1002/jmv.26654.
    >> Share

  615. HAN X, Ye Q
    Kidney involvement in COVID-19 and its treatments.
    J Med Virol. 2020 Nov 5. doi: 10.1002/jmv.26653.
    >> Share

  616. MASCOLO S, Carleo MA, Contieri M, Izzo S, et al
    SARS-CoV-2 and inflammatory responses: from mechanisms to the potential therapeutic use of intravenous immunoglobulin.
    J Med Virol. 2020 Nov 5. doi: 10.1002/jmv.26651.
    >> Share

  617. LIN SF, Lai CC, Chao CM, Tang HJ, et al
    Impact of COVID-19 preventative measures on dengue infections in Taiwan.
    J Med Virol. 2020 Nov 3. doi: 10.1002/jmv.26650.
    >> Share

  618. ALBERT E, Bracho MA, Serrano A, Ferrer B, et al
    Assessing the potential association between SARS-CoV-2 RNA load in the respiratory tract and COVID-19 mortality.
    J Med Virol. 2020 Nov 2. doi: 10.1002/jmv.26644.
    >> Share

  619. OZCELIK N, Ozyurt S, Yilmaz Kara B, Gumus A, et al
    The Value of Platelet Count and Platelet Indices in Differentiation of COVID-19 and Influenza Pneumonia.
    J Med Virol. 2020 Nov 2. doi: 10.1002/jmv.26645.
    >> Share

  620. LIU C, Yu X, Gao C, Zhang L, et al
    Characterization of Antibody Responses to SARS-CoV-2 in Convalescent COVID-19 Patients.
    J Med Virol. 2020 Nov 2. doi: 10.1002/jmv.26646.
    >> Share

  621. HOANG T
    Systematic review and meta-analysis of factors associated with re-positive viral RNA after recovery from COVID-19.
    J Med Virol. 2020 Nov 2. doi: 10.1002/jmv.26648.
    >> Share

    October 2020
  622. ALSHARIF KF, Alzahrani AB, Alharbi AO, Algregri TO, et al
    The prevalence of MERS-CoV among military personnel and their families: A single center study.
    J Med Virol. 2020 Oct 31. doi: 10.1002/jmv.26642.
    >> Share

  623. PENROD Y, Garcia D, Dunn ST
    Evaluation of transport media for laboratory detection of SARS-CoV-2 in upper respiratory tract swab specimens.
    J Med Virol. 2020 Oct 31. doi: 10.1002/jmv.26643.
    >> Share

  624. KOW CS, Aldeyab M, Hasan SS
    Effect of remdesivir on mortality in patients with COVID-19: A meta-analysis of randomized control trials.
    J Med Virol. 2020 Oct 29. doi: 10.1002/jmv.26638.
    >> Share

  625. TORRES DA, Ribeiro LDCB, Riello APFL, Horovitz DDG, et al
    Reinfection of COVID-19 after 3 months with a distinct and more aggressive clinical presentation: case report.
    J Med Virol. 2020 Oct 28. doi: 10.1002/jmv.26637.
    >> Share

  626. ARAIMO F, Imperiale C, Tordiglione P, Ceccarelli G, et al
    Ozone as Adjuvant Support in the Treatment of COVID-19: A Preliminary Report of Probiozovid Trial.
    J Med Virol. 2020 Oct 28. doi: 10.1002/jmv.26636.
    >> Share

  627. ZHANG C, Wu Z, Li JW, Tan K, et al
    Discharge may not be the end of treatment: pay attention to pulmonary fibrosis caused by severe COVID-19.
    J Med Virol. 2020 Oct 27. doi: 10.1002/jmv.26634.
    >> Share

  628. RAGAB D, Salah Eldin H, Afify M, Soliman W, et al
    A case of COVID-19, with cytokine storm, treated by consecutive use of therapeutic plasma exchange followed by convalescent plasma transfusion: a case report.
    J Med Virol. 2020 Oct 27. doi: 10.1002/jmv.26630.
    >> Share

  629. MENG M, Zhou X, Zhang Q, Zou J, et al
    The positive rate of saliva for the detection of 2019-nCoV and possible factors related to the sensitivity results.
    J Med Virol. 2020 Oct 27. doi: 10.1002/jmv.26627.
    >> Share

  630. BISHBURG E, Okoh A, Nagarakanti SR, Lindner M, et al
    Fungemia in COVID -19 ICU Patients, a Single Medical Center Experience.
    J Med Virol. 2020 Oct 27. doi: 10.1002/jmv.26633.
    >> Share

  631. CHEN F, Geng Z, Wang J, Liuchang W, et al
    Comparing two sample pooling strategies for SARS-CoV-2 RNA detection for efficient screening of COVID-19.
    J Med Virol. 2020 Oct 27. doi: 10.1002/jmv.26632.
    >> Share

  632. TORTAJADA C, Colomer E, Andreu-Ballester JC, Esparcia A, et al
    Corticosteroids for COVID-19 patients requiring oxygen support? Yes, but not for everyone: Effect of corticosteroids on mortality and Intensive Care Unit admission in patients with COVID-19 according to patients' oxygen requirements.
    J Med Virol. 2020 Oct 27. doi: 10.1002/jmv.26635.
    >> Share

  633. YAZIHAN N, Tanacan A, Erol SA, Anuk AT, et al
    Comparison of VEGF-A Values between Pregnant Women with COVID-19 and Healthy Pregnancies and Its Association with Composite Adverse Outcomes.
    J Med Virol. 2020 Oct 27. doi: 10.1002/jmv.26631.
    >> Share

  634. BOUASSA RM, Pere H, Tonen-Wolyec S, Longo JD, et al
    Unexpected high frequency of unspecific reactivities by testing pre-epidemic blood specimens from Europe and Africa with SARS-CoV-2 IgG-IgM antibody rapid tests points IgM as Achilles heel.
    J Med Virol. 2020 Oct 27. doi: 10.1002/jmv.26628.
    >> Share

  635. WANG Y, Chen B, Li Y, Zhang L, et al
    The Use of Renin-Angiotensin-Aldosterone System (RAAS) Inhibitors is Associated with a Lower Risk of Mortality in Hypertensive COVID-19 Patients: A Systematic Review and Meta-analysis.
    J Med Virol. 2020 Oct 23. doi: 10.1002/jmv.26625.
    >> Share

  636. BAIG AM
    Chronic COVID Syndrome: Need for an appropriate medical terminology for Long-COVID and COVID Long-Haulers.
    J Med Virol. 2020 Oct 23. doi: 10.1002/jmv.26624.
    >> Share

  637. SHAMINUR RAHMAN M, Rafiul Islam M, Rubayet Ul Alam ASM, Islam I, et al
    Evolutionary dynamics of SARS-CoV-2 nucleocapsid (N) protein and its consequences.
    J Med Virol. 2020 Oct 23. doi: 10.1002/jmv.26626.
    >> Share

  638. BWIRE GM, Njiro BJ, Mwakawanga DL, Sabas D, et al
    Possible vertical transmission and antibodies against SARS-CoV-2 among infants born to mothers with COVID-19: A living systematic review.
    J Med Virol. 2020 Oct 22. doi: 10.1002/jmv.26622.
    >> Share

  639. TAKAGI H
    Presidential vote 2016 and COVID-19 epidemic.
    J Med Virol. 2020 Oct 22. doi: 10.1002/jmv.26620.
    >> Share

  640. SREENIVASAN CC, Thomas M, Wang D, Li F, et al
    Susceptibility of livestock and companion animals to COVID-19.
    J Med Virol. 2020 Oct 22. doi: 10.1002/jmv.26621.
    >> Share

  641. MOHANTY S, Ravindra A, Gupta K, Hallur V, et al
    Intricacies in characterizing positivity in pooled sample testing for SARS-CoV-2.
    J Med Virol. 2020 Oct 21. doi: 10.1002/jmv.26618.
    >> Share

  642. CHEN Y, Ke Y, Liu X, Wang Z, et al
    Clinical features and antibody response of patients from a COVID-19 treatment hospital in Wuhan, China.
    J Med Virol. 2020 Oct 21. doi: 10.1002/jmv.26617.
    >> Share

  643. MATTOS EC, Matsuda EM, Colpas DR, Carvalho F, et al
    Can urine be a potential biohazard in times of SARS-CoV-2 pandemic?
    J Med Virol. 2020 Oct 21. doi: 10.1002/jmv.26616.
    >> Share

  644. KUMAR A, Prasoon P, Kumari C, Pareek V, et al
    SARS-CoV-2 specific virulence factors in COVID-19.
    J Med Virol. 2020 Oct 21. doi: 10.1002/jmv.26615.
    >> Share

  645. KIVELA JM, Jarva H, Lappalainen M, Kurkela S, et al
    Saliva-based testing for diagnosis of SARS-CoV-2 infection: A meta-analysis.
    J Med Virol. 2020 Oct 20. doi: 10.1002/jmv.26613.
    >> Share

  646. SELINGEROVA I, Valik D, Gescheidtova L, Sramek V, et al
    Interpretive discrepancies caused by target values inter-batch variations in chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG by MAGLUMI.
    J Med Virol. 2020 Oct 20. doi: 10.1002/jmv.26612.
    >> Share

  647. YUN HE, Ryu BY, Choe YJ
    Impact of Social Distancing on Incidence of Vaccine-Preventable Diseases, South Korea.
    J Med Virol. 2020 Oct 20. doi: 10.1002/jmv.26614.
    >> Share

  648. CAVALIERE AF, Marchi L, Aquilini D, Brunelli T, et al
    Passive Immunity in Newborn from SARS-CoV-2 Infected Mother.
    J Med Virol. 2020 Oct 19. doi: 10.1002/jmv.26609.
    >> Share

  649. YANG P, Wang N, Wang J, Luo A, et al
    Admission fasting plasma glucose is an independent risk factor for 28-day mortality in patients with COVID-19.
    J Med Virol. 2020 Oct 19. doi: 10.1002/jmv.26608.
    >> Share

  650. STRATTON CW, Tang YW, Lu H
    Pathogenesis-Directed Therapy of 2019 Novel Coronavirus Disease.
    J Med Virol. 2020 Oct 19. doi: 10.1002/jmv.26610.
    >> Share

  651. CRISCUOLO E, Diotti RA, Strollo M, Rolla S, et al
    Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects.
    J Med Virol. 2020 Oct 16. doi: 10.1002/jmv.26605.
    >> Share

  652. YIGENOGLU TN, Basci S, Sinan Dal M, Korkmaz S, et al
    The outcome of COVID-19 in patients with hematological malignancy.
    J Med Virol. 2020 Oct 16. doi: 10.1002/jmv.26607.
    >> Share

  653. SILVA JUNIOR JVJ, Lopes TRR, Weiblen R, Flores EF, et al
    Background immunity: how important is it for SARS-CoV-2?
    J Med Virol. 2020 Oct 15. doi: 10.1002/jmv.26602.
    >> Share

  654. YAZDANPANAH Y
    Impact on disease mortality of clinical, biological and virological characteristics at hospital admission and over time in COVID-19 patients.
    J Med Virol. 2020 Oct 15. doi: 10.1002/jmv.26601.
    >> Share

  655. HE J, Huang F, Zhang J, Chen Q, et al
    Vaccine design based on 16 epitopes of SARS-CoV-2 spike protein.
    J Med Virol. 2020 Oct 14. doi: 10.1002/jmv.26596.
    >> Share

  656. HIGUCHI T, Nishida T, Iwahashi H, Morimura O, et al
    Early Clinical Factors Predicting the Development of Critical Disease in Japanese Patients with COVID-19: A Single-Center, Retrospective, Observational Study.
    J Med Virol. 2020 Oct 14. doi: 10.1002/jmv.26599.
    >> Share

  657. ROSEN HR, O'Connell C, Nadim MK, DeClerck B, et al
    Extrapulmonary Manifestations of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Infection.
    J Med Virol. 2020 Oct 14. doi: 10.1002/jmv.26595.
    >> Share

  658. WU S, Tian C, Liu P, Guo D, et al
    Effects of SARS-CoV-2 mutations on protein structures and intraviral protein-protein interactions.
    J Med Virol. 2020 Oct 14. doi: 10.1002/jmv.26597.
    >> Share

  659. PODDER S, Ghosh A, Ghosh T
    Mutations in membrane-fusion subunit of spike glycoprotein play crucial role in the recent outbreak of COVID-19.
    J Med Virol. 2020 Oct 14. doi: 10.1002/jmv.26598.
    >> Share

  660. HERNANDEZ-HUERTA MT, Mayoral LP, Diaz CR, Cruz MM, et al
    Analysis of SARS-CoV-2 mutations in Mexico, Belize and isolated regions of Guatemala and its implication in the diagnosis.
    J Med Virol. 2020 Oct 13. doi: 10.1002/jmv.26591.
    >> Share

  661. MANSOOR SR, Ghasemi-Kasman M
    Impact of disease-modifying drugs on severity of COVID-19 infection in multiple sclerosis patients.
    J Med Virol. 2020 Oct 12. doi: 10.1002/jmv.26593.
    >> Share

  662. DAUNT A, Perez-Guzman PN, Cafferkey J, Manalan K, et al
    Factors associated with re-attendance to emergency services following COVID-19 hospitalisation.
    J Med Virol. 2020 Oct 12. doi: 10.1002/jmv.26594.
    >> Share

  663. YOKOYAMA Y, Aikawa T, Takagi H, Briasoulis A, et al
    Association of Renin-Angiotensin-Aldosterone System Inhibitors with Mortality and Testing Positive of COVID-19; Meta-Analysis.
    J Med Virol. 2020 Oct 10. doi: 10.1002/jmv.26588.
    >> Share

  664. CHIRUMBOLO S
    SARS-CoV2 virions in PM10 pollutants. May further research reject this thesis?
    J Med Virol. 2020 Oct 10. doi: 10.1002/jmv.26590.
    >> Share

  665. KERGET B, Kerget F, Aksakal A, Askin S, et al
    Evaluation of alpha defensin, IL-1 receptor antagonist, and IL-18 levels in COVID-19 patients with macrophage activation syndrome and acute respiratory distress syndrome.
    J Med Virol. 2020 Oct 10. doi: 10.1002/jmv.26589.
    >> Share

  666. HALPIN S, O'Connor R, Sivan M
    Long COVID and chronic COVID syndromes.
    J Med Virol. 2020 Oct 9. doi: 10.1002/jmv.26587.
    >> Share

  667. SPEROTTO A, Candoni A, Petruzzellis G, Mullai R, et al
    Screening Procedure for SARS-CoV-2 infection combining Triage, nasopharyngeal swab and serological test in allogeneic stem cell transplantation Recipients Undergoing Outpatient Post Transplant Follow-Up.
    J Med Virol. 2020 Oct 8. doi: 10.1002/jmv.26586.
    >> Share

  668. LENG Y, Chen M, Dai M, Wu Y, et al
    Minimize glycemic fluctuation decrease the risk of severe illness and death in patients with COVID-19.
    J Med Virol. 2020 Oct 7. doi: 10.1002/jmv.26584.
    >> Share

  669. PEZZUTO A, Tammaro A, Tonini G, Ciccozzi M, et al
    COPD influences survival in patients affected by Covid-19, comparison between subjects admitted to an internal medicine unit and subjects admitted to an intensive care unit :an Italian experience.
    J Med Virol. 2020 Oct 7. doi: 10.1002/jmv.26585.
    >> Share

  670. YUEN CK, Wong WM, Mak LF, Wang X, et al
    Suppression of SARS-CoV-2 infection in ex-vivo human lung tissues by targeting class III phosphoinositide 3-kinase.
    J Med Virol. 2020 Oct 7. doi: 10.1002/jmv.26583.
    >> Share

  671. FINSTERER J, Stollberger C
    SARS-CoV-2 triggered Takotsubo in 38 patients.
    J Med Virol. 2020 Oct 6. doi: 10.1002/jmv.26581.
    >> Share

  672. HUANG F, Liu X, Sun X, Li Z, et al
    IL-10 served as an indicator in severe COVID-19 patients.
    J Med Virol. 2020 Oct 6. doi: 10.1002/jmv.26580.
    >> Share

  673. URRA JM, Ferreras-Colino E, Contreras M, Cabrera CM, et al
    The antibody response to the glycan alpha-Gal correlates with COVID-19 disease symptoms.
    J Med Virol. 2020 Oct 3. doi: 10.1002/jmv.26575.
    >> Share

  674. CAKIR B
    The outcome of COVID-19 in patients with hematological malignancy.
    J Med Virol. 2020 Oct 2. doi: 10.1002/jmv.26576.
    >> Share

  675. D'ALESSANDRO M, Bergantini L, Cameli P, Curatola G, et al
    Peripheral biomarkers' panel for severe COVID-19 patients.
    J Med Virol. 2020 Oct 2. doi: 10.1002/jmv.26577.
    >> Share

  676. LIU JM, Tan BH, Wu S, Gui Y, et al
    Evidence of central nervous system infection and neuroinvasive routes, as well as neurological involvement in the lethality of SARS-CoV-2 infection.
    J Med Virol. 2020 Oct 1. doi: 10.1002/jmv.26570.
    >> Share

  677. KASIBHATLA SM, Kinikar M, Limaye S, Kale MM, et al
    Understanding evolution of SARS-CoV-2: A perspective from analysis of genetic diversity of RdRp gene.
    J Med Virol. 2020;92:1932-1937.
    >> Share

  678. LA MAESTRA S, Abbondandolo A, De Flora S
    Epidemiological trends of COVID-19 epidemic in Italy over March 2020: From 1000 to 100 000 cases.
    J Med Virol. 2020;92:1956-1961.
    >> Share

  679. MORRISON AR, Johnson JM, Ramesh M, Bradley P, et al
    Acute hypertriglyceridemia in patients with COVID-19 receiving tocilizumab.
    J Med Virol. 2020;92:1791-1792.
    >> Share

  680. LI Y, Hu Y, Yu Y, Zhang X, et al
    Positive result of Sars-Cov-2 in faeces and sputum from discharged patients with COVID-19 in Yiwu, China.
    J Med Virol. 2020;92:1938-1947.
    >> Share

  681. CIMOLAI N
    Defining protective epitopes for COVID-19 vaccination models.
    J Med Virol. 2020;92:1772-1773.
    >> Share

  682. ZAYET S, Kadiane-Oussou NJ, Royer PY, Toko L, et al
    Coronavirus disease 2019: New things to know!
    J Med Virol. 2020;92:1767-1768.
    >> Share

  683. NATAF S
    An alteration of the dopamine synthetic pathway is possibly involved in the pathophysiology of COVID-19.
    J Med Virol. 2020;92:1743-1744.
    >> Share

  684. CIULLA MM
    Coronavirus uses as binding site in humans angiotensin-converting enzyme 2 functional receptor that is involved in arterial blood pressure control and fibrotic response to damage and is a drug target in cardiovascular disease. Is this just a phylogene
    J Med Virol. 2020;92:1713-1714.
    >> Share

  685. GUO F, Du Z, Wang T
    An effective screening and management process in the outpatient clinic for patients requiring hospitalization during the COVID-19 pandemic.
    J Med Virol. 2020;92:1797-1798.
    >> Share

  686. WU X, Fu B, Chen L, Feng Y, et al
    Serological tests facilitate identification of asymptomatic SARS-CoV-2 infection in Wuhan, China.
    J Med Virol. 2020;92:1795-1796.
    >> Share

  687. FINSTERER J, Stollberger C
    Causes of hypogeusia/hyposmia in SARS-CoV2 infected patients.
    J Med Virol. 2020;92:1793-1794.
    >> Share

  688. LIU J, Xiao Y, Shen Y, Shi C, et al
    Detection of SARS-CoV-2 by RT-PCR in anal from patients who have recovered from coronavirus disease 2019.
    J Med Virol. 2020;92:1769-1771.
    >> Share

  689. WANG W, Zhou D, Jia X, Feng Y, et al
    Influenza-like illnesses caused by a cluster of imported Italian COVID-19.
    J Med Virol. 2020;92:1764-1766.
    >> Share

  690. TRESOLDI I, Sangiuolo CF, Manzari V, Modesti A, et al
    SARS-COV-2 and infectivity: Possible increase in infectivity associated to integrin motif expression.
    J Med Virol. 2020;92:1741-1742.
    >> Share

  691. WU W, Zhang Y, Wang P, Zhang L, et al
    Psychological stress of medical staffs during outbreak of COVID-19 and adjustment strategy.
    J Med Virol. 2020;92:1962-1970.
    >> Share

  692. WANG G, Chen W, Jin X, Chen YP, et al
    Description of COVID-19 cases along with the measures taken on prevention and control in Zhejiang, China.
    J Med Virol. 2020;92:1948-1955.
    >> Share

  693. SAHU KK, Mishra AK, Lal A
    A twin challenge to handle: COVID-19 with pregnancy.
    J Med Virol. 2020;92:1718-1720.
    >> Share

  694. LENG Z, Yin D, Zhao Z, Yan M, et al
    A survey of 434 clinical trials about coronavirus disease 2019 in China.
    J Med Virol. 2020;92:1715-1717.
    >> Share

    September 2020
  695. GUMUS T, Cengiz D, Kartal F, Atceken Z, et al
    Changes in Computed Tomography Findings of COVID-19 Pneumonia: Less Extensive Lung Involvement with Decreasing Disease Prevalence.
    J Med Virol. 2020 Sep 30. doi: 10.1002/jmv.26573.
    >> Share

  696. WONG RC, Wong AH, Ho YI, Leung EC, et al
    Performance evaluation of Panther Fusion SARS-CoV-2 assay for detection of SARS-CoV-2 from deep throat saliva, nasopharyngeal and lower-respiratory-tract specimens.
    J Med Virol. 2020 Sep 30. doi: 10.1002/jmv.26574.
    >> Share

  697. CHEN Y, Linli Z, Lei Y, Yang Y, et al
    Risk Factors for Mortality in Critically Ill Patients with COVID-19 in Huanggang, China: A Single-Centre Multivariate Pattern Analysis.
    J Med Virol. 2020 Sep 30. doi: 10.1002/jmv.26572.
    >> Share

  698. RANA MS, Alam MM, Ikram A, Zaidi SSZ, et al
    Co-circulation of COVID-19 and dengue: A perspective from Pakistan.
    J Med Virol. 2020 Sep 29. doi: 10.1002/jmv.26567.
    >> Share

  699. ZHAO Y, He J, Wang J, Li WM, et al
    Development of Pancytopenia in a Patient with COVID-19.
    J Med Virol. 2020 Sep 29. doi: 10.1002/jmv.26566.
    >> Share

  700. BONGIOVANNI M
    COVID-19 re-infection in an healthcare worker.
    J Med Virol. 2020 Sep 29. doi: 10.1002/jmv.26565.
    >> Share

  701. MANDAL AKJ, Baktash V, Hosack T, Van den Abbeele K, et al
    Vitamin D status may indeed be a prognosticator for morbidity and mortality in patients with COVID-19.
    J Med Virol. 2020 Sep 29. doi: 10.1002/jmv.26569.
    >> Share

  702. HU J, Li S, Wu Y, Xiong Z, et al
    Surveillance and re-Positive RNA test in Patients recovered from COVID-19.
    J Med Virol. 2020 Sep 29. doi: 10.1002/jmv.26568.
    >> Share

  703. ROMERO-LOPEZ JP, Carnalla-Cortes M, Pacheco-Olvera DL, Ocampo-Godinez JM, et al
    A bioinformatic prediction of antigen presentation from SARS-CoV-2 spike protein revealed a theorical correlation of HLA-DRB1*01 with COVID-19 fatality in Mexican population: an ecological approach.
    J Med Virol. 2020 Sep 28. doi: 10.1002/jmv.26561.
    >> Share

  704. ALMAGHLOUTH NK, Davis MG, Davis MA, Anyiam FE, et al
    Risk factors for mortality among patients with SARS-CoV-2 infection: A longitudinal observational study.
    J Med Virol. 2020 Sep 28. doi: 10.1002/jmv.26560.
    >> Share

  705. HAUSLER M, van Helden J, Kleines M
    Retarded decline of the share of SARS-CoV-2-positive children in North Rhine-Westphalia, Germany.
    J Med Virol. 2020 Sep 28. doi: 10.1002/jmv.26564.
    >> Share

  706. TAKAGI H
    Government's policy, citizens' behavior, and COVID-19 pandemic.
    J Med Virol. 2020 Sep 26. doi: 10.1002/jmv.26559.
    >> Share

  707. SAFARI I, InanlooRahatloo K, Elahi E
    11Evolution of SARS-CoV-2 genome from December 2019 to late March 2020: emerged haplotypes and informative Tag nucleotide variations.
    J Med Virol. 2020 Sep 25. doi: 10.1002/jmv.26553.
    >> Share

  708. GUDMUNDSDOTTIR A, Scheving R, Lindberg F, Stefansson B, et al
    Inactivation of SARS-CoV-2 and HCoV-229E in vitro by ColdZyme(R) a medical device mouth spray against common cold.
    J Med Virol. 2020 Sep 25. doi: 10.1002/jmv.26554.
    >> Share

  709. MONDI A, Cimini E, Colavita F, Cicalini S, et al
    COVID-19 in people living with HIV: clinical implications of dynamics of immune response to SARS-CoV-2.
    J Med Virol. 2020 Sep 25. doi: 10.1002/jmv.26556.
    >> Share

  710. XU R, Cui J, Hu L, Wang Y, et al
    Development and validation of a simplified nomogram predicting individual critical illness of risk in COVID-19: a retrospective study.
    J Med Virol. 2020 Sep 25. doi: 10.1002/jmv.26551.
    >> Share

  711. FINSTERER J, Scorza FA
    SARS-CoV-2 myopathy.
    J Med Virol. 2020 Sep 25. doi: 10.1002/jmv.26550.
    >> Share

  712. MALIK P, Patel U, Patel K, Martin M, et al
    Obesity a predictor of outcomes of COVID-19 hospitalized patients- A systematic Review and Meta-Analysis.
    J Med Virol. 2020 Sep 25. doi: 10.1002/jmv.26555.
    >> Share

  713. LO YL
    Covid-19, fatigue and dysautonomia.
    J Med Virol. 2020 Sep 25. doi: 10.1002/jmv.26552.
    >> Share

  714. BADUA CLDC, Baldo KAT, Medina PMB
    Genomic and Proteomic Mutation Landscapes of SARS-CoV-2.
    J Med Virol. 2020 Sep 24. doi: 10.1002/jmv.26548.
    >> Share

  715. DRAGO F, Ciccarese G, Rebora A, Parodi A, et al
    Human herpesvirus 6, 7 and Epstein Barr virus reactivation in pityriasis rosea during COVID-19.
    J Med Virol. 2020 Sep 24. doi: 10.1002/jmv.26549.
    >> Share

  716. AMBADE V
    Biochemical rationale for hypoalbuminemia in COVID-19 patients.
    J Med Virol. 2020 Sep 23. doi: 10.1002/jmv.26542.
    >> Share

  717. PERESON MJ, Mojsiejczuk L, Martinez AP, Flichman DM, et al
    Phylogenetic analysis of SARS-CoV-2 IN THE FIRST MONTHS SINCE ITS EMERGENCE.
    J Med Virol. 2020 Sep 23. doi: 10.1002/jmv.26545.
    >> Share

  718. GONCHAROVA EA, Dedkov VG, Dolgova AS, Kassirov IS, et al
    One-Step Quantitative RT-PCR Assay with Armored RNA Controls for Detection of SARS-CoV-2.
    J Med Virol. 2020 Sep 23. doi: 10.1002/jmv.26540.
    >> Share

  719. YASRI S, Wiwanitkit V
    Systemic lupus erythematosus, varicella-like rash and COVID-19.
    J Med Virol. 2020 Sep 23. doi: 10.1002/jmv.26547.
    >> Share

  720. LIPPI G, Mattiuzzi C
    Clinical value anti-SARS-COV-2 serum IgA titration in patients with COVID-19.
    J Med Virol. 2020 Sep 23. doi: 10.1002/jmv.26539.
    >> Share

  721. OMRANI AS, Zaqout A, Baiou A, Daghfal J, et al
    Convalescent Plasma for the Treatment of Patients with Severe Coronavirus Disease 2019; a Preliminary Report.
    J Med Virol. 2020 Sep 23. doi: 10.1002/jmv.26537.
    >> Share

  722. TURAL ONUR S, Altin S, Nedime Sokucu S, Ileri Fikri B, et al
    Could ferritin level be an indicator of COVID-19 disease mortality?
    J Med Virol. 2020 Sep 23. doi: 10.1002/jmv.26543.
    >> Share

  723. YUE L, Cao H, Xie T, Long R, et al
    N-terminally truncated nucleocapsid protein of SARS-CoV-2 as a better serological marker than whole nucleocapsid protein in evaluating the immunogenicity of inactive SARS-CoV-2.
    J Med Virol. 2020 Sep 23. doi: 10.1002/jmv.26541.
    >> Share

  724. YAN H, Lu S, Chen L, Wang Y, et al
    Multiple Organ Injury on Admission Predicts In-Hospital Mortality in Patients with COVID -19.
    J Med Virol. 2020 Sep 19. doi: 10.1002/jmv.26534.
    >> Share

  725. SILVA SJRD, Pena L
    A Word of Caution in Interpreting Covid-19 Diagnostics Tests.
    J Med Virol. 2020 Sep 19. doi: 10.1002/jmv.26531.
    >> Share

  726. BENOIT JL, Benoit SW, Oliveira MHS, Lippi G, et al
    Anemia and COVID-19: a prospective perspective.
    J Med Virol. 2020 Sep 19. doi: 10.1002/jmv.26530.
    >> Share

  727. LI L, Lowe CF, Ritchie G, Stefanovic A, et al
    SARS-CoV-2 molecular testing for the diagnosis of COVID-19: One test does not fit all.
    J Med Virol. 2020 Sep 19. doi: 10.1002/jmv.26532.
    >> Share

  728. AKIYAMA S, Yamada A, Sakuraba A
    Safety of non-tumor necrosis factor-targeted biologics in the COVID-19 pandemic.
    J Med Virol. 2020 Sep 19. doi: 10.1002/jmv.26528.
    >> Share

  729. NAGARAKANTI SR, Okoh AK, Grinberg S, Bishburg E, et al
    Clinical outcomes of patients with COVID-19 and HIV coinfection.
    J Med Virol. 2020 Sep 19. doi: 10.1002/jmv.26533.
    >> Share

  730. FEI F, Smith JA, Cao L
    Clinical laboratory characteristics in patients with suspected COVID-19: one single institution experience.
    J Med Virol. 2020 Sep 18. doi: 10.1002/jmv.26527.
    >> Share

  731. BREWER J, Marti JLG, Brufsky A
    Potential Interventions for SARS-CoV-2 Infections: Zinc Showing Promise.
    J Med Virol. 2020 Sep 17. doi: 10.1002/jmv.26523.
    >> Share

  732. NOROOZNEZHAD AH, Eskandarion S, Akbari R, Alimohammadi S, et al
    Changes of Leukocytes, Neutrophils, and Lymphocytes Count and Dependent Variables in Pregnant Women with Coronavirus Disease 2019 (COVID-19) Before and After Cesarean Delivery.
    J Med Virol. 2020 Sep 17. doi: 10.1002/jmv.26525.
    >> Share

  733. MEYERS C, Robison R, Milici J, Alam S, et al
    Lowering the Transmission and Spread of Human Coronavirus.
    J Med Virol. 2020 Sep 17. doi: 10.1002/jmv.26514.
    >> Share

  734. YANG S, Shan T, Xiao Y, Zhang H, et al
    Digging metagenomic data of pangolins revealed SARS-CoV-2 related viruses and other significant viruses.
    J Med Virol. 2020 Sep 17. doi: 10.1002/jmv.26524.
    >> Share

  735. BATEMAN AC, Mueller S, Guenther K, Shult P, et al
    Assessing the Dilution Effect of Specimen Pooling on the Sensitivity of SARS-CoV-2 PCR Tests.
    J Med Virol. 2020 Sep 16. doi: 10.1002/jmv.26519.
    >> Share

  736. ZHOU P, Li Z, Xie L, An D, et al
    Research progress and challenges to coronavirus vaccine development.
    J Med Virol. 2020 Sep 16. doi: 10.1002/jmv.26517.
    >> Share

  737. DEY J, Alam MT, Chandra S, Gupta J, et al
    Neuroinvasion of SARS-CoV-2 may play a role in the breakdown of respiratory center of the brain.
    J Med Virol. 2020 Sep 16. doi: 10.1002/jmv.26521.
    >> Share

  738. CARUSO A, Caccuri F, Bugatti A, Zani A, et al
    Methotrexate inhibits SARS-CoV-2 virus replication "in vitro".
    J Med Virol. 2020 Sep 14. doi: 10.1002/jmv.26512.
    >> Share

  739. CHEN T, Li G, Liu H, Wan W, et al
    Clinical characteristics of 132 healthcare workers cases with COVID-19: a retrospective study from a single center in Wuhan, China.
    J Med Virol. 2020 Sep 14. doi: 10.1002/jmv.26511.
    >> Share

  740. SLIMANI Y, Abbassi R, El Fatoiki FZ, Barrou L, et al
    Systemic lupus erythematosus and varicella-like rash following COVID-19 in a previously healthy patient.
    J Med Virol. 2020 Sep 14. doi: 10.1002/jmv.26513.
    >> Share

  741. YANG C, Ma X, Wu J, Han J, et al
    Low serum calcium and phosphorus and their clinical performance in detecting COVID-19 patients.
    J Med Virol. 2020 Sep 14. doi: 10.1002/jmv.26515.
    >> Share

  742. AZIZ M, Haghbin H, Sitta EA, Nawras Y, et al
    Efficacy of Tocilizumab in COVID-19: A Systematic review and Meta-Analysis.
    J Med Virol. 2020 Sep 12. doi: 10.1002/jmv.26509.
    >> Share

  743. SPEECKAERT MM, De Buyzere ML, Delanghe JR
    Vitamin D binding protein polymorphism and COVID-19.
    J Med Virol. 2020 Sep 12. doi: 10.1002/jmv.26508.
    >> Share

  744. HENDERSON CE, Rezai S, Jackman JM
    Universal Screening for Novel Coronavirus Disease 2019 (COVID-19) for Asymptomatic Parturients - May Not Be Beneficial At This Time.
    J Med Virol. 2020 Sep 11. doi: 10.1002/jmv.26507.
    >> Share

  745. TAN Y, Zhou J, Zhou Q, Hu L, et al
    Role of Eosinophils in the Diagnosis and Prognostic Evaluation of COVID-19.
    J Med Virol. 2020 Sep 11. doi: 10.1002/jmv.26506.
    >> Share

  746. FINSTERER J, Scorza FA, Scorza CA, Fiorini AC, et al
    SARS-CoV-2 and myasthenia.
    J Med Virol. 2020 Sep 10. doi: 10.1002/jmv.26501.
    >> Share

  747. TAKAGI H
    COVID-19 epidemic and community mobility in Tokyo.
    J Med Virol. 2020 Sep 10. doi: 10.1002/jmv.26502.
    >> Share

  748. TAKAHASHI M, Egorova NN, Kuno T
    COVID-19 and influenza testing in New York City.
    J Med Virol. 2020 Sep 10. doi: 10.1002/jmv.26500.
    >> Share

  749. ZHANG B, Yue D, Wang Y, Wang F, et al
    The dynamics of immune response in COVID-19 patients with different illness severity.
    J Med Virol. 2020 Sep 10. doi: 10.1002/jmv.26504.
    >> Share

  750. TAGHILOO S, Aliyali M, Abedi S, Mehravaran H, et al
    Apoptosis and immunophenotyping of peripheral blood lymphocytes in Iranian COVID-19 patients; clinical and laboratory characteristics.
    J Med Virol. 2020 Sep 10. doi: 10.1002/jmv.26505.
    >> Share

  751. DE FLORA S, La Maestra S
    Growth and decline of the COVID-19 epidemic wave in Italy from March to June 2020.
    J Med Virol. 2020 Sep 9. doi: 10.1002/jmv.26499.
    >> Share

  752. KANDEEL M, Kitade Y, Fayez M, Venugopala KN, et al
    The Emerging SARS-CoV-2 Papain-like Protease: Its Relationship with Recent Coronavirus Epidemics.
    J Med Virol. 2020 Sep 9. doi: 10.1002/jmv.26497.
    >> Share

  753. KOW CS, Hasan SS
    Mortality of COVID-19 with preadmission metformin use in patients with diabetes: a meta-analysis.
    J Med Virol. 2020 Sep 9. doi: 10.1002/jmv.26498.
    >> Share

  754. YAMAMOTO S, Saito M, Nagai E, Toriuchi K, et al
    Seroconversion against SARS-CoV-2 occurred after the recovery in patients with COVID-19.
    J Med Virol. 2020 Sep 8. doi: 10.1002/jmv.26495.
    >> Share

  755. ARAFKAS M, Khosrawipour T, Kocbach P, Zielinski K, et al
    Current meta-analysis does not support the possibility of COVID-19 reinfections.
    J Med Virol. 2020 Sep 8. doi: 10.1002/jmv.26496.
    >> Share

  756. KAWAMURA Y, Higashimoto Y, Miura H, Ihira M, et al
    Immune response against SARS-CoV-2 in pediatric patients including young infants.
    J Med Virol. 2020 Sep 8. doi: 10.1002/jmv.26493.
    >> Share

  757. LIU X, Liu Y, Wang L, Hu L, et al
    Analysis of the prophylactic effect of thymosin drugs on COVID-19 for 435 medical staff: A hospital-based retrospective study.
    J Med Virol. 2020 Sep 8. doi: 10.1002/jmv.26492.
    >> Share

  758. GRECO G, Ripamonti D, Binda F, Fabretti F, et al
    Potential role of subcutaneous tocilizumab injections in patients with COVID-19 associated pneumonia.
    J Med Virol. 2020 Sep 8. doi: 10.1002/jmv.26494.
    >> Share

  759. LI Y, Ji D, Cai W, Hu Y, et al
    Clinical characteristics, cause analysis and infectivity of COVID-19 nucleic acid re-positive patients: A literature review.
    J Med Virol. 2020 Sep 5. doi: 10.1002/jmv.26491.
    >> Share

  760. BIGUENET A, Bouiller K, Marty-Quinternet S, Brunel AS, et al
    SARS-CoV-2 respiratory viral loads and association with clinical and biological features.
    J Med Virol. 2020 Sep 5. doi: 10.1002/jmv.26489.
    >> Share

  761. ABBAS HM, Nassir KF, Al Khames Aga QA, Al-Gharawi AA, et al
    Presenting characteristics, smoking versus diabetes and outcome among patients hospitalized with COVID-19.
    J Med Virol. 2020 Sep 4. doi: 10.1002/jmv.26487.
    >> Share

  762. DAUBY N, Van Praet S, Vanhomwegen C, Veliziotis I, et al
    Tolerability of Favipiravir therapy in critically-ill patients with COVID-19: a report of 4 cases.
    J Med Virol. 2020 Sep 4. doi: 10.1002/jmv.26488.
    >> Share

  763. GIRIJA A S S
    Fox3(+) CD25(+) CD4(+) T regulatory cells (Tregs) may transform the n-CoV's final destiny to CNS!
    J Med Virol. 2020 Sep 3. doi: 10.1002/jmv.26482.
    >> Share

  764. TAN JY, Sim XYJ, Liang En W, Chua YY, et al
    A comparative study on the clinical features of COVID-19 with non-SARS-CoV-2 respiratory viral infections.
    J Med Virol. 2020 Sep 3. doi: 10.1002/jmv.26486.
    >> Share

  765. ESTOFOLETE CF, Machado LF, Zini N, Luckemeyer GD, et al
    Fatal stroke as presentation of SARS-CoV-2 and dengue virus coinfection.
    J Med Virol. 2020 Sep 3. doi: 10.1002/jmv.26476.
    >> Share

  766. CAPETTI AF, Borgonovo F, Morena V, Lupo A, et al
    Short-term inhibition of SARS-CoV-2 by hydrogen peroxide in persistent nasopharyngeal carriers.
    J Med Virol. 2020 Sep 3. doi: 10.1002/jmv.26485.
    >> Share

  767. CLIFT AK
    Deriving 'definitive' results in observational COVID-19 research: a problematic endeavour.
    J Med Virol. 2020 Sep 3. doi: 10.1002/jmv.26481.
    >> Share

  768. KHAN AW, Ullah I, Khan KS
    Ischemic stroke leading to bilateral vision loss in COVID-19 patient- A rare case report.
    J Med Virol. 2020 Sep 3. doi: 10.1002/jmv.26484.
    >> Share

  769. SARKAR S, Khanna P, Soni KD
    Are the steroids a blanket solution for COVID-19? a systematic review and meta-analysis.
    J Med Virol. 2020 Sep 3. doi: 10.1002/jmv.26483.
    >> Share

  770. SEYRAN M, Pizzol D, Adadi P, El-Aziz TMA, et al
    Questions concerning the proximal origin of SARS-CoV-2.
    J Med Virol. 2020 Sep 3. doi: 10.1002/jmv.26478.
    >> Share

  771. ANASTASIOU OE, Theodoropoulos F, Taube C, Fiedler M, et al
    Common respiratory viral infections: Bilateral vs unilateral bronchoalveolar lavage vs endotracheal aspiration.
    J Med Virol. 2020 Sep 3. doi: 10.1002/jmv.26477.
    >> Share

  772. HENRY BM, Benoit J, Berger B, Pulvino C, et al
    Coronavirus Disease 2019 (COVID-19) is Associated with Low Circulating Plasma Levels of Angiotensin 1 and Angiotensin 1,7.
    J Med Virol. 2020 Sep 3. doi: 10.1002/jmv.26479.
    >> Share

  773. GARG J, Singh V, Pandey P, Verma A, et al
    Evaluation of sample pooling for diagnosis of COVID-19 by Real time PCR- A resource saving combat strategy.
    J Med Virol. 2020 Sep 1. doi: 10.1002/jmv.26475.
    >> Share

  774. LEUNG C
    Comment on Li et al: COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis.
    J Med Virol. 2020;92:1431-1432.
    >> Share

  775. BRUFSKY A
    Distinct viral clades of SARS-CoV-2: Implications for modeling of viral spread.
    J Med Virol. 2020;92:1386-1390.
    >> Share

  776. SYAL K
    COVID-19: Herd immunity and convalescent plasma transfer therapy.
    J Med Virol. 2020;92:1380-1382.
    >> Share

  777. CHENG H, Wang Y, Wang GQ
    Reply to: "Reporting of all cardiac medications and their outcome in COVID-19".
    J Med Virol. 2020;92:1421-1422.
    >> Share

  778. CARLETTI F, Lalle E, Messina F, Ippolito G, et al
    About the origin of the first two Sars-CoV-2 infections in Italy: Inference not supported by appropriate sequence analysis.
    J Med Virol. 2020;92:1404-1405.
    >> Share

  779. ZHANG C, Huang S, Zheng F, Dai Y, et al
    Controversial treatments: An updated understanding of the coronavirus disease 2019.
    J Med Virol. 2020;92:1441-1448.
    >> Share

  780. KANDEEL M, Al-Taher A, Park BK, Kwon HJ, et al
    A pilot study of the antiviral activity of anionic and cationic polyamidoamine dendrimers against the Middle East respiratory syndrome coronavirus.
    J Med Virol. 2020;92:1665-1670.
    >> Share

  781. HUSSAIN M, Jabeen N, Raza F, Shabbir S, et al
    Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein.
    J Med Virol. 2020;92:1580-1586.
    >> Share

  782. MO C, Tan D, Mai T, Bei C, et al
    An analysis of spatiotemporal pattern for COIVD-19 in China based on space-time cube.
    J Med Virol. 2020;92:1587-1595.
    >> Share

  783. HAN YN, Feng ZW, Sun LN, Ren XX, et al
    A comparative-descriptive analysis of clinical characteristics in 2019-coronavirus-infected children and adults.
    J Med Virol. 2020;92:1596-1602.
    >> Share

    August 2020
  784. OZGER HS, Dizbay M, Corbacioglu SK, Aysert P, et al
    The prognostic role of neopterin in COVID-19 patients.
    J Med Virol. 2020 Aug 29. doi: 10.1002/jmv.26472.
    >> Share

  785. OKOH AK, Bishburg E, Grinberg S, Nagarakanti S, et al
    Tocilizumab use in COVID -19 associated pneumonia.
    J Med Virol. 2020 Aug 29. doi: 10.1002/jmv.26471.
    >> Share

  786. ERDEN A, Ozdemir B, Karakas O, Mutlu NM, et al
    Evaluation of seventeen patients with COVID-19 pneumonia treated with anakinra according to HScore, SOFA, MuLBSTA and Brescia-COVID respiratory severity scale (BCRSS) scoring systems.
    J Med Virol. 2020 Aug 29. doi: 10.1002/jmv.26473.
    >> Share

  787. ZHANG J, Ding D, Huang X, Zhang J, et al
    Differentiation of COVID-19 from seasonal influenza: a multicenter comparative study.
    J Med Virol. 2020 Aug 28. doi: 10.1002/jmv.26469.
    >> Share

  788. SAGNELLI C, Celia B, Monari C, Cirillo S, et al
    Management of SARS-CoV-2 Pneumonia.
    J Med Virol. 2020 Aug 28. doi: 10.1002/jmv.26470.
    >> Share

  789. CHRISTOU MS, Mohamed MS, Tsigarides J
    Tocilizumab - A beacon of hope in the management of severe COVID-19?
    J Med Virol. 2020 Aug 28. doi: 10.1002/jmv.26466.
    >> Share

  790. GARG P, Arora U, Kumar A, Wig N, et al
    The "Post-COVID" Syndrome: How Deep is the Damage?
    J Med Virol. 2020 Aug 27. doi: 10.1002/jmv.26465.
    >> Share

  791. BUTT MH, Ahmad A, Misbah S, Mallhi TH, et al
    Dengue Fever and COVID-19 Co-Infection; A Threat to Public Health for Co-epidemic in Pakistan.
    J Med Virol. 2020 Aug 27. doi: 10.1002/jmv.26464.
    >> Share

  792. AMIN D, McKitish K, Shah PS
    Association of Mortality and Recent M. Pneumoniae Infection in COVID-19 Patients.
    J Med Virol. 2020 Aug 27. doi: 10.1002/jmv.26467.
    >> Share

  793. SERGI CM, Chiu B
    Targeting NLRP3 Inflammasome in an Animal Model for SARS-CoV-2.
    J Med Virol. 2020 Aug 25. doi: 10.1002/jmv.26461.
    >> Share

  794. PASOMSUB E, Watcharananan SP, Watthanachockchai T, Rakmanee K, et al
    Saliva sample pooling for the detection of SARS-CoV-2.
    J Med Virol. 2020 Aug 25. doi: 10.1002/jmv.26460.
    >> Share

  795. REDDY RK, Charles WN, Sklavounos A, Seed PT, et al
    Impact of smoking on COVID-19 severity.
    J Med Virol. 2020 Aug 25. doi: 10.1002/jmv.26456.
    >> Share

  796. MASSAROTTI C, Adriano M, Cagnacci A, Gorlero F, et al
    Asymptomatic SARS-CoV-2 infections in pregnant patients in an Italian city during complete lockdown.
    J Med Virol. 2020 Aug 25. doi: 10.1002/jmv.26458.
    >> Share

  797. MITTAL S, Madan K, Mohan A, Tiwari P, et al
    Diabetes in COVID-19: Steroid effect.
    J Med Virol. 2020 Aug 25. doi: 10.1002/jmv.26457.
    >> Share

  798. TOMASONI D, Bai F, Castoldi R, Barbanotti D, et al
    Anxiety and depression symptoms after virological clearance of COVID-19: a cross-sectional study in Milan, Italy.
    J Med Virol. 2020 Aug 25. doi: 10.1002/jmv.26459.
    >> Share

  799. CHEN JM
    Live unattenuated vaccines for controlling viral diseases including COVID-19.
    J Med Virol. 2020 Aug 24. doi: 10.1002/jmv.26453.
    >> Share

  800. DE SOUSA FACG, Paradella TC
    Considerations on oral manifestations of COVID-19.
    J Med Virol. 2020 Aug 22. doi: 10.1002/jmv.26451.
    >> Share

  801. ISLAM MZ, E-Zahan MK, Al-Bari MAA
    Convergence between global BCG vaccination and COVID-19 pandemic.
    J Med Virol. 2020 Aug 22. doi: 10.1002/jmv.26450.
    >> Share

  802. MICHELI V, Rimoldi SG, Romeri F, Comandatore F, et al
    Geographical reconstruction of the SARS-CoV-2 outbreak in Lombardy (Italy) during the early phase.
    J Med Virol. 2020 Aug 20. doi: 10.1002/jmv.26447.
    >> Share

  803. KHOURY NC, Russi TJ
    A Case of Gastrointestinal-Predominant COVID-19 Demonstrates Value of Stool PCR Test.
    J Med Virol. 2020 Aug 20. doi: 10.1002/jmv.26448.
    >> Share

  804. TAO Z, Xu J, Chen W, Yang Z, et al
    Anaemia is associated with severe illness in COVID-19: a retrospective cohort study.
    J Med Virol. 2020 Aug 19. doi: 10.1002/jmv.26444.
    >> Share

  805. BOUAYED J, Bohn T
    Behavioural manipulation - key to the successful global spread of the new Coronavirus SARS-Cov-2?
    J Med Virol. 2020 Aug 19. doi: 10.1002/jmv.26446.
    >> Share

  806. JIANG Y, Chen D, Cai D, Yi Y, et al
    Effectiveness of remdesivir for the treatment of hospitalized Covid-19 persons: a network meta-analysis.
    J Med Virol. 2020 Aug 19. doi: 10.1002/jmv.26443.
    >> Share

  807. XU R, Huang J, Duan C, Liao Q, et al
    Low prevalence of antibodies against SARS-CoV-2 among voluntary blood donors in Guangzhou, China.
    J Med Virol. 2020 Aug 19. doi: 10.1002/jmv.26445.
    >> Share

  808. ELSAWAH HK, Elsokary MA, Elrazzaz MG, ElShafey AH, et al
    Hydroxychloroquine for treatment of non-severe COVID-19 patients; systematic review and meta-analysis of controlled clinical trials.
    J Med Virol. 2020 Aug 18. doi: 10.1002/jmv.26442.
    >> Share

  809. GONCALVES MENDES NETO A, Lo KB, Wattoo A, Salacup G, et al
    Bacterial Infections and Patterns of Antibiotic Use in Patients with COVID-19.
    J Med Virol. 2020 Aug 18. doi: 10.1002/jmv.26441.
    >> Share

  810. JOVANI V, Pascual E, Vela P, Andres M, et al
    Acute arthritis following SARS-CoV-2 infection.
    J Med Virol. 2020 Aug 18. doi: 10.1002/jmv.26440.
    >> Share

  811. XUE M, Zhang T, Hu H, Huang Z, et al
    Predictive effects of IgA and IgG combination to assess pulmonary exudation progression in COVID-19 patients.
    J Med Virol. 2020 Aug 17. doi: 10.1002/jmv.26437.
    >> Share

  812. SOLEIMANI R, Khourssaji M, Gruson D, Rodriguez-Villalobos H, et al
    Clinical usefulness of fully automated chemiluminescent immunoassay for quantitative antibody measurements in COVID-19 patients.
    J Med Virol. 2020 Aug 14. doi: 10.1002/jmv.26430.
    >> Share

  813. D'ALESSANDRO M, Cameli P, Bergantini L, Franchi F, et al
    Serum concentrations of Krebs von den Lungen-6 in different COVID-19 phenotypes.
    J Med Virol. 2020 Aug 14. doi: 10.1002/jmv.26431.
    >> Share

  814. ALONSO FOM, Sabino BD, Guimaraes MAAM, Varella RB, et al
    Recurrence of SARS-CoV-2 infection with a more severe case after mild COVID-19, reversion of RT-qPCR for positive and late antibody response: case report.
    J Med Virol. 2020 Aug 14. doi: 10.1002/jmv.26432.
    >> Share

  815. BASIRJAFARI S, Rafiee M, Shahhosseini B, Mohammadi M, et al
    Association of Pediatric COVID-19 and Subarachnoid Hemorrhage.
    J Med Virol. 2020 Aug 14. doi: 10.1002/jmv.26434.
    >> Share

  816. CHOE SA, An HS, Choe YJ
    No Temporal Association between Human Coronavirus and Kawasaki Disease: National Data from South Korea.
    J Med Virol. 2020 Aug 14. doi: 10.1002/jmv.26435.
    >> Share

  817. BARTILOTTI-MATOS F, Davies P
    Pearls and Pitfalls: two contrasting HIV diagnoses in the COVID-19 era and the case for screening.
    J Med Virol. 2020 Aug 13. doi: 10.1002/jmv.26428.
    >> Share

  818. SAM IC, Chong YM, Tan CW, Chan YF, et al
    Low post-pandemic wave SARS-CoV-2 seroprevalence in Kuala Lumpur and Selangor, Malaysia.
    J Med Virol. 2020 Aug 13. doi: 10.1002/jmv.26426.
    >> Share

  819. TAKAGI H
    Risk and protective factors of SARS-CoV-2 infection.
    J Med Virol. 2020 Aug 13. doi: 10.1002/jmv.26427.
    >> Share

  820. INFANTINO M, Manfredi M, Grossi V, Lari B, et al
    Closing the Serological Gap in the Diagnostic Testing for COVID-19: The Value of Anti-SARS-CoV-2 IgA Antibodies.
    J Med Virol. 2020 Aug 13. doi: 10.1002/jmv.26422.
    >> Share

  821. LI J, Huang DQ, Zou B, Yang H, et al
    Epidemiology of COVID-19: A Systematic Review and Meta-analysis of Clinical Characteristics, Risk factors and Outcomes.
    J Med Virol. 2020 Aug 13. doi: 10.1002/jmv.26424.
    >> Share

  822. FIORE JR, Centra M, De Carlo A, Granato T, et al
    Results from a survey in healthy blood donors in South Eastern Italy indicate that we are far away from herd immunity to SARS-CoV-2.
    J Med Virol. 2020 Aug 13. doi: 10.1002/jmv.26425.
    >> Share

  823. PETTIT NN, Nguyen CT, Mutlu GM, Wu D, et al
    Late Onset Infectious Complications and Safety of Tocilizumab in the Management of COVID-19.
    J Med Virol. 2020 Aug 13. doi: 10.1002/jmv.26429.
    >> Share

  824. BURGOS-BLASCO B, Guemes-Villahoz N, Vidal-Villegas B, Donate-Lopez J, et al
    Evaluation of retinotoxicity of COVID-19 treatment: hydroxychloroquine and lopinavir/ritonavir.
    J Med Virol. 2020 Aug 12. doi: 10.1002/jmv.26420.
    >> Share

  825. BANERJEE S, Seal S, Dey R, Mondal KK, et al
    Mutational spectra of SARS-CoV-2 orf1ab polyprotein and signature mutations in the United States of America.
    J Med Virol. 2020 Aug 11. doi: 10.1002/jmv.26417.
    >> Share

  826. SHU L, Wang X, Li M, Chen X, et al
    Clinical Characteristics of Moderate COVID-19 Patients Aggravation in Wuhan Stadium Cabin Hospital: A 571 Cases of Retrospective Cohort Study.
    J Med Virol. 2020 Aug 11. doi: 10.1002/jmv.26414.
    >> Share

  827. PATEL RH, Acharya A, Mohan M, Byrareddy SN, et al
    COVID-19 and AIDS: outcomes from the co-existence of two global pandemics and the importance of chronic antiretroviral therapy.
    J Med Virol. 2020 Aug 11. doi: 10.1002/jmv.26416.
    >> Share

  828. ONCUL H, Oncul FY, Alakus MF, Caglayan M, et al
    Ocular findings in patients with coronavirus disease 2019 (COVID-19) in an outbreak hospital.
    J Med Virol. 2020 Aug 10. doi: 10.1002/jmv.26412.
    >> Share

  829. YIGENOGLU TN, Ata N, Altuntas F, Basci S, et al
    The Outcome of COVID-19 in Patients with Hematological Malignancy.
    J Med Virol. 2020 Aug 10. doi: 10.1002/jmv.26404.
    >> Share

  830. SARKAR S, Soni KD, Khanna P
    Convalescent plasma a clutch at straws in COVID-19 management! A systematic review and meta-analysis.
    J Med Virol. 2020 Aug 10. doi: 10.1002/jmv.26408.
    >> Share

  831. LU W, Liu X, Wang T, Liu F, et al
    Elevated MUC1 and MUC5AC mucin protein levels in airway mucus of critical ill COVID-19 Patients.
    J Med Virol. 2020 Aug 10. doi: 10.1002/jmv.26406.
    >> Share

  832. KHINDA J, Janjua NZ, Cheng S, van den Heuvel ER, et al
    Association between markers of immune response at hospital admission and COVID-19 disease severity and mortality: A meta-analysis and meta-regression.
    J Med Virol. 2020 Aug 10. doi: 10.1002/jmv.26411.
    >> Share

  833. MIYAZAWA D, Kaneko G
    Clinical trials of inhaled beclomethasone and mometasone for COVID-19 should be conducted.
    J Med Virol. 2020 Aug 10. doi: 10.1002/jmv.26413.
    >> Share

  834. SAHU KK, Borogovac A, Cerny J
    COVID-19 related immune hemolysis and thrombocytopenia.
    J Med Virol. 2020 Aug 10. doi: 10.1002/jmv.26402.
    >> Share

  835. GIACOMELLI A, Pagani G, Ridolfo AL, Bit LO, et al
    Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: a retrospective cohort study.
    J Med Virol. 2020 Aug 10. doi: 10.1002/jmv.26407.
    >> Share

  836. BATUR LK, Hekim N
    The role of DBP gene polymorphisms in the prevalence of new coronavirus disease 2019 infection and mortality rate.
    J Med Virol. 2020 Aug 8. doi: 10.1002/jmv.26409.
    >> Share

  837. HARTNACK S, Eusebi P, Kostoulas P
    Bayesian latent class models to estimate diagnostic test accuracies of COVID-19 tests.
    J Med Virol. 2020 Aug 8. doi: 10.1002/jmv.26405.
    >> Share

  838. ALPAYDIN AO, Gezer NS, Simsek GO, Tertemiz KC, et al
    Clinical and Radiological Diagnosis of Non-SARS-CoV-2 Viruses in the Era of Covid-19 Pandemic.
    J Med Virol. 2020 Aug 8. doi: 10.1002/jmv.26410.
    >> Share

  839. MALTEZOU HC, Vorou R, Papadima K, Kossyvakis A, et al
    Transmission dynamics of SARS-CoV-2 within families with children in Greece: a study of 23 clusters.
    J Med Virol. 2020 Aug 7. doi: 10.1002/jmv.26394.
    >> Share

  840. KO M, Jeon S, Ryu WS, Kim S, et al
    Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells.
    J Med Virol. 2020 Aug 7. doi: 10.1002/jmv.26397.
    >> Share

  841. HASHEMI SA, Safamanesh S, Zadeh-Moghaddam HG, Ghafouri M, et al
    Report of death in children with SARS-CoV-2 and Human metapneumovirus (hMPV) co-infection: is hMPV the trigger?
    J Med Virol. 2020 Aug 7. doi: 10.1002/jmv.26401.
    >> Share

  842. FINSTERER J, Scorza FA
    SARS-CoV-2 myopathy.
    J Med Virol. 2020 Aug 6. doi: 10.1002/jmv.26399.
    >> Share

  843. VALDIVIA A, Torres I, Huntley D, Alcaraz MJ, et al
    Caveats in interpreting SARS-CoV-2 IgM positive/IgG negative antibody profile in asymptomatic health care workers.
    J Med Virol. 2020 Aug 6. doi: 10.1002/jmv.26400.
    >> Share

  844. RAMIREZ JD, Florez C, Munoz M, Hernandez C, et al
    The arrival and spread of SARS-CoV2 in Colombia.
    J Med Virol. 2020 Aug 6. doi: 10.1002/jmv.26393.
    >> Share

  845. FAQIHI F, Alharthy A, Memish ZA, Karakitsos D, et al
    Comment on Hu et al: The cytokine storm and COVID-19.
    J Med Virol. 2020 Aug 6. doi: 10.1002/jmv.26396.
    >> Share

  846. CUI X, Zhao Z, Zhang T, Guo W, et al
    A systematic review and meta-analysis of children with Coronavirus Disease 2019 (COVID-19).
    J Med Virol. 2020 Aug 6. doi: 10.1002/jmv.26398.
    >> Share

  847. BUTT MH, Ahmad A, Misbah S, Mallhi TH, et al
    Crimean-Congo Haemorrhagic Fever and Eid-Ul-Adha; A potential threat during the COVID-19 Pandemic.
    J Med Virol. 2020 Aug 4. doi: 10.1002/jmv.26388.
    >> Share

  848. HSU AL, Guan M, Johannesen E, Stephens AJ, et al
    Placental SARS-CoV-2 in a Pregnant Woman with Mild COVID-19 Disease.
    J Med Virol. 2020 Aug 4. doi: 10.1002/jmv.26386.
    >> Share

  849. CHEN J, Pan Y, Li G, Xu W, et al
    Distinguishing between COVID-19 and influenza during the early stages by measurement of peripheral blood parameters.
    J Med Virol. 2020 Aug 4. doi: 10.1002/jmv.26384.
    >> Share

  850. CAMPANA P, Flocco V, Aruta F, Cacciatore F, et al
    Can Aldosterone increase Interleukin-6 levels in Covid-19 Pneumonia?
    J Med Virol. 2020 Aug 4. doi: 10.1002/jmv.26382.
    >> Share

  851. REDDY RK, Charles WN, Sklavounos A, Dutt A, et al
    The effect of smoking on COVID-19 severity: a systematic review and meta-analysis.
    J Med Virol. 2020 Aug 4. doi: 10.1002/jmv.26389.
    >> Share

  852. COLLINS GS, Wilkinson J
    Statistical issues in the development a COVID-19 prediction models.
    J Med Virol. 2020 Aug 4. doi: 10.1002/jmv.26390.
    >> Share

  853. PATRA R, Chandra Das N, Mukherjee S
    Targeting human TLRs to combat COVID-19: A solution?
    J Med Virol. 2020 Aug 4. doi: 10.1002/jmv.26387.
    >> Share

  854. MATTIUZZI C, Lippi G
    Serum prealbumin values predict the severity of coronavirus disease 2019 (COVID-19).
    J Med Virol. 2020 Aug 4. doi: 10.1002/jmv.26385.
    >> Share

  855. GOES LGB, Zerbinati RM, Tateno AF, de Souza AV, et al
    Typical epidemiology of respiratory virus infections in a Brazilian slum.
    J Med Virol. 2020;92:1316-1321.
    >> Share

    July 2020
  856. ZHAO T, Xuan K, Uy JP, Sun C, et al
    In the shadow of COVID-19: HIV-infected individuals need more attention.
    J Med Virol. 2020 Jul 31. doi: 10.1002/jmv.26378.
    >> Share

  857. SHANG Y, Liu T, Li J, Wang X, et al
    Factors affecting antibody response to SARS-CoV-2 in patients with severe COVID-19.
    J Med Virol. 2020 Jul 31. doi: 10.1002/jmv.26379.
    >> Share

  858. TATIANA S
    Could an acute respiratory distress syndrome (ARDS) in COVID-19 infected patients be calmed down simply by iron withdrawal from lung tissues?
    J Med Virol. 2020 Jul 30. doi: 10.1002/jmv.26372.
    >> Share

  859. BANSAL N, Bansal Y, Ralta A
    Thrombocytopenia in COVID-19 patients in Himachal Pradesh (India) and the absence of dengue false positive tests: Insights for patient management.
    J Med Virol. 2020 Jul 30. doi: 10.1002/jmv.26373.
    >> Share

  860. HALPIN SJ, McIvor C, Whyatt G, Adams A, et al
    Post-discharge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation.
    J Med Virol. 2020 Jul 30. doi: 10.1002/jmv.26368.